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MECHANISM OF TRANSLATIONAL CONTROL  
BY THE FRAGILE X MENTAL RETARDATION PROTEIN  
AND CREATION OF THE FMRP CTAG MOUSE 
 
 
The Rockefeller University 2013 
 
 
The Fragile X Mental Retardation Protein (FMRP) is a neuronal RNA-binding protein 
that is predominantly associated with polyribosomes.  Loss of FMRP results in Fragile X 
Syndrome, characterized by mental retardation, autism and epilepsy.  FMRP was recently 
found to be associated with a specific set of mRNAs with key roles in neuronal function 
and to physically interact with targeted mRNAs along their entire coding sequences 
(Darnell 2011).  Here, we find that FMRP inhibits translation on these target transcripts 
by stalling ribosomes, both in vivo and in rabbit reticulocyte lysate programmed with 
endogenous brain polyribosomes.  In these systems, loss of FMRP function resulted in 
increased ribosome runoff after treatment with puromycin, a drug that acts specifically on 
translocating ribosomes.  In addition to genetic loss-of-function models, FMRP-
dependent relief of ribosome stalling could be induced by acute biochemical removal of 
FMRP from polysomes, indicating reversibility of stalling.  FMRP was also directly 
visualized on stalled polysomes by immunoelectron microscopy.  Together, these results 
suggest a model in which FMRP actively regulates translation of target mRNAs by 
stalling ribosomes.  To further advance our understanding of FMRP function, we have 
created the FMRP cTAG mouse, a knock-in model in which FMRP can be conditionally 
tagged with AcGFP in a Cre-dependent manner while maintaining wt FMRP expression 
in all Cre-negative cells.  The cTAG mouse will be a valuable tool in the study of cell 
type-specific FMRP function.  
 
Sarah Van Driesche, Ph.D.
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Chapter I. General Introduction 
 
Fragile X Syndrome and FMRP 
Fragile X Syndrome (FXS) is the most common form of inherited mental retardation and 
the leading known single-gene cause of autism, occurring in 1:4500 males and 1:9000 
females (O'Donnell and Warren, 2002), (Hagerman et al., 2010).  Fragile X syndrome is 
characterized by mild to severe intellectual disability, sensory hypersensitivity, seizures, 
and autistic features such as poor eye contact and social anxiety, as well as by a mild 
craniofacial phenotype and macroorchidism.  FXS is caused by expansion of a tandem 
CGG repeat region in the 5’UTR of the Fmr1 gene, resulting in methylation and silencing 
of the locus (O'Donnell and Warren, 2002).  Normal individuals have fewer than 50 of 
these CGG repeats, while those with FXS have 200 or more.   
 
The protein that is absent in Fragile X syndrome, FMRP (fragile X mental retardation 
protein), is predominantly expressed in neurons and testes and is primarily associated 
with polyribosomes.  FMRP was first characterized as a polysome-associated protein in 
non-neuronal cell lines (Eberhart et al., 1996), (Khandjian et al., 1996), (Feng et al., 
1997a), (Corbin et al., 1997), (Ceman et al., 2003).  FMRP was shown to comigrate with 
polyribosomes on sucrose gradients, and to shift to light fractions when polysomes were 
disrupted by RNAse or EDTA.  FMRP could also be removed from polysomes by 
treatment with 0.5M KCl, a condition that leaves the majority of ribosomes still 
associated with mRNA (Corbin et al., 1997).  Establishment of FMRP as a polysome-
binding protein in brain initially met with some resistance due to technical issues with 
fractionating polysomes from neuronal tissue and an early report that FMRP was not 
associated with brain polysomes (Zalfa et al., 2003).  However, improved methods of 
polysome preparation from brain later clearly showed that the majority of neuronal 
FMRP is polysome-associated, and that this association is sensitive to EDTA, RNAse and 
sodium deoxycholate as in earlier cell studies (Stefani et al., 2004), (Khandjian et al., 
2004).  Our lab routinely prepares polysomes from mouse brain with 90% of cellular 
FMRP on heavy polysomes. 
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RNA binding properties of FMRP 
FMRP has three well-characterized RNA-binding domains: two hnRNP K homology 
(KH) domains and an RGG box (Siomi et al., 1993b).  KH domains were first discovered 
in the hnRNP K proteins (Siomi et al., 1993a) and are present in many other RNA 
binding proteins (RBPs) such as the Nova proteins, which contain three KH domains that 
mediate RNA splicing (Teplova et al., 2011), (Licatalosi et al., 2008).  The importance of 
the KH domains to FMRP function was first indicated by a severe case of FXS associated 
with an I304N point mutation in the KH2 domain of FMRP (De Boulle et al., 1993).  
Cocrystallization of the Nova KH3 domain with a bound stem-loop YCAY RNA 
predicted that the Fmr1 I304 residue should lie directly within the RNA-binding pocket 
of the FMRP KH2 domain (Lewis et al., 2000).  In vitro RNA selection studies found that 
the FMRP KH2 domain bound to a kissing complex RNA motif (kcRNA) (Darnell et al., 
2005a) and the RGG box bound to a G-quadruplex motif (Darnell et al., 2001), (Phan et 
al., 2011) though the in vivo significance of these interactions is not yet understood.  
Biochemical evidence also suggested that FMRP interactions with polysomal RNA were 
primarily mediated through the KH domains, since RGG box deletion mutants 
maintained normal polysome association in neuroblastoma cells, while I304N FMRP did 
not (Darnell et al., 2005b).  In addition, kcRNA disrupted FMRP association with 
polyribosomes in brain extracts, while G quartet RNA did not (Darnell et al., 2005a).  
Finally, creation of the I304N knock-in mouse confirmed that endogenously expressed 
I304N FMRP was not associated with polysomes in brain (Zang et al., 2009).  Critically, 
the I304N mutant mouse also exhibited several phenotypes associated with FMRP loss-
of-function, linking loss of polysome association to FXS pathology.  Collectively, these 
results underscore the centrality of polysome association to FMRP function.   
 
FMRP has two paralogs in mammals and fish, FXR1P and FXR2P, collectively termed 
the FXRPs.  FXR1P and FXR2P are also polysome-associated and contain KH1 and KH2 
domains, although the FMRP KH2 domain contains an extended variable loop not 
present in the FXR1P or FXR2P domains (Price et al., 1996), (Blonden et al., 2005).  
Interestingly, this expansion loop is only found in mammals, suggesting that mammalian 
FMRP may have unique properties.  In addition, the region containing the RGG box is 
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significantly diverged among the three family members and only FMRP recognizes G 
quartet RNA with high affinity (Darnell et al., 2009).  The KH domains are also 
conserved in the single ancestral FXR that exists in Drosophila, dFMR (Wan et al., 
2000).  dFMR binds kcRNA with the same affinity as mammalian FXRPs, but does not 
bind G quartet RNA (Darnell et al., 2009).  Overall, the data suggest that the most ancient 
function of FMRP involves its KH domains (and therefore presumably is related to 
polysome association), and the currently enigmatic function of the RGG box evolved 
more recently.   
 
Synaptic plasticity and translational control in neurons 
The overall organizational principle governing brain function is one of nested sub-
modules, such that incoming information is successively broken down into discrete bits 
that can be processed by local circuitry, and output from these local circuits is then 
successively reintegrated at higher and higher levels until a response is achieved that 
unifies output from disparate brain regions.  Individual neurons integrate signals from 
several to hundreds of thousands of synapses, responding by an all-or-none decision to 
fire or not to fire.  Thus, synaptic signaling underpins complex multilayer neuronal 
circuitry.   
 
Synapses are not static “input-output” devices: the properties of both signaling and 
reception can be modulated at many stages, with effects on plasticity that last from 
milliseconds to years.  One of many examples of short-term plasticity is paired pulse 
facilitation, in which the postsynaptic potential produced by a stimulus is increased if a 
previous stimulus has just occurred.  This is due to residual presynaptic calcium from the 
first stimulus augmenting vesicle release during the second stimulus.  This type of 
plasticity adds a layer of richness to signaling dynamics, but does not persist beyond a 
few seconds.  In order for learning and memory to occur, the brain must possess 
mechanisms by which certain stimuli can result in long-term changes to synaptic 
efficacy.  The first such example of long-term synaptic plasticity was discovered by Bliss 
and Lomo in 1973.  They found that a short, high frequency stimulation of perforant path 
inputs onto granule neurons in the dentate gyrus resulted in increased synaptic strength 
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and an increased likelihood that the granule neurons would fire in response to a stimulus 
of a given strength (Bliss and Lomo, 1973).  These phenomena, which were termed long-
term potentiation (LTP), lasted several hours, suggesting that these long-term changes in 
synaptic strength had properties consistent with the support of learning and memory.  
This conjecture has been substantiated over the years, with studies linking long-term 
changes in synaptic strength evoked by experimental manipulation to outcomes in 
learning tasks (reviewed in (Ito, 1986), (Lynch, 2004), (Collingridge et al., 2010). 
 
Neurons also have special requirements for control of protein synthesis, due both to their 
complex morphology and to the need for rapid and dynamic control of events at the 
synapse (Cajigas et al., 2010).  Forty years ago, studies that originally suggested the 
importance of protein synthesis to learning and memory showed that injection of the 
protein synthesis inhibitor puromycin into mouse brain 1-3 days after learning an 
avoidance task blocked the ability of the animal to later remember its training 
(FLEXNER et al., 1963), while increased radiolabeling of brain proteins was observed in 
goldfish recently trained in a learning task (compared to untrained fish), indicating that de 
novo protein synthesis was increased after learning (Shashoua, 1976).  These avenues of 
research converged with those concerning long-term plasticity several years later, when it 
was discovered that increased radiolabeling of proteins occurred in the CA1 region of 
hippocampal slices after induction of LTP at CA1 synapses (Duffy et al., 1981) and that 
blockade of protein synthesis inhibited LTP at these synapses (Stanton and Sarvey, 
1984).  Together, these studies demonstrated a requirement for protein synthesis during 
synaptic plasticity.  This link was later substantiated by genetic studies in which 
manipulations that either increased or decreased translation resulted in alterations in the 
translation-dependent late phase of LTP and defects in learning and memory tasks 
(Kelleher et al., 2004), (Banko et al., 2005).  Finally, protein synthesis has been shown to 
be necessary for the expression of other forms of synaptic plasticity, in particular long-
term depression (LTD), a form especially relevant to the FMRP literature (Linden, 1996), 
(Huber et al., 2000), (Bear et al., 2004), (Collingridge et al., 2010). 
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Neurons employ diverse mechanisms of translational control.  For example, translation 
can trigger regulated mRNA turnover in transcripts that contain an intron within their 
3’UTR.  During splicing, exon junction complexes (EJCs) are deposited upstream of 
exon-exon boundaries and are displaced during the pioneer round of translation.  These 
EJCs serve a surveillance function, recruiting mRNA degradation factors to transcripts 
that retain EJCs due to nonsense mutations that prematurely terminate translation (Chang 
et al., 2007).  However, EJCs deposited within 3’UTRs are not displaced during 
translation and remain to recruit components of the nonsense-mediated mRNA decay 
(NMD) pathway.  The time lag between when translation begins and when the message is 
degraded allows a brief burst of translation to occur.  Knockdown of a core EJC 
component, eIF4AIII, resulted in increased translation of the dendritically localized 
mRNA Arc as well as defects in synaptic plasticity, suggesting that the EJC-NMD 
mechanism is important for the control of protein synthesis at synapses (Giorgi et al., 
2007).  Synaptic plasticity can also be regulated by miRNA-mediated translational 
control.  For example, binding of Limk1 mRNA by the brain-specific miRNA miR-134 
decreased Limk1 synthesis and was associated with changes in dendritic spine volume, 
although it should not be concluded that Limk1 is the sole executor of miR-134 function 
with relation to spine dynamics (Schratt et al., 2006).  In a third example, short open 
reading frames upstream of the main start codon (uORFs) can regulate translation of 
certain proteins.  These mechanisms depend on the fact that ribosomes that finish 
translating a uORF can resume scanning and reinitiate on downstream open reading 
frames if they reacquire the requisite initiation factors in time.  Formation of the required 
initiation factor complex, consisting of the initiation factor eIF2a, GTP and initiator 
methionine tRNA, is prevented by phosphorylation of eIF2a.  Thus, when eIF2a 
phosphorylation levels are high, the eIF2a initiation complex is in short supply and 
scanning ribosomes travel further before they acquire it.  Depending on the relative 
spacing of uORFs and the main open reading frame, scanning ribosomes may reinitiate 
either at a second, downstream uORF or at the main open reading frame, with profound 
consequences for expression of the encoded protein.  In the case of ATF4, a transcription 
factor linked to synaptic plasticity and memory (Chen et al., 2003a), increased levels of 
eIF2a phosphorylation facilitate translation of the main open reading frame (Vattem and 
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Wek, 2004).  Specific deletion of the eIF2a kinase PERK in mouse forebrain resulted in 
decreased ATF4 expression without detectable changes in global translation, and also 
resulted in impaired cognitive function (Trinh et al., 2012).  While it was not shown 
whether restored ATF4 expression could rescue observed defects in cognitive function, a 
reduction in ATF4 expression was noted in schizophrenic patients, suggesting that 
regulation of ATF4 translation plays a role in neuronal function and cognition.  Finally, 
local translation at synapses is important for the expression of various forms of synaptic 
plasticity.  In an early example, BDNF-induced LTP was shown to require protein 
synthesis and yet be inducible in hippocampal slices in which both the presynaptic and 
postsynaptic neurites were severed from their cell bodies (Kang and Schuman, 1996).  In 
another example, genetic restriction of CaMKIIa expression to neuronal soma by 
mutation of the dendritic targeting signal in the CaMKIIa 3’UTR caused a reduction in 
hippocampal late phase LTP and impairments in learning and memory (Miller et al., 
2002).  CaMKIIa is a major constituent of the postsynaptic compartment and these results 
suggest that transport of this protein from the soma is insufficient to support normal 
synaptic function. 
 
Historic efforts to identify FMRP-associated mRNAs  
As it became clear that polysome association was essential to FMRP function, 
identification of the mRNAs associated with FMRP became a major priority, although 
originally it was unknown whether FMRP was a general translation factor or regulated a 
specific subset of mRNAs.  In an early approach, FMRP immunoprecipitation (IP) from 
wt and Fmr1 KO mouse brains under stringent conditions was followed by microarray 
analysis of coIPed RNAs (RIP-CHIP), resulting in identification of more than 400 
mRNAs enriched at least four-fold in the wt IP (Brown et al., 2001).  A second approach 
at target identification used RNA SELEX, a method in which an RNA pool is passed over 
an immobilized protein ligand and the bound fraction is then eluted and passed again over 
the ligand again in repeated cycles.  Each successive cycle enriches for RNAs that bind 
the ligand with greatest affinity.  RNA SELEX has previously been used in our lab to 
show that the neuronal protein Nova binds YCAY motifs on target mRNAs 
(Buckanovich and Darnell, 1997), (Jensen et al., 2000), although the YCAY motif was 
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not sufficiently complex for de novo identification of unknown targets.  A similar 
approach was undertaken to discover binding motifs for FMRP.  A library of RNAs 
containing 52 nt of random sequence was selected against full-length FMRP for eight 
rounds, with all resulting sequences containing a G-quartet motif, which bound FMRP 
with an affinity of 10-30nM Kd in a filter binding assay (Darnell et al., 2001).  Binding 
activity was mapped to the RGG domain of FMRP using truncation constructs.  This 
experiment was later repeated under conditions designed to select for lower affinity 
aptamers specific for the KH domains (in detail, the 52 nt library was selected for six 
rounds over full-length FMRP, followed by eight additional rounds of selection over a 
KH1-KH2 fragment) resulting in identification of a consensus kissing complex motif that 
bound FMRP with an affinity of 30-100nM Kd (Darnell et al., 2005a).  However, 
secondary structure of this motif was too complicated to permit bioinformatic target 
prediction.  To try to circumvent this problem, Chen et al employed SELEX using a full-
length cDNA library from human brain (Chen et al., 2003b).  Selection was limited to 
three rounds in order to preserve complexity; however, this had the unavoidable 
downside of limiting enrichment.  Fifty-seven mRNAs were cloned that corresponded to 
cDNA sequences, many of which contained U-rich elements.  Finally, a third approach 
used antibody-positioned RNA amplification (APRA) to assess target binding by FMRP 
in fixed primary hippocampal neuron culture (Miyashiro et al., 2003).  Anti-FMRP 
antibodies were used to position a degenerate priming oligo next to endogenous FMRP, 
such that nearby exposed, single-stranded RNA could be transcribed in situ.  Purified 
sequences were characterized by microarray, identifying more than 800 mRNAs bound 
by FMRP. 
 
Each of the assays presented above has advantages and limitations.  In vivo protein-RNA 
interactions are determined by a number of factors including binding affinities, 
dissociation constants, exposure or masking of epitopes due to interaction with other 
binding partners, and physical compartmentalization within the cell. When cells are 
lysed, these factors change due to differences between buffer composition and cytosolic 
composition and physical disruption of the cell, and protein:RNA complexes may 
reassort according to the new equilibrium conditions in vitro.  This was demonstrated by 
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mixing separate cell lysates expressing either the protein HuR or its target mRNA, c-fos, 
and comparing an IP from the combined lysates to an IP from a single lysate expressing 
both HuR protein and c-fos mRNA (Mili and Steitz, 2004).  Nearly equal amounts of c-
fos mRNA associated with HuR protein in both IPs, indicating that the IPs reflected the 
equilibrium binding state of these two factors in vitro, and not their in vivo interactions.  
Thus, assays such as RIP-CHIP that rely on IP in the absence of crosslinking likely 
contain interactions that are not found in vivo.  In particular, the very high affinity RNA 
aptamers identified by the SELEX assay may or may not have in vivo relevance.  The 
APRA approach attempts to circumvent this problem by performing reverse transcription 
in situ without lysing cells.  However, the positioning of the priming oligo relative to the 
protein of interest is not very precise due to the size of the antibody and the flexibility of 
the oligo, and mRNAs in vivo can exist in large multiprotein, multi-mRNA complexes.  
These factors may allow the oligo to prime mRNAs that are not directly bound by the 
protein of interest.  Alternatively, the protein of interest may bind RNA in a physical 
context not accessible to the oligo, for example in a region containing secondary structure 
or other RNA-binding proteins. 
 
HITS-CLIP of polysomal FMRP 
An assay developed in our lab termed CLIP (crosslinking and immunoprecipitation of 
RNA-protein complexes) offers significant improvement over previous methods (Jensen 
and Darnell, 2008).  In CLIP, immediate UV254 crosslinking captures in vivo binding 
interactions in intact cells or tissue.  Crosslinking forms covalent bonds between proteins 
and nucleic acids, but only sparsely and only if the two molecules are within a bond 
length, thus providing tight spatial specificity without generating extensively crosslinked 
macrocomplexes.  Limited RNAse treatment generates ~100nt RNA fragments (termed  
“tags”), some of which are covalently crosslinked to a protein of interest.  Such 
protein:RNA complexes can then be stringently purified, starting with 
immunoprecipitation and stringent washes.  Specificity of the IP is also promoted by 
preclearing of lysate, limiting the time of IP, and using magnetic beads from which 100% 
of supernatant/buffer can be easily removed.   
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While protein:RNA complexes are still bound to antibody-coupled beads, they are treated 
with alkaline phosphatase to remove any 3’ phosphate groups left by RNAse digestion, as 
well as exposed 5’ phosphates.  An RNA linker is then ligated to the 3’ end of the RNA 
tag (the linker has a blocked 3’ end to prevent linker-linker concatamerization during 
ligation, and the tag cannot self-ligate due to earlier removal of 5’ phosphates).   Linker 
ligation is followed by T4 polynucleotide kinase treatment to re-phosphorylate and 
32
P -
label the 5’ end of the tag. 
 
Protein:RNA complexes are then boiled in SDS, separated on a polyacrylamide gel and 
transferred to nitrocellulose.  This step offers significant further purification of desired 
complexes, as contaminating complexes that bound nonspecifically during the IP are 
likely to migrate at different molecular weights on the gel, and any RNA not crosslinked 
to protein will pass through the nitrocellulose during transfer.  Desired complexes can be 
visualized on film as a smear approximately 30kD larger than the protein of interest.  A 
band containing this smear is cut out and treated with proteinase K to free RNA from 
protein.  The RNA is then extracted and precipitated by standard methods. 
 
After resuspension, a 5’ linker is ligated to the RNA tag.  All tags now have linkers of 
known sequence at either end.  The RNA is then DNAse treated to remove any trace 
contaminants prior to reverse transcription and PCR amplification.  PCR amplification is 
titrated so that the minimum number of cycles need to successfully sequence the products 
is used, in order to not to skew tag abundance ratios by over-amplification.  For this same 
reason, the entire cDNA pool is amplified (except 20% reserved for –RT control) so that 
rare transcripts are not missed.  PCR products are then further purified on a denaturing 
acrylamide gel to select for products of ~175nt (length of tag plus linker sequences) and 
analyzed by high-throughput sequencing (HITS).   Sequencing data are bioinformatically 
filtered and mapped to the annotated genome of interest.  A typical experiment may 
return up to a million unique sequences, each ideally representing a discrete site of in vivo 
RNA binding by the protein of interest. 
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Recent HITS-CLIP analysis of polysomal FMRP has identified 842 mRNAs associated 
with FMRP in mouse brain (Darnell et al., 2011).  Satisfyingly, the number of CLIP tags 
per target mRNA was uncorrelated with neuronal mRNA abundance, suggesting that 
FMRP regulates a discrete subset of mRNAs.  Surprisingly, FMRP CLIP tags were 
distributed across the entire exonic sequences of target mRNAs, with higher tag densities 
in coding sequences than in UTRs.  This differed from CLIP data for other RBPs such as 
Nova and Hu, which have discrete binding peaks in particular regions of transcripts (eg, 
introns or 3’UTRs) (Licatalosi et al., 2008), (Darnell et al., 2011) and suggested that 
FMRP may be associated with a processive factor such as a helicase or the ribosome (see 
later chapters for discussion).  The FMRP CLIP targets were characterized 
bioinformatically using the DAVID database (Huang da et al., 2009) and Ingenuity 
software to identify enriched gene ontology (GO) categories and enriched signaling 
pathways, respectively.  GO analysis revealed that the FMRP targets were enriched for 
genes involved in synaptic transmission and small GTPase signaling, while Ingenuity 
analysis identified the most enriched signaling pathways as those involved with neuronal 
CREB, synaptic long term potentiation, Huntington’s disease, glutamate receptors, 
neuropathic pain and axonal guidance.  The CLIP dataset was also overlapped with 
datasets representing the postsynaptic (Croning et al., 2009) and presynaptic (Abul-Husn 
et al., 2009) proteomes and genes linked to autism (Basu et al., 2009).  Substantial 
overlap was found with each, suggesting that FMRP regulates the translation of a specific 
set of genes with roles in synaptic function.  However, the mechanism of translational 
control by FMRP remained a mystery. 
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Chapter II. Experimental Procedures 
 
Preparation of mouse brain extracts 
Mice were sacrificed by brief isoflurane anesthesia and decapitation. The brain was 
removed and placed in ice-cold polysome buffer (20mM HEPES pH 7.3, 150mM NaCl, 
5mM MgCl2).  Cortex, hippocampus and cerebellum were dissected free of underlying 
white matter, homogenized in 1 ml polyribosome lysis buffer (polysome buffer plus 0.5 
mM dithiothreitol, 0.1 mg/ml CHX [Sigma C-7698, made fresh in methanol], 1X 
Complete EDTA-free protease inhibitor cocktail [Roche], 40 U/ml RNAsin [Promega]) 
per brain, with 10 strokes at 900 rpm in a motor-driven Teflon-pestle 5 ml glass 
homogenizer (Wheaton). NP-40 was added to a final concentration of 1% from a 10% 
stock (Calbiochem) and lysate was allowed to sit on wet ice for 10 min. The homogenate 
was spun at 2,000 x g for 10 min at 4°C. The supernatant (S1) was respun at 20,000 x g 
for 10 min at 4°C. The resulting supernatant (S2) was used for Western blot or loaded 
over sucrose gradients. 
 
SDS-PAGE and Western blotting 
Proteins from sucrose gradient fractions or S2 lysates were TCA-precipitated from 50-
200 ul and analyzed by Western blot. Samples were run on handcast 10% or commercial 
4%–12% gradient SDS-polyacrylamide gels (BioRad) and transferred to Immobilin-P 
PVDF membranes (Millipore) by standard methods.  Membranes were blocked for 1hr at 
room temperature in 5% non-fat dry milk (Carnation) in PBS followed by addition of 
primary antibody for 1 hr at room temperature or overnight at 4 degrees. Blots were 
washed 3x10 min with Western blot wash buffer (23mM Tris, pH 8.0, 190mM NaCl, 
0.1% w/v BSA, 1 mM EDTA, 0.5% Triton X-100, 0.02% SDS) after each antibody 
incubation.  HRP-conjugated secondary antibodies (Jackson Immunochemicals) were 
used at 1:10,000 in 5% milk/PBS for 1 hr at RT, washed as before, and HRP signal was 
detected by Enhanced ChemiLuminescence (Western Lightning detection kit, Perkin 
Elmer) and detected on film (Kodak MR). 
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Antibodies 
 
The following antibodies were used for Western blotting:  
 
anti-FMRP 17722 at 1:1000 (Abcam ab17722) 
anti-FMRP 27455 at 1:1000 (Abcam ab27455) 
anti-FMRP 2F5 at 1:1000 (obtained from the Developmental Studies Hybridoma Bank) 
anti-FXR1P ML13 at 1:20,000 (a gift from Dr. Eduoard Khandjian) 
anti-FXR2P 1G2 ascites at 1:100 (obtained from the Developmental Studies Hybridoma 
Bank) 
anti-rpP0 at 1:20,000 (polysomes) or 1:5000 (whole cell lysate) (US Biological R2031-
25) 
anti-GFP B-2 (HRP-conjugated) at 1:200 (Santa Cruz sc-9996 HRP) 
anti-GFP 19C8 at 1:1000 (developed by Nat Heintz, produced in Monoclonal Antibody 
Core Facility) 
anti-GAPDH 6C5 at 1:25,000 (Abcam ab8245) 
anti-NeUN A60 (biotinylated) at 1:1000 (Abcam ab77315) 
anti-calnexin at 1:1000 (Abcam ab13504) 
anti-hnRNP C1/C2 at 1:1000 (Abcam ab10294) 
anti-histones at 1:500 (Millipore mab052) 
anti-eIF2a at 1:1000 (Cell Signaling 9722) 
anti-eIF2a [pS
52
] (phosphospecific) at 1:1000 (Invitrogen 44728G) 
anti-eEF2 at 1:1000 (Cell Signaling 2332) 
anti-eEF2 (Thr56) (phosphospecific) at 1:200 (Cell Signaling 2331) 
HRP-conjugated anti-rabbit, anti-mouse and anti-human secondaries at 1:10,000 (Jackson 
Immunoresearch) 
Neutra-Avidin secondary at 1:1500 (Abcam ab77315) 
 
The following antibodies were used for immunoprecipitations: 
 
anti-FMRP ab17722 (Abcam) 
anti-FMRP ab27455 (Abcam) 
anti-FMRP 7G1-1 ascites developed by Drs. Ceman and Warren (Brown et al., 2001), 
obtained from the Developmental Studies Hybridoma Bank 
anti-GFP 19C8 (developed by Nat Heintz, produced in Monoclonal Antibody Core 
Facility) 
anti-GFP 19F7 (developed by Nat Heintz, produced in Monoclonal Antibody Core 
Facility) 
 
The following antibody was used for immuno-electron microscopy: 
 
anti-GFP (Abcam ab6556) 
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Immunoprecipitations 
Amounts of beads and antibodies for CLIP 
40uL of Protein A Dynabeads (Invitrogen) loaded with 12ug 17722 or 27455 FMRP 
antibodies, 20ug mixed 19C8/19F7 anti-GFP monoclonals (mixed, yet specific, 
monoclonals were used to markedly increase avidity), or 20uL rabbit anti-mouse 
secondary (2.3 mg/ml IgG, Jackson ImmunoResearch 315-005-008, for preclearing) were 
used per 1 brain-equivalent (nuclei from 1 brain was estimated to be 0.1 brain-
equivalents).  For beads loaded with anti-GFP monoclonals, beads were pre-coated with 
rabbit anti-mouse secondary for use as a bridging antibody (5uL secondary per 20uL 
beads.  20uL beads can hold 5ug antibody, so beads will be saturated by secondary). 
 
Loading beads with antibody for CLIP 
Protein A Dynabeads were washed 3X with 0.1 M Na-phosphate buffer, pH 8.1, plus 
0.01% Tween-20 (bead wash buffer, BWB).  Antibodies were then added to beads in 
amounts indicated above, in total volume of 100uL with BWB.  Beads plus antibodies 
were rotated for 1 hr at 4°C (for primaries) or 30 minutes at RT (for secondaries), 
followed by 3X wash with BWB (1 ml each time) and final suspension in 100uL BWB. 
Loaded beads were stored on ice or at 4°C until use. 
 
Immunoprecipitations for CLIP 
DNAse- and RNAse-treated samples precleared by addition of 40uL Protein A 
Dynabeads loaded with 20uL rabbit anti-mouse secondary as described above and 
rotating at 4°C for 1 hour.  Samples were then rotated with primary antibody-loaded 
beads at 4°C for 1 hour.  Following IP beads were washed sequentially (1 ml washes) 
with high stringency buffer (15 mM Tris-HCl, pH 7.5, 5 mM EDTA, 2.5 mM EGTA, 1% 
Triton X-100, 1% Na-deoxycholate (DOC), 0.1% SDS, 120 mM NaCl, 25 mM KCl), 
high salt buffer (15 mM Tris-HCl, pH 7.5, 5 mM EDTA, 2.5 mM EGTA, 1% Triton X-
100, 1% Na-DOC, 0.1% SDS, 1 M NaCl) and twice with low salt buffer (15 mM Tris-
HCl, pH 7.5, 5 mM EDTA) followed by one wash with NT-2 buffer (50 mM Tris-HCl 
pH 7.4, 150 mM NaCl, 1 mM MgCl2, and 0.05% NP-40). After each capture on the 
magnet beads, the beads were resuspended by end-over-end rotation for a few minutes. 
Resuspended beads were transferred to new microfuge tubes once during the protocol, 
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and throughout the washes tubes were treated in a random order to diminish the chance of 
artifacts. Throughout the CLIP protocol 1.5 ml SlickSeal microfuge tubes (National 
Diagnostics) were used to reduce non-crosslinked RNA binding to tubes. 
 
IP-Westerns from mouse brain 
FMRP antibody 7G1 was covalently coupled to Affiprep Protein A beads (Biorad).  7G1 
antibody was purified from ascites using Pierce ImmunoPure (A Plus) IgG Purification 
Kit, exchanged into 0.1M phosphate buffer using PD-10 columns (Biorad) and 
concentrated using Amicon Ultra 50mL concentrators.  30uL beads were washed 2X in 
0.1M Na-phosphate buffer pH 8.1, sedimenting beads by gravity and removing 
supernatant by needle vacuum.  600uG purified 7G1 was added to washed beads (1X the 
molar saturation of the beads) and rotated at RT for 30 min.  Beads were then washed 2X 
in 0.2M Na-borate buffer pH 9.0 and resuspended in the same buffer plus 20mM 
dimethyl pimelimidate (a crosslinking reagent – note all reagents must be azide-free for 
successful crosslinking) and rotated at RT for 30 min.  Beads were washed 2X in 0.2M 
ethanolamine pH 9.0 and then resuspended in this same buffer and rotated at RT for 2 
hours to quench the crosslinking reaction.  Beads were then washed in polysome buffer 
and kept on ice. 
 
100uL aliquots of wt or Fmr1 KO S2 brain lysates were treated as described in Figure 11 
with either 200nM kc7 RNA, 15uL of 1ug/uL RNAse A plus 4uL 1U/uL RNAse T1, 
30mM EDTA or untreated.  For the kcRNA and RNAse treatments, lysate was incubated 
at RT for 15 minutes.  Each aliquot of lysate was then combined with 5uL beads (as 
prepared above, containing approximately 100ug 7G1) and rotated at 4°C for 1 hour.  
Beads were then washed 3X in polysome buffer and proteins were eluted by rotating with 
0.5M ammonium hydroxide plus 0.5mM EDTA at RT for 20 min.  The eluant was then 
frozen in an ethanol/dry ice bath, speedvac’ed to dryness, and resuspended in SDS 
sample buffer.  Samples were separated by SDS-PAGE and blotted with FMRP antibody 
2F5. 
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In vitro transcription of kcRNA 
Transcription templates for kcRNA and kcRNAC50G were prepared by PCR and purified 
over G-25 columns as follows. In vitro transcription reactions included 80uL of DNA 
template, 80uL of 5X transcription buffer (Stratagene), 50uL of 100mM NTP mix 
(Amersham), 24uL 0.1M DTT, 4.8uL 1M MgCl2, 4uL of RNAsin (Promega), 16uL of T7 
RNA polymerase (Stratagene) and RNAse-free water to 400uL.  Reactions were 
incubated overnight at 37°C.  RNA was treated with 5uL of RQ1 DNase at 37°C for 45 
minutes, concentrated in Amicon concentrators (10,000 kD cutoff), heated in gel loading 
buffer at 75°C for 10 minutes and gel purified on 8% urea-polyacrylamide gels followed 
by UV shadowing, excision and precipitation. Quality was checked by end labeling with 
T4PNK and !-P
32
-ATP and running on 8% urea-polyacrylamide gels, drying, and 
exposure to Kodak MR film. 
 
RNA preparation and QPCR analysis from whole brain 
Half brains from ten littermate pairs of P10-P15 Fmr1
-/-
, Fxr2
-/-
 and Fmr1
+/+
, Fxr2
+/-
 
mice were mashed in 1mL Trizol (Invitrogen) in Eppendorf tubes using 1mL syringe 
plungers.  Samples were blinded to genotype.  Samples were extracted in chloroform and 
precipitated in isopropanol.  Pellets were washed once in 75% EtOH, resuspended in 
water and RNA was recovered using RNAeasy spin columns (Qiagen) with on-column 
DNAse treatment.  3ug of RNA was then reverse transcribed using random hexamers and 
Superscript III (Invitrogen) and digested with RNAse H.  cDNAs were amplified by 
QPCR using iTaq SYBR Green Supermix with ROX (Biorad), a 1:100 dilution of cDNA 
and 200 nM primers (sequences included in following section). QPCR was performed on 
an iQ5 Multicolor Real-Time PCR Detection System (Biorad) using a 58°C annealing 
temperature.  Melt curves and (-)RT controls were performed.  A panel of 16 control 
genes (listed below) were screened against all 20 samples and results were analyzed 
using GeNorm software to select the best internal controls (Vandesompele 2002).  A 
normalization factor was calculated using GeNorm based on the data from Hprt1, TBP 
and B2M.  The efficiencies for all primers were calculated using four 5X serial dilutions.  
To calculate efficiency, the log10 value of ng input (assuming 1:1 RNA:cDNA 
correspondence) was plotted against the Ct value (y-axis); efficiency (E) then equals   
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10
^-(1/slope)
, and the amount of product is E
^Ct
. 
 
Preparation of RNA from cTAG mouse brains was done by homogenization of brain in 
polysome lysis buffer followed by addition of Trizol LS (Invitrogen) and 
chloroform:isoamyl alcohol per manufacturor’s instructions.  Extracted samples were 
precipitated with 1uL glycoblue and 1 volume isopropanol and washed 2X in cold 75% 
EtOH.  Pellets were resuspended in water and RNA was purified using High Pure RNA 
isolation kit (Roche) with on-column DNAse digest.   1ug of RNA from each sample was 
reverse transcribed using random hexamers and Superscript III (Invitrogen).  cDNAs 
were amplified by QPCR using FastStart SYBR master mix (Roche), using a 1:50 
dilution of cDNA and 400nM each primer.  QPCR was performed on an iQ5 Multicolor 
Real-Time PCR Detection System (Biorad) using a 58°C annealing temperature. Melt 
curves and (-)RT controls were performed.  Primers amplified either from Fmr1 exon 16 
to exon 17 (133nt amplicon) or from Fmr1 exon 16 to AcGFP (177nt amplicon). 
 
QPCR primers used for cTAG mouse 
Exon 16 (forward): 5’-ccaagagaggctaaaggaagaacagct-3’ 
Exon 17 (reverse): 5’-gttgcagcccatctacgctgtctg-3’ 
AcGFP (reverse): 5’-cacgatgccggtgaacagctc-3’ 
 
 
QPCR Primers screened for use as internal controls (for others, see list below): 
 
B2M beta-2-microglobulin (NM_009735) 
F: CTGACCGGCCTGTATGCTAT;  R: TGCATGCTATCTGAGCCATC 
 
GAPDH glyceraldehyde-3-phosphate dehydrogenase (NM_008084) 
CATGGCCTTCCGTGTTCCTA 
GCGGCACGTCAGATCCA 
  
HMBS hydroxymethyl-bilane synthase variant 1 (NM_013551) 
F: TGCACGATCCTGAAACTCTG; R: TGCATGCTATCTGAGCCATC 
 
HPRT1 hypoxanthine phosphoribosyl-transferase-1 (NM_013556) 
F: AAGCTTGCTGGTGAAAAGGA; R: TTGCGCTCATCTTAGGCTTT 
 
SDHA succinate dehydrogenase complex, subunit A  (NM_023281) 
F: GATTACTCCAAGCCCATCCA; R: GCACAGTCAGCCTCATTCAA 
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TBP TATA box binding protein  (NM_013684) 
F: GGGAGAATCATGGACCAGAA; R: CCGTAAGGCATCATTGGACT 
 
YWHAZ  tyrosine 3-monoxygenase 1 tryptophan 5-monoxygenase activation protein, 
zinc polypeptide (NM_011740) 
F: TTGAGCAGAAGACGGAAGGT; R: GAAGCATTGGGGATCAAGAA 
 
GUSB beta-glucoronidase (NM_010368) 
F: TCAGCTCTGTGACCGATACG; R: GCCACAGACCACATCACAAC 
 
IPO8 importin8  NM_(001081113) 
F: CGTGACAACATTGTGGAAGG; R: GTAAACTGCCAAGCCAGCTC 
 
PGK1 phosphoglycerate kinase (NM_008828) 
F: CAAGGCTTTGGAGAGTCCAG; R: TGTGCCAATCTCCATGTTGT 
 
PPIA peptidylprolyl isomerase A (NM_008907) 
F: AGCATACAGGTCCTGGCATC; R: TTCACCTTCCCAAAGACCAC 
 
TFRC transferrin receptor (NM_011638) 
F: TCCGCTCGTGGAGACTACTT; R: ACATAGGGCGACAGGAAGTG 
 
Tubg1 Gamma-tubulin (NM_134024) 
F: GCCGAGAGAAATCATCACCCTAC; R: TAGACTGTCACTGCCATCTGCCTC 
 
GfaP  glial fibrillary acidic protein (NM_010277)  
F: AGAAAACCGCATCACCATTC; R: AGAAAACCGCATCACCATTC 
 
RPL13A ribosomal protein large subunit A (NM_009438) 
F: CCCTCCACCCTATGACAAGA; R: TTCTCCTCCAGAGTGGCTGT 
 
RPS6 ribosomal protein small subunit 6 (NM_009096) 
F: AAGCTCCGCACCTTCTATGA; R: CATGGGAAAACCTTGCTTGT 
 
 
Polyribosome analysis (mouse brain and cells) 
Supernatants from mouse brain (S2 lysates) or cells (S1 lysates) were loaded onto a 20%–
50% w/w linear density gradient of sucrose in gradient buffer (20 mM HEPES-KOH pH 
7.4, 150 mM NaCl, and 5 mM MgCl2) prepared using a Gradient Master 107 (BioComp), 
in 14x3x89 mm polyallomer ultracentrifuge tubes (Beckman 331372). Gradients were 
centrifuged at 40,000 rpm for 2 hrs at 4°C in a Beckman SW41 rotor and sixteen 
fractions of 0.72 ml volume were collected with continuous monitoring at 254 nm using 
an ISCO UA-6 UV detector. 
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RNA preparation and QPCR analysis from polysome gradients 
RNA from polyribosome fractions was extracted using Trizol LS Reagent according to 
manufacturer’s instructions (Invitrogen) and then back-extracted in chloroform:isoamyl 
alcohol (49:1) and spun at 10,000 3 g for 15 min. The aqueous phase was precipitated 
with 15 mg glycoblue (Ambion) and 1 volume isopropanol. RNA was pelleted at 20,000 
x g for 10min at 4°C, washed twice with cold 75% ethanol and resuspended in water. 
Samples were digested with RQ1 DNase (Promega) for 1 hr at 37°C, extracted with 
phenol-chloroform, back-extracted with chloroform:isoamyl alcohol, precipitated with 
glycoblue in 2 volumes of 1:1 ethanol:isopro- panol and washed as before. cDNA was 
prepared with equal volumes of RNA from each fraction, using random hexamers 
(Roche) and Superscript III Reverse Transcriptase (Invitrogen) according to 
manufacturer’s instructions. cDNAs were amplified by qPCR using iTaq SYBR Green 
Supermix with ROX (Biorad) and 200 nM primers (sequences included in following 
section). qPCR was performed on an iQ5 Multicolor Real-Time PCR Detection System 
(Biorad) using a 58°C annealing temperature. Relative RNA levels were calculated using 
a Ct threshold of 100 and the formula 2
(40-Ct)
. Normalization to an internal control was not 
necessary. For each gene, polyribosome fractions were plotted as percentages of the total 
amount of the gene on the gradient (obtained by summing values of individual fractions). 
Error bars refer to technical replicates of qPCR measurements within single experiments.  
Primers were checked for single products of correct size by separating amplified products 
from pooled polysome fractions on an agarose gel. 
 
Primer sets used for QPCR in runoff assays (intron spanning) 
 
Bsn Bassoon (NM_007567) 
F: GGAGCACTCCTCTACGTTGC; R: GCTGCTGCTTTGCTTCTTCT 
 
Kif1a Kinesin 1A (NM_008440)  
F: ACCAGAGTGGGCAGAGAAGA; R: TGTGTCTGCTCCTTCACAGG 
 
Adcy1 Adenylate cyclase 1 (NM_009622)  
F: CTTACCAGGGAAGGTCCACA; R: GGCTGGTTTGATATCCGAGA 
 
Cyfip2 Cytoplasmic FMRP-interacting protein 2 (NM_133769) 
 F: CGGTCTTGGACGAGCTAAAG; R: CACTGGGTGATCCTGTTGTG 
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Mtap1b Microtubule-associated protein 1B (NM_008634)  
F: CGGACAGTGCTTTGAGAACA; R: GTGGTGCTTAGGAGCTCACC 
 
Nisch Nischarin (NM_022656) 
 F: GACAGGTGGCCTCTGATGAT; R: CTGAGGCGCTGGATAAAGTC 
 
Bai2 Brain-specific angiogenesis inhibitor 2 (NM_173071)  
F: GGGACCTGCTCTTCTCTGTG; R: AATCCACCATGAAGCTCACC 
 
Atp1a3 ATPase, Na+/K+ transporting, alpha 3 (NM_144921.1)  
F: CCATTGTCACTGGTGTGGAG; R: CAATGCAGAGGATGGTGATG 
 
Bat2 HLA-B associated transcript 2 (NM_020027)  
F: CCTACCCCAACACCAGAGAA; R: TGGTTCAGGACCCTCTTTTG 
 
Pde2a Phosphodiesterase 2a (NM_001008548)  
F: GGGAGTCCAGACTGGTGTGT; R: CAGGGGTATGACCAGCACTT  
 
Camk2a Ca/Calmodulin dep. kinase IIa (NM_009792.3) 
F: TCTGAGAGCACCAACACCAC; R: CCATTGCTTATGGCTTCGAT  
 
Grik5 Kainate receptor subunit 5, KA5 (NM_008168.2)  
F: AGTACGAGACCACGGACACC; R: CGAAGCGAAGGTACTGAAGG  
 
Grin2b NMDAR subunit 2B (NM_008171) 
F: TGCGCTCTCCCTTAATCTGT; R: GCCAACACCAACCAGAACTT  
 
Lingo1 Leucine-rich repeat and IgG domain-containing-1 (NM_181074.4) 
F: CCTGAGGATCCATCCAGAAA; R: AGCCTGTAGCAGAGCCTGAC  
 
Dlg4 PSD-95 (NM_007864.2) 
F: AACAGAGGGGGAGATGGAGT; R: CAAACAGGATGCTGTCGTTG  
 
Dlgap3 SAPAP3 (NM_198618) 
F: TCAGATGGTAGCCCCAAGAC; R: TGTAGCCAGGGATGGAACTC  
 
Grin2a NMDAR subunit 2A (NM_008170) 
F: GGTTCTGCATCGACATCCTT; R: GAACGCTCCTCATTGATGGT  
 
Pctk1 PCTAIRE protein kinase 1 (NM_011049.4) 
F: GCTAGACAAGCTGGGTGAGG; R: AGTACAGGGTGCCCCTTCTT  
 
Ndrg4 NDRG family member 4 (NM_145602.2) 
F: CAGCCATCCTCACCTACCAT; R: TGGCACACCACAAAGTGTTT  
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Gnb1 G protein, beta polypeptide 1 (NM_008142.4) 
F: GCGGGACACACAGGTTATCT; R: CAGTCTGGTGTCAGGAGCAA  
 
Ttyh3 Tweety homolog 3 (NM_175274.4) 
F: GGAGGTGCTAGCTGAACAGG; R: AGACCCCAACCAAGATACCC  
 
Arc Arg3.1/Arc (NM_018790) 
F: GAGAGCTGAAAGGGTTGCAC; R: GCCTTGATGGACTTCTTCCA  
 
Pabpc1 polyadenylate binding protein (NM_008774.3) 
F: GAGACCAGCTTCCTCACAGG; R: GGACTCCCGCAGCATATTTA  
 
Gria1 AMPAR subunit GluR1 (NM_008165.3) 
F: ACCACTACATCCTCGCCAAC; R: TCACTTGTCCTCCACTGCTG  
 
Hyou1 Hypoxia upregulated 1 (NM_021395.4) 
F: TACCAAACTTGGCAACACCA; R: GGCTCTCCTCTTCCTCCTGT  
 
Clcn6 Chloride channel 6 (NM_011929.2) 
F: CTGGAGGTGTTGGAGACCAT; R: ACGTTTGAACCACTCCGAAC  
 
Sae1 SUMO1 activating enzyme subunit 1 (NM_019748) 
F: CTGCTGCAGATACGGAATGA; R: CCAACCACAGCACATACTGG  
 
Hprt1 Hypoxanthine phosphoribosyltrans. 1 (NM_013556) 
F: AAGCTTGCTGGTGAAAAGGA; R: TTGCGCTCATCTTAGGCTTT  
 
Eif3a Eukaryotic initiation factor 3a (NM_010123.3) 
F: ACTCCCTGGGTCAAGTTCCT; R: CACATAGCTTGCGGAACTCA  
 
Tcerg1 Transcription elongation regulator 1 (NM_001039474.1) 
F: TTCGAGAACGGGAAAGAGAA; R: CCGGAGGGTCCTCCTAGTAT  
 
Npepps Aminopeptidase puromycin sensitive (NM_008942.2) 
F: CAAAAGAATGCTGCCACAGA; R: GGTCCACTGGCACAAAACTT  
 
Gria2 AMPAR subunit GluR2 (NM_001039195) 
F: AACGGCGTGTAATCCTTGAC; R: CACCAGGGAGTCGTCGTAGT  
 
Vldlr Very low density lipoprotein receptor (NM_013703.2) 
F: ACGGCCAGTGTGTTCCTAAC; R: ATTTTCACCATCGCATCTCC  
 
Canx Calnexin (NM__001110499.1) 
F: GCCTGAAGATTGGGATGAAA; R: CAATCCTCTGGCTTCTCTGC  
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Glrb Glycine receptor, beta (NM__010298.5) 
F: TGTGGTTCTCTCCTGGCTCT; R: CAGCGCCTTCACATAAGACA  
 
 
Slc35f1 Solute carrier family 35, member F1 (NM_178675) 
F: CGGTCAACCTTTCTCTGCTC; R: GGGGATCCTGGGCTATGTAT  
 
St8sia3 ST8 a-N-Ac-neuraminide a-2, 8-sialyltransf. 3 (NM_009182.2)  
F: CGGACAGCGTTTTTACATCA; R: AGCAGGGACCGGAAGTTATT 
 
Atp6ap2 ATPase, H+ transp., lysosomal acc. prot.2 (NM_027439.3)  
F: TTTGGATGAACTTGGGAAGC; R: CACAAGGGATGTGTCGAATG 
 
Tmem65 Transmembrane protein 65 (NM_175212.4)  
F: CATCTACAGCCTGCACTCCA; R: GCGTTATCCAAAAAGCCAAA 
 
 
IVT-EBP system and ribosome runoff assays 
Two- to three-week old wild-type mice (CD1, FVB or C57Bl6/J, both sexes) or paired 
littermates (Fmr1 KO versus WT (FVB background) or I304N versus WT (C57Bl6/J 
background) (Zang et al., 2009), only males) were sacrificed by isoflurane anesthesia and 
decapitation. Postnuclear supernatants (S1) of cerebral cortex and cerebellum, dissected 
free from white matter, were prepared by homogenizing 2 mouse brains in 1 ml 
polyribosome lysis buffer (without addition of NP-40 or CHX) and yielded 300uL of S1 
following a 10 min, 2000xg spin at 4°C. ATP was added to 2 mM, 15 ml each of the (-
)Met and (-)Leu amino acid mixtures (1mM stocks, Promega nuclease-treated RRL kit 
L4960) and 150 ml of the nuclease-treated rabbit reticulocyte lysate (RRL, Promega 
L4960) were added to 300uL of S1 and incubated at 30°C in the presence of puromycin 
(7.2 ug/ml) for the indicated times. 75uL reactions were terminated by addition of 1 ml 
polysome lysis buffer including 1% NP-40 and 0.1 mg/ml CHX, on ice (10 min) followed 
by a 20,000 x g spin (10 min, 4°C) and S2 was applied to 20%–50% sucrose gradients to 
frationate polysomes. Where indicated, in vitro transcribed RNAs (1.0 uM final 
concentration; unlabeled) were added to the S1 lysate (after heating RNA to 75 degrees 
for 10 min and bench cooling for 5 min in 1X SBB buffer (Selex binding buffer, 50 mM 
Tris acetate, pH 7.7, 200 mM potassium acetate, 5 mM Mg-acetate) as previously 
described for filter binding assays (Darnell et al., 2009) at the start of the incubation. 
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In one set of experiments, kcRNA or mutant kcRNA was added after puromycin run-off, 
as follows. Brains from three WT FVB mice aged P14 were dissected of white matter and 
homogenized together in 750 ml polyribosome lysis buffer (without addition of NP-40 or 
CHX). Polyribosome run-off was conducted in the presence of puromycin as above, for 
20 min at 30°C, and then placed on ice water. 1.2 mM CHX and 0.2 mM anisomycin 
were added for 10 min on ice water, followed by 1 uM kcRNA or 1 uM mutant kcRNA. 
Samples were incubated on ice water for 20 min, then diluted in 2.5 volumes gradient 
buffer containing protease inhibitors, RNAsin Plus, 1.2 mM CHX, 0.2 mM anisomycin 
and 1% NP-40. Samples were incubated on ice 10 min, then loaded onto 20%–50% 
(w/w) sucrose gradients. 
 
EDTA treatment during puromycin runoff 
FVB P15 brain lysate was prepared for the IVT-EBP assay, and run-off was performed in 
the presence of ATP, amino acids, and RRL as described above. Samples were split into 
3 aliquots and treated with either 1 uM kcRNA, 1 uM kcRNA + 30 mM EDTA, or 1 uM 
kcRNAC50G.  Puromycin was then added and each reaction was allowed to run off for 20 
min at 30°C. Reactions were stopped by the addition of 1 ml of lysis buffer containing 
CHX and 1% NP-40. Samples were incubated on ice for 10 min and then loaded onto 
sucrose gradients for analysis. 
 
FXRP knockdown and puromycin runoff in N2A cells 
A mouse siGENOME ON-TARGETplus SMARTpool (Fisher Dharmacon) containing 4 
siRNAs was used for each gene (Fmr1, Fxr1 and Fxr2). N2A cells were transfected at 
30% confluence in OptiMEM-I + GlutaMax medium (Invitrogen), with 11.7nM of each 
of the three oligo pools using Lipofectamine (Invitrogen) according to manufacturer’s 
instructions. Medium was changed after 4-6 hrs and knockdown was repeated the same 
way on the subsequent day. 15 hrs after the second knockdown, cells were treated with 
0.5 mg/ml puromycin (Sigma) for 1 hr, and then with 0.10 mg/ml cycloheximide for 20 
min.  Cells were washed twice in PBS to remove RNAse-containing medium and cells 
were scraped in 1mL  in polysome lysis buffer containing RNAsin and CHX.   Cells were 
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Dounce homogenized and lysates were spun at 5000xg for 10 min at 4°C and 
supernatants were loaded over 20-50% gradients for polysome separation. 
 
siRNA pools (Dharmacon): 
 
FXR1H  (NM_008053) 
Sense: CUAAUUACACCUCCGGUUAUU 
Anti-Sense: 5’-P UAACCGGAGGUGUAAUUAGUU 
 
Sense: CGGACGAAGUUGAUGCUUAUU 
Anti-Sense: 5’-P UAAGCAUCAACUUCGUCCGUU 
 
Sense: UAGAGUAUCACAUCGCUUAUU 
Anti-Sense: 5’-P UAAGCGAUGUGAUACUCUAUU 
 
Sense: UGAAGACACCGGAACGUUUUU 
Anti-Sense: 5’-P AAACGUUCCGGUGUCUUCAUU 
 
 
Fmr1  (NM_008031) 
Sense: GAUGAGCAGUUGCGACAAAUU 
Anti-Sense: 5’-P UUUGUCGCAACUGCUCAUCUU 
 
Sense: CCAGAAGAUUUACGACAAAUU 
Anti-Sense: 5’-P UUUGUCGUAAAUCUUCUGGUU 
 
Sense: GCACCAAGUUGUCUCUUAUUU 
Anti-Sense: 5’-P AUAAGAGACAACUUGGUGCUU 
 
Sense: GAUCAUUCCCGAACAGAUAUU 
Anti-Sense: 5’-P UAUCUGUUCGGGAAUGAUCUU 
 
FXR2H (NM_011814) 
Sense: CAUCAGUGGAGACCGCCAAUU 
Anti-Sense: 5’-P UUGGCGGUCUCCACUGAUGUU 
 
Sense: UGGAUGAGAAGGCGUAUUUUU 
Anti-Sense: 5’-P AAAUACGCCUUCUCAUCCAUU 
 
Sense: CCGCCGUAAUCGUGGUAACUU 
Anti-Sense: 5’-P GUUACCACGAUUACGGCGGUU 
 
Sense: CCUUGGAGUUGGGUAGUUUUU 
Anti-Sense: 5’-P  AAACUACCCAACUCCAGGUU 
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Estimation of Ribosomes/mRNA Per Sucrose Gradient Fraction 
A representative gradient from a CHX-treated sample was used to quantify the number of 
ribosomes per gradient fraction. Individual ribosome peaks on the A254 trace were 
resolved between fractions 4 and 9, allowing polyribosome size to be directly counted up 
to 10 ribosomes. Polyribosome sizes in fractions 10-16 were extrapolated by fitting a 
polynomial trend line to the resolved data in fractions 4-9 (y = 0.125x2 + 0.025x – 0.8). 
To verify that the sucrose gradient was linear, the concentration of sucrose in each 
fraction of a blank gradient was measured using a sucrose refractometer (Hanna 
Instruments). 
 
Selection of FMRP Targets and Nontargets for Analysis 
Genes were selected for validation as FMRP targets on the basis of total number of CLIP 
tags. Because many top targets have long coding sequences compared to nontargets, 
several targets of moderate CDS length were included. Nontargets were required to have 
few CLIP tags, moderate to high representation in polyribosome fractions (measured by 
Affymetrix Exon Array) and strong neuronal expression (based on the neuronal 
transcriptome previously described (Cahoy et al., 2008)). Special effort was made to 
include nontargets of long CDS length. 
 
Calculation of Ribosome Retention Score (RRS) and Ribosome Load 
In order to quantify the FMRP-dependent effect on ribosome stalling we devised a means 
of estimating ribosome occupancy on mRNA in polyribosome gradient fractions, and 
weighting the differences in polyribosome profiles from WT and Fmr1 KO fractions for 
this ribosome occupancy. By counting the number of ribosomes in each fraction from 
A254 traces and extrapolating, the average number of mRNA-associated ribosomes in 
each gradient fraction can be estimated based on linearity of the sucrose gradients. 
Multiplying the percentage of mRNA in each fraction by the number of ribosomes in that 
fraction and summing over the gradient puts a value on total ribosome occupancy 
(‘‘ribosome load’’) under any one condition. The difference between this value of stalled 
ribosomes from WT and the corresponding FMRP loss-of-function model value (Fmr1 
KO, I304N, or kcRNA-treated) after puromycin run-off yields an FMRP-dependent 
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ribosome retention score. 
 
Electron Microscopic Analysis of Sucrose Gradient Fractions Containing Stalled 
Polyribosomes 
Negative staining with uranyl acetate was performed by the Rockefeller University 
Electron Microscopy Resource Center as follows: 10 ul of fraction 9-10 from a WT 
puromycin-treated IVTEBP experiment sucrose gradient was deposited on a glow 
discharged, carbon-coated grid (EMS Cat#CF400-Cu-50) for 30 s to 1 min. After 
washing the sample quickly by passing over two drops of dd-H2O, the grid was then 
treated with 2 drops of 2% uranyl acetate (Fisher Cat#79853) for a total of 30 s. Excess 
stain was removed by touching the edge of the grid carefully to a filter paper wedge. 
After air drying the grid was viewed with a TecnaiSpiritBT Transmission Electron 
Microscope (FEI) at 80 KV and pictures were taken with Gatan 895 ULTRASCAN 
Digital Camera. 
 
Immunogold-electron microscopy to detect polyribosomes by localization of EGFP-
tagged ribosomal protein L10a was performed following 20%–50% sucrose gradient 
purification of cerebellar extracts, prepared as described above, from Bac transgenic 
Purkinje cell-specific Pcp2 promoter driven EGFP-tagged rpL10a adult male mice 
(provided by Dr. Nat Heintz, Rockefeller University). Sucrose gradient fraction 9 or 10 
was fixed in suspension using concentrated paraformaldehyde (PF) (16%) to reach a final 
concentration of 4% PF on ice. 10 ul of sucrose fraction 9 or 10 was deposited on a glow 
discharged and carbon-coated grid for 1 min and fixed again in 0.08% glutaraldehyde for 
10 min at RT. After PBS washes and blocking in 1% BSA/PBS the polyribosomes were 
incubated first with anti-GFP antibody (Abcam #ab6556, 1:1000 dilution) and then with 
6nm or 12nm colloidal gold conjugated to goat anti-rabbit IgG (H+L) for 30 min. The 
grids were washed and negatively stained with 2% uranyl acetate (Fisher Cat#79853) for 
a total of 30 s. Excess stain was removed by touching the edge of the grid carefully to a 
filter paper wedge. After air drying the grid was viewed with a TecnaiSpiritBT 
Transmission Electron Microscope (FEI) at 80 KV and pictures were taken with Gatan 
895 ULTRASCAN Digital Camera. 
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In experiments using transfected EGFP-FMRP in cultured cells, 20 ug of pEGFP-C1 
(negative control expressing only EGFP) or pEGFP-iso7-hFMRP (Darnell et al., 2005b) 
was transfected using FuGene 6 into 6 100 mm tissue culture plates of HEK293T cells at 
30% confluence and allowed to express for 48 hr. Plates were treated with 1 mM 
puromycin or vehicle alone for 1 hr in the incubator, followed by 0.1 mg/ml 
cycloheximide for 20 min. Plates were washed twice with warm PBS and post 
mitochondrial cell lysates were prepared and fractionated on 20%–50% (w/w) linear 
sucrose gradients as described above. 10 ul of each fraction number 10 was fixed in 4% 
PF at 4_C overnight. 10 ul was deposited on a glow discharged and carbon-coated grid 
for 1 min and fixed again in 0.095% glutaraldehyde for 10 min at RT. The remainder of 
the protocol was performed as in the previous paragraph with 12 nm colloidal gold 
conjugated to goat anti-rabbit IgG (H+L). 
 
Expression of GFP-FMRP in 293T cells 
A sequence containing the human Fmr1 cDNA seqeunce with a Kozak/ATG site and the 
TAA stop codon replaced by a Gly-Pro-Val swivel (contains AgeI site) was cloned in-
frame to AcGFP in pAcGFP1-N1 by Jen Darnell (Clontech).  Note that this construct 
does not contain the 3’UTR of Fmr1, since AcGFP is C-terminal to FMRP.  The final 
plasmid was maxiprepped using an EndoFree kit (Qiagen) and transfected into 293T cells 
using FuGene (Promega) according to manufacturer’s instructions.  One plate of cells 
was transfected with 18ug of plasmid.  Cells were grown 24 hours and were then treated 
with 0.1mg/mL CHX for 20 min.  Cells were washed 2X with PBS to remove RNAse-
containing medium and scraped in 1mL polysome lysis buffer containing RNAsin and 
CHX.   Cells were Dounce homogenized and lysates were spun at 5000xg for 10 min at 
4°C and supernatants were loaded over 20-50% gradients for polysome separation. 
 
Purification of BAC DNA 
A single colony was innoculated into 2mL TB medium and grown overnight at 37°C 
shaking at 250rpm.  Cells were pelleted and resuspended in 0.3mL of P1 buffer (15mM 
Tris pH 8, 10mM EDTA, 100ug/mL RNAse A) by vortexing.  0.3mL of P2 buffer was 
then added (0.2N NaOH, 1% SDS), gently shaken and incubated 5 min at RT.  0.3mL of 
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P3 buffer (3M KOAc pH 5.5) was then slowly added while gently shaking to mix, and 
then incubated on ice for at least 5 min.  Lysates were spun on benchtop microfuge at 
10,000rpm for 10 min at 4°C.  Supernatant was transferred to 1.5mL tube containing 
0.8mL cold isopropanol and incubated on ice for at least 5 min or -20°C overnight.  DNA 
was precipitated by spinning in benchtop microfuge at max speed for 15 min.  DNA was 
washed twice in 0.5mL of 70% EtOH, dried on benchtop to a translucent color (not 
overdried) and resuspended in 40uL TE.  Important: DNA was not vortexed or pipetted at 
any stage, and resuspension was achieved by soaking DNA in TE for about an hour, 
occasionally tapping tube. 
 
Recombineering protocol 
An overnight 5mL culture of the desired strain (SW106 or SW102, containing target 
plasmid as appropriate) was grown at 32°C, plus antibiotic as appropriate.  Note that it is 
critical not to grow these cells any higher than 32°C, because the recombination genes are 
temperature-controlled.  The overnight culture was added at approximately 1:50 ratio to 
50mL LB (plus antibiotic as appropriate) and grown 2-3 hours at 32°C to an OD600 of 
0.6.  10mL of culture was put on a slush of ice+water as the uninduced control.  Another 
10mL was transferred to a small Erylenmeyer flask and swirled in a 42°C water bath for 
15 min (to induce recombination genes), and then swirled in the ice slush for 2 min and 
left on ice.  Both sets of cells were spun down at 4000xg for 6 min at 4°C.  Pellets were 
resuspended in 0.9mL ice-cold water by extremely gentle pipetting.  Cells were washed 
twice more, spinning down in benchtop centrifuge at max speed for 20 sec, being careful 
to remove all the supernatant so residual salt did not ruin electroporation.  Cells were 
resuspended extremely gently in 40uL ice-cold water.  DNA was then added to cells 
(50ng linearized retrieval vector, 6ug BAC DNA, or 300ng lox-neo-lox PCR product was 
used) and 50uL of cells were put in a 0.1cm electroporation cuvette on ice.  
Electroporation was done at 1.7kV, 25uF, 200".  Cells were recovered in 1mL LB at 
32°C for 1 hour and then plated and grown at 32°C for 18-24hrs.  Cells containing 
correctly recombineered constructs were miniprepped and plasmid was retransformed to 
obtain a pure clone (since not all copies of plasmid recombine in each cell originally).  To 
retransform, cells were grown and washed as before but not heat-shocked. 
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Ligations 
For average-sized constructs:  Vector and inserts were digested overnight and vector was 
treated with 1uL calf alkaline intestinal phosphatase (CIAP, Roche) in a 35uL volume at 
37°C for 15 min.  An additional 1uL of CIAP was added and incubated at 55°C for 45 
min.  70uL water, 1uL 0.5M EDTA, 2.5uL 20% SDS and 1.5uL Proteinase K were added 
and incubated at 55°C for 30 min.  Sample was extracted in 100uL 
phenol:chloroform:isoamyl alcohol (25:24:1) and the aqueous layer was gel purified over 
a 0.8% agarose gel at 135V for 1 hour and extracted using a QiaQuick Gel Extraction kit 
(Qiagen).  Ligation was performed using a 3X molar excess of insert to vector and a total 
DNA concentration of 10ng/uL total DNA concentration, with 1uL T4 DNA ligase 
(NEB) at room temperature for 5-30 min. 
 
For large constructs: Final cloning into PL253 involved ligation of a 6.5kB insert into a 
19.7kB vector.  This ligation was achieved using a 3:1 molar ratio of insert to vector with 
a 25ng/uL total DNA concentration.  Although such a high DNA concentration typically 
causes end-to-end linear products to predominate in the reaction, in this case because the 
fragments are so large, the concentrations are appropriate.  25ug of PL253 (19.7kB, 
containing lox-exon17-Fmr1 3’UTR) and 25ug of pCR4-TOPO (containing the 6.5kB 
Proudfoot-Frt-Neo-Frt-lox-exon17-AcGFP-Fmr1 3’UTR insert) were digested overnight 
with 2uL Bsu36I in a 100uL volume.  For pCR4-TOPO, adequate purification of the 
6.5kB insert from the 4kB backbone and the 10.5kB uncut vector was achieved by 
running the reaction over a 0.8% gel for 2 hours and repurifying the upper band over 
another 0.8% gel for another 3 hours, resulting in a 28% yield.  Digested PL253 was 
treated with CIAP and the CIAP was removed by proteinase K digest, organic extraction 
and gel purification as above.  The vector was recovered using a Qiaex II Gel Extraction 
kit (Qiagen) designed for large vectors, which when double-eluted with EB resulted in a 
10% overall yield.  Fragments were ligated using a 3:1 molar ratio of insert to vector, 
25ng/uL total DNA in a volume of 20uL, and incubation with 0.5uL concentrated T4 
DNA ligase (NEB) for 2 hours at 25°C, followed by addition of another 0.5uL ligase and 
overnight incubation at 16°C. 
 
 
 29 
14.3kB of Fmr1 sequence spanning exon 17 was subcloned into PL253 (Frederick 
National Laboratory Biological Resources Branch) from the BAC RP23-149C7 (obtained 
from BacPac CHORI, derived from C56BL/6 mice) in the SW106 recombineering strain 
(Frederick National Laboratory Biological Resources Branch) (see Figure 36).  500nt 
homology “arms” to each end of the 14.3kB segment were first cloned into PL253.  
These arms were PCR amplified from the BAC using Accuprime Pfx Supermix 
(Invitrogen) and the following primers (restriction sites shown in capital letters): 
 
5' Fmr1 miniarm F (Not1 site) 
5’-gccGCGGCCGCgattgaactattctcagcttagaatgtgtc-3’ 
 
5' Fmr1 miniarm R (HindIII site) 
5’-gccAAGCTTcaagggcagatcaatatagtgatttcttag-3’ 
 
3' Fmr1 miniarm F (HindIII site) 
5’-gccAAGCTTgttgtcctcatcaaaccttcatttcttg-3’ 
 
3' Fmr1 miniarm R (BamH1 site) 
5’-gccGGATCCcaaagggttacattatttcaacctgcc-3’ 
 
The PCR products and PL253 were digested overnight with the appropriate restriction 
enzymes (NEB), the vector was CIPped (see protocol below) and all products were gel 
purified.  The fragments were then assembled into PL253 (between the Not1 and BamH1 
sites) in a triple ligation using 3X molar excess of miniarms (which are about 1/10
th
 the 
size of the vector) and T4 DNA ligase (NEB).  Ligations were transformed into XL10-
Gold Ultracompetent cells (Agilent) according to manufacturer’s protocol.  A plasmid 
containing both miniarms in correct orientation was chosen by sequencing (Macrogen), 
maxiprepped (Qiagen HiSpeed Plasmid Maxi Kit), linearized by overnight HindIII digest 
and gel purified. 
 
Purified BAC RP23-149C7 was transformed into SW106 (see transformation protocol 
below) with chloramphenicol selection.  Purified, linearized PL253 with miniarms was 
transformed into SW106 cells carrying BAC RP23-149C7 and retrieval of the Fmr1 
sequence by gap repair was achieved by recombineering (see protocol below).  Correct 
clones were selected on carbenicillin and retransformed into SW106 (not carrying the 
BAC) to obtain pure clones.  This step is very important, as cells contain multiple copies 
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of plasmid during gap repair and not all plasmids will retrieve the Fmr1 sequence.  A 
correct clone was chosen by restriction digest and fully sequenced (Macrogen). 
 
Targeting of upstream (lone) lox site and arabinose-induced Neo pop-out 
100nt PCR primers were designed as depicted in Figure 36.  These primers contain 48 or 
36nt of homology on either side of a site 439nt upstream of the annotated end of exon 17 
(note that an unannotated alternative splice site exists 51nt upstream of the annotated 
exon boundary), as well as loxP seqeunces, restriction sites and homology to the ends of 
the Neo cassette in PL452 (Frederick National Laboratory Biological Resources Branch).  
The sequences of these primers are as follows (Fmr1 homology is underlined, Neo 
homology is in capital, restriction sites are in bold, loxP sequence is in plain lowercase):  
Note that primers must be purified by 2-step HPLC. 
 
F primer 
5'-
tgctgtatactttgcctataccttatatattttctattagccaataatataacttcgtataatgtatgctatacgaagttatCGACCTG
CAG 
CCTGTTGA-3' 
 
R primer 
5'agcaaaaatcagtgaggccattcaaattaagttactgatatcgaattcataacttcgtatagcatacattatacgaagttatGT
C 
GAGGCTGATCAGCGA-3' 
 
The Neo cassette in PL452 was amplified using these primers and the product was gel 
purified and transfected into SW106 cells containing PL253 with the retrieved Fmr1 
sequence.  (Note that residual plasmid can be digested away using DpnI, but was not 
done here.) Recombineering resulted in insertion of the lox-neo-lox sequence 439nt 
upstream of Fmr1 exon 17.  A correct clone was selected by Neo resistance and 
retransformed, checked by restriction digest and the insert was sequenced through the 
junctions (Macrogen).  Note that as PL253 gets bigger, the correct clones tend to be the 
more slow-growing ones.  The lox-neo-lox cassette was recombined to a single lox site 
by arabinose-induced lox recombination (SW106 cells contain arabinose-inducible Cre).  
From an overnight culture of “plain” SW106 cells, 2mL was inoculated into 40mL of LB 
and grown at 32°C for 2 hrs to OD600 of 0.5. 10mL additional LB plus 500uL of 10% 
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arabinose was added and cells were grown at 32°C for 1 hour to a final OD600 of 0.9.  1ng 
of PL253 containing lox-neo-lox- Fmr1 was electroporated into the cells.  Cells were 
recovered in 1mL LB at 32°C for 1hr and plated on carbenicillin.  Cells were also plated 
on kanamycin to check for efficiency of pop-out.  Correct clones were selected by 
restriction digest, re-checked on carb and kan plates to ensure they were correct, and 
sequenced across the lox site (Macrogen).  Finally, the correct clone was transformed into 
SW102, a recombineering strain similar to SW106 that does not contain Cre, and is thus a 
more stable line to continue with. 
 
Insertion of Proudfoot polyadenylation sequence upstream of Frt-Neo-Frt-lox site 
Forward and reverse oligos corresponding to the Proudfoot sequence plus restriction sites 
were ordered (Fisher, 2-step HPLC purified) and annealed by incubating in a beaker of 
90°C water and letting the water cool on the benchtop to room temperature.  Oligo was 
then ligated into  PL451 (Frederick National Laboratory Biological Resources Branch) at 
the HindIII site just upstream of the Frt-Neo-Frt-lox cassette, using 3X molar excess of 
oligo, in XL10-Gold cells (Agilent).  Correct clones were selected by digest and 
sequenced across junctions (Macrogen).  Sequence of the Proudfoot oligo is as follows 
(added restriction sites in bold): 
 
5'-cccaagcttaataaaagatctttattttcattagatctgtgtgttggttttttgtgtgcatatgaagcttggg-3' 
 
 
Site directed mutagenesis of the Bsu36I site in AcGFP 
The Bsu36I site in AcGFP (pAcGFP1-N1, Clontech) was destroyed by a conservative 
point mutation for cloning purposes using the Stratagene QuikChange Multi Site-
Directed Mutagenesis kit.  The Bsu36I sequence was changed from CCTGAGG to 
CCAGAGG using the following PAGE-purified primer (Fisher):  
 
5’-caagagcgccatgcatgagggctacatcc-3’ 
 
Plasmids were transformed into XL10-Gold cells (Agilent) and a correct clone was 
obtained by sequencing (Macrogen). 
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Construction of Fmr1 exon 17 – AcGFP – fmr1 3’UTR via overlap extension PCR 
Design of PCR strategy is depicted below.  The TAA stop codon of Fmr1 exon 17 was 
removed and a Gly-Pro-Val linker was added.  AcGFP (with mutated Bsu36I site) was 
added in-frame to the linker with a TGA stop codon, followed by the Fmr1 3’UTR.  PacI 
and Bsu36I cloning sites were included at the 5’ and 3’ ends of the final product as 
indicated in the figure below.  Six sets of PCR reactions were performed using Pfx 
supermix (Invitrogen), followed by gel purifications of each product, as follows: 
 
PCR#1: Primers AF and AR, plasmid PL253- Fmr1 (“product A” = Fmr1 exon17 + 
linker) 
PCR#2: Primers BF and BR, plasmid pAcGFP1-N1 (“product B” = linker + AcGFP) 
 Primers AR and BF create the Gly-Pro-Val linker between exon 17 and AcGFP 
PCR#3: Primers AF and BR, products A and B (“product AB” = exon17+AcGFP) 
Products A and B overlap (via the linker sequence), so will prime off each other 
and create product AB in early cycles of PCR#3, which will then be amplified by 
primers AF and BR 
PCR#4: Primers AF and B2R, product AB (“product AB2” = exon17+AcGFP+overlap) 
Note – this PCR was necessary because I had not added an overlap “tail” 
matching the Fmr1 3’UTR sequence to Primer BR originally. 
PCR#5: Primers CF and CR, plasmid PL253-fmr1 (“product C” = overlap+ Fmr1 
3’UTR) 
PCR#6: Primers AF and CR, products AB2 and C (“product ABC” = 
exon17+linker+AcGFP+ Fmr1 3’UTR) 
Products AB2 and C overlap, so will prime off each other as before and create 
product ABC in early cycles of PCR#6, which will then be amplified by primers 
AF and CR. 
 
Products AB and ABC were A-tailed using old-fashioned Taq at 70°C for 20 min, 
TOPO-TA cloned per manufacturer’s instructions (Invitrogen) in TOP10 cells 
(Invitrogen), and sequenced (Macrogen). 
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Primers used for overlap extension PCR (AF and AR = forward and reverse 
respectively, etc): 
 
Gly-Pro-Val linker region is in capitals.  PacI and Bsu36I restriction sites in bold.  
Overlap regions underlined. 
 
Primer AF:  5'-cccttaattaaagtaacttaatttgaatggcc-3'   
 
Primer AR: 5'-TGACCGGTCCgggtactccattc-3'   
 
Primer BF: 5'-cGGACCGGTCatggtgagcaag-3'   
         
Primer BR: 5'- tcacttgtacagctcatccatgccg -3'  
 
(the 5’ end of this primer corresponds to the TGA stop codon of AcGFP) 
 
Primer B2R: 5'-ggaattatgtagcttattcacttgtacagctcatc-3'  
 
Primer CF:  5'-gatgagctgtacaagtgaataagctacataattcc-3' 
 
(Primers B2R and CF are reverse complements of each other, but the primers were never 
used together in the same reaction.  Thus, the entire sequence of each primer generates 
an overlap region in the products) 
   
Primer CR: 5'- aacaagcctgaggacttgagtttgattc -3'   
 
 
 
Note: Segments are not drawn to scale, but primers are drawn to show which segments 
they overlap. 
 
 
 
 
--GGACCGGTC-- mutant AcGFP Fmr1 3‘UTR
exon 
17
0.4 kB 0.8 kB0.1 kB 0.8 kB2.3 kB
PrimerAF PrimerCR
PrimerBR
PrimerB2R
PrimerCF
PrimerBF
PrimerAR
Bsu36IPacI
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Assembly of final cassette and cloning into PL253 
 
The Bsu36I-Proudfoot-Frt-Neo-Frt-lox cassette was PCR amplified using primers ending 
in PacI and cloned into pCR4-TOPO (containing Fmr1exon17-linker-AcGFP- Fmr1 
3’UTR cassette as assembled via overlap extension PCR) at the PacI site (see Figure 37).  
Next, the resulting cassette (Proudfoot-Frt-Neo-Frt-lox- Fmr1 exon17-linker-AcGFP- 
Fmr1 3’UTR) was cut out by Bsu36I digest and cloned into the Bsu36I site in PL253 
(containing lox- Fmr1 exon17- Fmr1 3’UTR) (see further descriptions in Ligations 
section).  Clones were checked by restriction digest and sequencing across junctions. 
 
Construct targeting and breeding of knockin mice  
The targeting vector was transfected into male albino C57BL/6 ES cells by the Gene 
Targeting Resource Center and positive ES cells identified based on Southern blots.  
7/200 injected ES cell lines were positive for Neo as assessed by Southern blot.  Of these, 
1/7 was confirmed correct by further Southern blots (See Figure 39).  This ES cell line 
was injected into C57BL/6 blastocysts and 14 chimeric males were obtained (3 grade A, 
3 grade B, 6 grade C and 2 grade D).  The best 10 chimeras were bred with female albino 
C57BL/6 mice.  Two chimeric males consistently gave rise all-white litters, indicating the 
germ cells were fully derived from the injected ES cell, while two other chimeras give 
litters with some white and some black pups, indicating that only some germ cells were 
derived from the injected ES cell.  In these crosses, all white female progeny were 
cTAG/+ (see Figure 41).  These cTAG/+ females were bred with C57BL/6 males, either 
wt or expressing Flp or Cre drivers of interest (Mice: EIIa-Cre was a gift from the Roeder 
lab, Emx1-Cre obtained from Jackson Labs #005628, actin-Flp obtained from Jackson 
Labs #005703, albino C57BL/6 obtained from Jackson labs #000058).  All mice were on 
the B6 background. 
 
Cre expression in ES cells  
ES cells from clone #189 were plated on a feeder layer of mouse embryonic fibroblasts 
and passaged once by the Gene Targeting Facility, using KDMEM medium (prepared in 
Gene Targeting facility) on 6-well plates.  Cells were then transfected with 1ug pPAC-
Cre as follows.  Per well, 1ug pPAC-Cre (obtained from Gene Targeting facility) was 
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mixed with 0.5mL OptiMEM medium (reduced serum plus GlutaMax, Invitrogen).  Per 
well, 20uL Lipofectamine (Invitrogen) was mixed with 0.5mL OptiMEM medium.  After 
5 min, the two were combined and let sit 20 min at RT. Medium was removed from cells 
and 1mL plasmid + Lipofectamine mixture was added per well.  Cells were incubated 5 
hours (cannot go longer or cells will die) and 6mL KDMEM medium was added without 
removing OptiMEM (cells not adherent under these conditions).  (500mL KDMEM 
prepared by Gene Targeting facility contains 395mL KDMEM, 75mL knockout serum 
replacement, 10mL L-Glu 100X, 5mL 2-mercaptoethanol 100X, 5mL nucleosides 100X, 
5mL nonessential amino acids 100X, and 75uL leukemia inhibitory factor.)   Cells were 
grown KDMEM while still on the feeder layer, changing medium twice per day.  22 
hours after transfection, one portion of cells was selected with 1ug/mL puromycin 
(ideally, should have been 6 hours post transfection).  Puromycin was maintained in the 
medium for 24 hours, and surviving cells were allowed to recover in puromycin-free 
KDMEM for 2 days.  As needed, cells were split into gelatinized flasks by trypsinization 
and gentle trituration.  Once on gelatin instead of the feeder layer, medium was changed 
to a 50-50 mix of KDMEM and ES Cell medium (500mL ES Cell medium prepared by 
Gene Targeting facility contains 400mL ES DMEM, 75mL ES FBS, 5mL 2-
mercaptoethanol 100X, 5mL nucleosides 100X, 5mL L-Glu 100X, 5mL nonessential 
amino acids 100X and 50uL leukemia inhibitory factor).  Cells were harvested by 
trypsinization and spun down.  Pellets were resuspended in polysome lysis buffer 
containing RNAsin (ideally, cells should have been washed before lysis to remove 
RNAse-containing medium.  RNA appeared intact on polysome gradients).  RNA was 
prepared from (–)Cre, (+)Cre and (+)Cre/(+)puromycin cells using Trizol LS (Invitrogen) 
extraction and High Pure RNA isolation kit (Roche) with on-column DNAse treatment.  
Fmr1 mRNA positive for AcGFP was detected by hot RT-PCR (see protocol below) 
using primers in Fmr1 exon 16 and 3’UTR. 
 
Southern blotting 
25ng of PCR-amplified DNA (250-300nt) was combined with 10uL random hexamers 
(Roche) in a 30uL volume and heated at 95°C for 3 min, then cooled at RT for 3 min.  To 
this, added 10uL 5X buffer (Stratagene Prime-It II kit), 10uL of 6000Ci/mmol P
 32
-dATP 
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and 1uL Exo-Klenow and incubated at 37°C for 30 min.  Reaction was passed twice over 
G-50 spin columns and specific activity was calculated using Cerenkov counting.  To 
calculate amount of probe needed, used the following formula: (mL of hybridization 
buffer x 2.5 x 10
6
)/CPM.  Typical result is 3 million counts per 1uL (specific activity of 
10
9
).  Membranes containing digested DNA (prepared by the Gene Targeting Facility) 
were combined with 10mL of preheated 65°C QuikHyb buffer (Stratagene) and incubated 
at 65°C for 1 hr.  The calculated volume of probe was combined with 2 volumes salmon 
sperm DNA and heated at 95°C for 3 minutes, cooled on benchtop, added to 10mL 
preheated QuikHyb buffer, and put on the membrane.  Hybridization was carried out at 
65°C for 90 minutes.  Longer incubation times, or using more than the calculated amount 
of probe, resulted in high background.  Membrane was then rinsed twice with 25mL 2X 
SSC and washed 1X at 65°C for 20 min in 50mL of 2X SSC (prewarmed).  If Geiger 
counter was above 0.1X range, another wash in 2X SSC was performed for 30 min.  
Membranes were exposed to Kodak MR film for 12 hrs-several days.  1L of 2X SSC 
contained 100mL 20X SSC, 5mL of 20% SDS and 10mL of 10% Na-pyrophosphate. 
 
Hot RT-PCR from ES cells and mouse brain 
RNA was prepared from mouse brain or cell lysates by extraction in Trizol LS 
(Invitrogen) and precipitation as described above (RNA isolation from whole brain).  
RNA was purified using the High Pure RNA isolation kit (Roche) as described above.  
cDNA was prepared as above using Superscript III (Invitrogen).  PCR was carried out 
using Accuprime Supermix I (Invitrogen) and 1uL of a 1:10 dilution of P
32
-dCTP was 
added in the last two cycles.  PCR products were resolved on 6% acrylamide-urea 
denaturing gels and imaged on Kodak MR film. 
 
Regions amplified: 
 
Fmr1 exon 16 to 3’UTR 
Exon 16 primer: 5’- GACGATCATTCCCGAACAGATAATCG-3’ 
3’UTR primer: 5’- GGACATGAAATGGCACAGCATTTC-3’ 
 
Fmr1 exon 11 to exon 17 
Exon 11 primer: 5’- CTCAACCTAACAGTACAAAAGTCCAGAGG-3’ 
Exon 17 primer: 5’- GGGTACTCCATTCACCAGCGG-3’ 
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Fmr1 exon 11 to AcGFP 
Exon 11 primer: 5’- CTCAACCTAACAGTACAAAAGTCCAGAGG-3’ 
AcGFP primer: 5’- GATGCCGGTGAACAGCTCGG-3’ 
 
 
Purification of nuclei from mouse brain 
Pelleting under sucrose: Brains from P7 mice were dissected free of white matter, placed 
with 0.5mL PBS in a 6-well plate over a bed of wet ice, chopped, and UV-crosslinked 
three times at 400 mJ/cm2 (254 nm UV light) with swirling between each irradiation, 
using a Stratalinker 2400 (Stratagene).  Crosslinked tissue was homogenized in nuclei 
buffer (0.32M sucrose, 20mM HEPES pH 7.4, 5mM MgCl2, 5mM CaCl2, 0.5 mM 
dithiothreitol, 1X Complete EDTA-free protease inhibitor cocktail (Roche) and 40 U/ml 
RNAsin (Promega)) with 10 strokes at 900 rpm in a motor-driven Teflon-pestle 5 ml 
glass homogenizer (Wheaton).  Homogenates were brought to 1% NP-40 or 1% Triton-X 
from 10% stocks, mixed by inversion and incubated on ice 10 minutes.  2mL of lysate 
was then loaded over 9mL of 50% sucrose in polysome buffer in 14x3x89 mm 
polyallomer ultracentrifuge tubes (Beckman 331372) and spun at 25,500 rpm for 2.5 hrs 
at 4°C in a Beckman SW41 rotor, reserving some input for Western blot.  After the spin, 
tubes were drained and pellets were resuspended in 50uL PBS. 
Pelleting in Eppendorf tubes: Brains from P9 mice were dissected free of white matter, 
chopped and crosslinked as above.  Tissue was homogenized as above in polysome lysis 
buffer (without CHX) and brought to 0.8% NP-40.  Lysate was spun at 2000xg for 10 
minutes at 4°C.  The top 60% of supernatant was removed as a “cytoplasm” sample.  The 
remaining supernatant was discarded and the pellet was very gently resuspended in 
polysome lysis (containing 0.8% NP-40) buffer by stirring with a P200 tip.  The wash 
was repeated a second time and then the nuclei were resuspended in 200uL lysis buffer 
(for Western) or PXL (for CLIP, see below). 
 
Separation of membrane-bound and free polysomes from mouse brain 
Method 1: Brains from P21 mice were dissected free from white matter and homogenized 
in 0.32M sucrose, 20mM HEPES pH 7.4, 5mM MgCl2, 0.1M DTT, 1X Complete EDTA-
free Protease Inhibitor cocktail (Roche) and 40U/mL RNAsin (Promega), with 10 strokes 
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at 900rpm in a motor-driven Teflon-pestle 5 ml glass homogenizer (Wheaton).  
Homogenates were spun at 2000xg at 4°C for 10 minutes.  Supernatant was then spun at 
10,000xg at 4°C for 10 minutes.  Supernatant was then spun at 12,000xg at 4°C for 10 
minutes.  Final supernatant was spun at 140,000xg at 4°C for 2 hrs in a TLA 120.2 rotor.  
Pellet was resuspended in the same buffer + 2% NP-40 in 20% of the original volume. 
 
Method 2: Brains from P15 mice were dissected free from white matter and homogenized 
in 0.8M sucrose, 20mM HEPES pH 7.4, 150mM NaCl, 5mM MgCl2, 0.1M DTT, 1X 
Complete EDTA-free Protease Inhibitor cocktail (Roche) and 40U/mL RNAsin 
(Promega), with 10 strokes at 900rpm in a motor-driven Teflon-pestle 5 ml glass 
homogenizer (Wheaton).  Homogenates were spun at 2000xg at 4°C for 10 minutes.  
Supernatant was then spun at 12,000xg at 4°C for 10 minutes.  Supernatant (0.5mL) was 
then loaded over a discontinuous gradient containing (from bottom): 1.6mL of 2.5M 
sucrose, 2.5mL of 2.15M sucrose, 5mL of 2.05M sucrose and 3mL of 1.3M sucrose in a 
14x3x89 mm polyallomer ultracentrifuge tube (Beckman 331372) and spun at 90,000xg 
at 4°C for 5 hrs in a Beckman SW41 rotor. 750uL fractions were collected from the top 
of the gradient by pipette. 
 
Method 3: Brains from P14 mice were dissected free from white matter and homogenized 
in 1mL polysome buffer + 0.25M sucrose, 0.1M DTT, 1X Complete EDTA-free Protease 
Inhibitor cocktail (Roche) and 40U/mL RNAsin (Promega), with 6 strokes at 500rpm in a 
motor-driven Teflon-pestle 5 ml glass homogenizer (Wheaton).  Homogenates were spun 
at 2000xg at 4°C for 10 minutes.  Supernatant was then spun at 12,000xg at 4°C for 10 
minutes.  Supernatant (1mL) was then loaded over a discontinuous gradient containing 
(from bottom): 1mL of 2.5M sucrose, 5mL of 1.3M sucrose, 4mL of 0.8M sucrose and 
spun at 140,000xg at 4°C for 2.5 hrs in a Beckman SW41 rotor. 700uL fractions were 
collected from the top of the gradient by pipette.  Samples were ligated to unique linkers 
and pooled for RNA Seq analysis. 
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Prepraration of samples for RNA Seq analysis: 
Samples were extracted equal volume phenol/chloroform pH4.5, back-extracted in 
chloroform:isoamyl alcohol and precipitated at -80.  Pellets were washed in 70% EtOH 
and resuspended in water.  2ug RNA was prepared using the Illumina TruSeq protocol 
using fragmentation instead of Ribo-Minus.  Samples were fragmented as follows:  16ul 
RNA was incubated with 4ul 5x Fragmentation Buffer (Illumina) for 5min at 94C.   2ul 
Fragmentation Stop Solution (illumina) was added and sample was placed on ice. 2ul 
3MNaOAc, 2ul glycogen and 60ul 100%EtOH was added.  After precipitation samples 
were spun at 20000g at 4C for 25min.  Samples were washed with 300ul 70%EtOH and 
resuspended in 11uL water. Preparation of 1st strand cDNA:  11ul fragmented RNA was 
combined with 1ul random primers and heated at 65C for 5min.   4ul 5x 1st strand buffer, 
2ul 100mM DDT, 0.4ul 25mMdNTP mix and 0.5ul RNase Inhibitor were added and 
incubated at RT for 2min.  1ul SuperScript II (Invitrogen) was then added and reaction 
was incubated at RT 10min, then at 42C for 50min and 70C for 15min.  The standard 
Illumina TruSeq protocol was then followed starting from 2nd strand cDNA synthesis. 
 
Induction of MECS 
Mice were hand carried from the mouse facility a few hours before the experiment and 
kept in a quiet space.  Ear clip pads were dipped in a 2.5M NaCl and placed on the ears.  
Settings were: Frequency 85 pulses/sec; pulse width 4ms; duration 1 sec, current 25mA.  
After seizure, if the mouse stopped breathing it was given rescue breaths with a blue 
rubber Pastuer pipette bulb for approximately 30 seconds until mouse began breathing 
spontaneously (refreshing air in bulb every 5 squeezes).  Mice were then returned to 
home cages until sacrifice.  Time was measured from the induction of the seizure. 
 
FMRP CLIP 
Preparation of tissue 
Brains were placed in a dish containing a small amount of ice-cold 1X HBSS + 10mM 
HEPES pH 7.4, chopped with a clean razor blade into ~2mm pieces and UV crosslinked 
on a bed of ice-slush three times at 400 mJ/cm2 (254 nm UV light) with swirling between 
each irradiation, using a Stratalinker 2400 (Stratagene).  Tissue was then removed from 
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buffer using curved forceps and homogenized in 1mL PXL (1X PBS [tissue culture 
grade; no Mg
2+
, no Ca
2+
, GIBCO], 0.1% SDS, 0.5% Na-DOC, 0.5% NP-40) plus 0.1M 
DTT, 1X Complete EDTA-free Protease Inhibitor cocktail (Roche) and 40U/mL RNAsin 
(Promega), with 10 strokes at 900rpm in a motor-driven Teflon-pestle 5 ml glass 
homogenizer (Wheaton).  For nuclear CLIP, crosslinking was done before purification of 
nuclei and pellets were resuspended in PXL (see above).  Samples were allowed to 
dissociate in PXL for 10 minutes on ice.  Samples were then treated with 50uL RQ1 
DNAse (Promega) at 37°C for 5 min, at 1200rpm in thermomixer.  Samples were then 
spun at 32,000xg at 4°C for 20 min in a TLA120.2 rotor.  Supernatants were brought to 
1mL in PXL and treated with RNase Cocktail, a mixture of RNases A and T1 for more 
complete digestion (AM2286, Applied Biosystems/Ambion), using a titration of dilutions 
in the range of 1:20,000 (ie, 10uL of a 1:20,000 serial dilution of RNAse was added to 
1mL of sample).  Samples were incubated with RNAse at 37°C for 10 minutes and 
reactions were stopped by putting on ice slush and adding 10uL Superasin (Ambion) plus 
4ul RNAsin (Promega) per sample.  Samples were then precleared and 
immunoprecipitated as descibed in the above Immunoprecipitations secion. 
 
Dephosphorylation of RNA, 3’ Linker Ligation, and SDS-PAGE Separation of 
RNABP:RNA Complexes 
 Immunoprecipitations were treated with calf intestinal phosphatase to remove the 5’ 
phosphate from RNA crosslinked to FMRP (‘‘RNA tags’’) so that the RNA could not 
circularize during ligation, an otherwise predominant competing intramolecular reaction. 
Beads were resuspended in 0.08 ml of 1X dephosphorylation buffer and 3 units of CIAP 
(Roche) and incubated in the Thermomixer R at 37°C for 20 min, programmed to shake 
at 1000rpm for 15 s every 4 min, followed by 2X 1ml washes with PNK buffer (+)EGTA 
(10mM Tris pH 7.5, 20mM EGTA, 0.5% NP-40) and 3X 1mL washes with PNK buffer 
(-)EGTA (10mM Tris pH 7.5, 10mM MgCl2, 0.05% NP-40) with one tube change during 
washing. To ligate a P
32
-labeled RNA linker to the 3’ end of the RNA, the puromycin-
blocked linker (L32, 5’-OH-GUGUCAGUCACUUCCAGCGG-3’-puromycin, 
Dharmacon) was first labeled using T4 phosphonucleotide kinase (PNK, New England 
Biolabs, NEB). 50 pmol of L32 RNA, 0.015 ml P
32
-! -ATP, 1uL RNAsin and 2 ul of T4 
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PNK in 1X PNK buffer were incubated at 37°C for 30 min, an additional 0.02 ml 1 mM 
ATP was added and the reaction incubated 5 min. Radiolabeled linker was spun through 
a G-25 column (Amersham) to remove free ATP. 30 pmol of the labeled 3’ RNA linker 
was added to a 0.08 ml T4 RNA ligase reaction (Fermentas), according to kit instructions, 
and on-bead ligation reactions were incubated at 16°C for 1 hr in a thermomixer 
programmed to shake at 1000rpm for 15 sec every 4 min. After 1 hr, 80 pmol of L32 
RNA linker WITH 5’ phosphate was added to each tube and incubated overnight, 
followed by 3X washes with PNK buffer.  To rephosphorylate the 5’ end of the RNA for 
5’ linker ligation, 80 ul of T4 PNK mix (6 ul of 1 mM ATP, 4 ul T4 PNK enzyme [NEB], 
1 ul RNasin in 1X T4 PNK buffer [NEB], total volume 80ul) was added to each tube and 
incubated for 20 min at 1000rpm shaking for 15 sec every 4 min and washed 3X with 
PNK buffer. Each tube of beads was resuspended in 40 ul NuPAGE loading buffer (LDS, 
Invitrogen), containing reducing agent, and incubated at 70°C for 10min at 1000rpm. 
Supernatants were taken off the beads and run on Novex NuPAGE 10% Bis-Tris gels 
(Invitrogen) in MOPS running buffer (Invitrogen) for 2 hr at 175V and transferred to 
Protran nitrocellulose (S&S) using a Novex wet transfer apparatus (Invitrogen). After 
transfer, the nitrocellulose was quickly rinsed with RNase-free PBS, blotted with 
Kimwipes, wrapped in plastic wrap and exposed to Biomax MR film (Kodak).  
 
Recovery of Complexes, Protease Digestion, and 5’ Linker Ligation 
 Nitrocellulose membranes were aligned carefully with the exposed film and filter 
excised with a scalpel from 105-140 kDa (the size range of FMRP crosslinked to RNA of 
approx. 100 nucleotides). Each band of nitrocellulose membrane was further cut into 
smaller pieces and proteinase K treated (0.2 ml of a 1:5 dilution of proteinase K (4 mg/ml, 
Roche) in PK buffer (100 mM Tris-Cl pH 7.5, 50 mM NaCl, 10 mM EDTA)) at 37°C, 
1100 rpm for 20 min. Then 0.2 ml of PK plus 7M urea solution was added and incubated 
for another 20min at 37°C at 1100 rpm. Finally, 0.4 ml of RNA phenol (pH 6.8, Applied 
Biosystems/Ambion) and 0.13 ml of 49:1 CHCl3:isoamyl alcohol were added and 
incubated at 37°C, 1100 rpm for additional 20 min. Tubes were spun at 20,000 x g in a 
desktop microcentrifuge. Glycogen (0.8 ul, Applied Biosystems/Ambion), 50 ul 3M 
NaOAc pH 5.2, and 1 ml of 1:1 ethanol:isopropanol were added to the aqueous phase in a 
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fresh tube and RNA was precipitated overnight at -20°C. RNA was pelleted, washed with 
75% ethanol, the pellet dried and dissolved in 6 ul RNase-free H2O. RNA ligation to add 
the 5’ linker (RL5D: 5’-OH-AGGGAGGACGAUGCGGr(N)r(N)r(N)r(N)G3’-OH) was 
performed with 1 ul 10X T4 RNA ligase buffer (Fermentas), 1 ul BSA (0.2ug/ul), 1 ul 
ATP (10mM), 0.1 ul T4 RNA ligase (3U, Fermentas), and 20 pmol of RL5D RNA linker 
in a total volume of 10 ul at 16°C for 5 hrs. To the ligation reaction, 77 ul H2O, 11 ul 10X 
RQ1 DNase buffer, 5 ul RQ1 DNase (Promega) and 5 ul RNasin (Promega) were added 
and incubated at 37°C for 20 min. 0.3 ml H2O, 0.3 ml RNA phenol (Ambion) and 0.1 ml 
CHCl3 were added, vortexed, spun and the aqueous layer taken. RNA was precipitated 
with 50 ul 3M NaOAc pH 5.2, 0.8 ul glycogen (Ambion) and 1 ml 1:1 
ethanol:isopropanol overnight at -20°C.  
 
RT-PCR and High-Throughput Sequencing of PCR Products 
RNA was pelleted, washed, dried, and resuspended in 8 ul of RNase-free H2O. The RNA 
was mixed with 2 ul of primer P32 (3’ DNA primer 32, 5’- 
CTTCACTCACCTCGCAACCG-3’, Operon) at 5 pmol/ul, incubated at 65°C for 5 min, 
chilled, and spun briefly. 3 ul 3mM dNTPs, 1 ul 0.1M DTT, 4 ul 5X SuperScript RT 
buffer, 1 ul RNasin, and 1 ul SuperScript III (Invitrogen) were added and incubated at 
50°C for 30 min, 90°C for 5 min and briefly at 4°C. PCR reactions were performed with 
27 ul Accuprime Pfx Supermix (Invitrogen), 1 ul P51 (5’ DNA primer 51, 5’- 
AGGGAGGACGATGCGG-3’, Operon) at 5 pmol/ul, 1 ul P32 primer, 5 pmol/ul and 2 ul 
of the RT reaction, cycled for 20-25 cycles using a program of 95°C for 20 s, 61°C for 30 
s, and 68C for 20 s. A 10% denaturing polyacrylamide was poured and the entire PCR 
reaction was loaded along with 3 ul of Amplisize Molecular Ruler (Biorad). To visualize 
DNA, the gel was immersed in a 1:10,000-fold dilution of SYBR Gold (Molecular 
Probes) in TBE for 10 min. Routinely, aliquots of the reaction were removed at various 
cycle numbers and product excised from the lowest cycle number giving visible product. 
Acrylamide bands containing DNA of 60-100nts were excised and DNA purified by 
crushing in diffusion buffer (0.5M ammonium acetate, 10mM Mg acetate, 1mM EDTA, 
0.1% SDS), incubating at 50°C for 30 min at 1200rpm, and filtering through Whatman 
GF/D filters in Nanosep columns (VWR).  DNA was recovered from filtrate using 
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Qiaquick gel purification buffers and columns (Qiagen) and eluted in 30uL TE. An 
additional PCR reaction was performed using the following fusion primers to permit 
sequencing on the Illumina platform.  
 
SP5fusion:  
5’-AATGATACGGCGACCACC 
GACTATGGATACTTAGTCAGGGAGGACGATGCGG-3’  
 
SP3fusion:  
5’-CAAGCAGAAGACGGCATACGACCGCTGGAAGTGACTGACAC3’. 
 
PCR amplification was performed using Accuprime Pfx (Invitrogen) and ranged between 
6 and 10 cycles. The product was then run on a 2% NuSieve agarose gel and purified 
using Qiaquick spin columns (QIAGEN). A total of 10-30 ul of DNA (quantified using 
the Quant-IT kit (Invitrogen)) at 10 nM was submitted for sequencing. The sequencing of 
CLIP tags was performed using the sequencing primer  
 
SSP1: 5’-CTATGGATACTTAGTCAGGGAGGACGATGCGG-3’.   
 
Data analysis was done using the Galaxy platform (Hillman et al 2012). 
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Chapter III.  Analysis of the mechanism of translational regulation by FMRP 
 
Introduction: 
FMRP HITS-CLIP provided the first rigorous, comprehensive view of the set of mRNAs 
regulated by FMRP.  However, a major open question remained – what is the mechanism 
of translational control that FMRP exerts on these transcripts?  Early studies investigating 
the role of FMRP in translation were based on expression of exogenous FMRP in various 
reporter systems.  For example, preincubation of recombinant FMRP with in vitro 
transcribed reporter mRNAs, followed by translation in either rabbit reticulocyte lysate or 
live microinjected Xenopus oocytes, resulted in FMRP-dependent inhibition of translation 
(Laggerbauer et al., 2001).  Similarly, preincubation of recombinant FMRP with total 
brain polyA+ mRNA followed by translation in reticulocyte lysate also caused FMRP-
dependent translational inhibition (Li et al., 2001).   However, results from these studies 
should be interpreted with caution due to overexpression of FMRP, use of reporter 
mRNAs, and the requirement for preincubation of FMRP with mRNA prior to translation 
assay, all factors that create substantial risk of nonphysiologic effects (Kozak, 2006).  
Efforts to measure FMRP’s effect on protein synthesis in more physiologic systems have 
found that 
35
S-methionine incorporation was increased in hippocampal slices from Fmr1 
KO mice (Dolen et al., 2007), (Osterweil et al., 2010) and in reticulocyte lysates 
programmed with brain lysate from Fmr1 KO mice (Darnell et al., 2011).  In perhaps the 
most physiologically relevant study, brains of live wt and Fmr1 KO mice were pulsed 
with radiolabeled leucine, followed by thin sectioning of the brains and exposure to film 
to measure incorporation of label into newly synthesized proteins in situ (Qin et al., 
2005).  In this assay, Fmr1 KO mice showed increased protein synthesis in several 
regions of the brain, most notably in the hippocampus.  Overall, these experiments 
support a model in which FMRP is a negative regulator of translation, although 
disagreement exists over whether it exerts a semi-global (Osterweil et al., 2010) or 
specific (Darnell et al., 2011) effect. 
 
Proteomic approaches have the potential to both determine whether FMRP positively or 
negatively regulates translation and also to identify specific proteins whose levels are 
changed in the absence of FMRP.  Detection of FMRP-dependent differences in steady-
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state protein levels by Western blot has been difficult, most likely because Westerns 
cannot accurately discriminate differences of less than 20%, potentially making small de 
novo changes impossible to detect over steady-state levels.  The only case where an 
FMRP-dependent change in the steady-state level of a protein in total lysate has been 
reproducibly demonstrated is for Map1B (Lu et al., 2004), (Zhang et al., 2001).  
However, this result stands out because the assays involved (Western blot and RNAse 
protection assay in mouse brain) are physiologic and because, in retrospect, they assay 
one of the top FMRP targets during the window of peak FMRP expression.  In addition, 
Western blots of subcompartments, for example synaptoneurosomes, have identified 
increases in a number of proteins in the absence of FMRP (Schutt et al., 2009).  Unbiased 
quantitative proteomic screens have met with limited success.  In one screen, 23 proteins 
were identified with differential expression in hippocampal synaptosomes prepared from 
Fmr1 KO mouse brain (Klemmer et al., 2011).  Encouragingly, of these, 22 had increased 
expression in the absence of FMRP, consistent with FMRP’s role as an inhibitor of 
translation.  Four of the 22 were strong HITS-CLIP targets (Pclo, Syn1, Ap2B1 and Eef2).  
In a second screen, 132 proteins with differential expression in cultured primary 
hippocampal neurons from Fmr1 KO mice were identified (Liao et al., 2008).  Of these, 
only 39 had increased expression in the KO, and most had only a few CLIP tags.  
However, this study did detect increased expression of the two top CLIP targets, Apc and 
Map1B, in Fmr1 KO neurons.  Overall, these studies suggest that FMRP is a negative 
regulator of translation and give some clue about which proteins are differentially 
expressed in the absence of FMRP, but give little insight into the mechanism of 
translational regulation. 
 
Efforts have also been made to characterize FMRP’s effect on translation at the mRNA 
level.  Polyribosomes of varying sizes can be separated on sucrose gradients with 
excellent resolution, such that small differences in ribosome loading are discernable. Two 
major efforts to characterize FMRP’s function using pooled polyribosomes have been 
made.  Careful microarray analysis of both total mRNA and pooled polysomal mRNA 
from six pairs of wt and Fmr1 KO mouse brains revealed that not a single gene was 
significantly increased or decreased in either total or polysomal pools between wt and 
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KO except, as expected, Fmr1 (Darnell et al., 2011).  However, another study found both 
increased and decreased mRNA levels in pooled polysomes from lymphoblastoid cells 
from FXS patients compared to normal controls, some of which were mRNAs that 
coIPed with FMRP (Brown et al., 2001).  These analyses have several limitations, 
including heterogeneity of cell samples from human patients, lack of a neuron-like 
phenotype for lymphoblastoid cells, lack of resolution due to pooling of polysomes, 
possible functional redundancy from FXR1P and/or FXR2P, and limitations in sensitivity 
and genome coverage of microarrays (at the time, it was not practical to employ more 
sensitive, low-throughput methods such as Northern blot, RNAse protection assay or 
QPCR because the identities of FMRP targets were not reliably known).  Therefore, from 
these experiments we cannot firmly conclude whether mRNA association with polysomes 
is altered in the absence of FMRP, although the microarray results from brain do suggest 
that any existing effect may be subtle. 
 
Finally, several attempts have been made to determine whether FMRP-associated 
polysomes are engaged in active translation.  Polysomes that are not actively translating 
should be insensitive to ribosome runoff assays.  If initiation is inhibited, ribosomes 
already engaged in translation will continue translocating and release upon reaching the 
stop codon, causing the average size of polysomes (as analyzed on sucrose gradients) to 
gradually diminish and the number of free monosomes to increase.  The behavior of 
FMRP in such a runoff system is predicted to depend on whether FMRP is associated 
with mRNA on which ribosomes are actively translocating, or is associated with mRNA 
on which ribosomes are stalled, or is bound to the ribosomes themselves, either 
translocating or stalled.  The behavior of FMRP in runoff assays has been studied using 
sodium fluoride or sodium azide as inhibitors of initiation, although these drugs act by 
depleting ATP, which is expected to have pleiotropic effects on other aspects of 
translation such as preventing amino acid charging of tRNA.  In these experiments, 
FMRP was enriched after runoff in light fractions containing free proteins, free mRNA 
and monosomes (Feng et al., 1997a), (Wang et al., 2008).  This could be interpreted as 
evidence that FMRP is associated with actively translating polysomes, but it could also 
be the result of pathologic polysome disassembly due to general poisoning of the cell or it 
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could reflect a requirement for ATP in FMRP association with polysomes.  A more 
specific method of disengaging translocating ribosomes from mRNAs is use of the drug 
puromycin, an aminoacyl tRNA analog that causes premature chain termination upon 
incorporation.  Translocating ribosomes that incorporate puromycin fall off of transcripts 
without completing translation; nontranslocating ribosomes are unaffected by puromycin 
because incorporation of puromycin into the growing polypeptide is predicated on 
translocation.  Treatment of cells with puromycin thus results in disassembly of actively 
translating polysomes by a mechanism that specifically acts on translocating ribosomes.  
Under these conditions, FMRP was observed to migrate in lighter fractions; however, it 
did not migrate with free proteins at the top of the gradient (Stefani et al., 2004), (Darnell 
et al., 2011).  Rather, FMRP remained in the middle of the gradient, in fractions 
containing residual polysomes, suggesting that it was associated with transcripts that still 
contained some ribosomes after puromycin treatment.  This suggests that some of the 
ribosomes on FMRP-associated transcripts are actively translating, while other ribosomes 
on the same transcripts are stalled. 
 
Results: 
Steady state levels of target mRNAs are unaffected by loss of FMRP and FXR2P 
As a first step in investigating the mechanism of translational control by FMRP, we 
looked for changes in total steady state mRNA levels of FMRP targets.  As a polysome-
associated protein, FMRP could inhibit translation by directing turnover of target 
mRNAs.  Examples of mRNA degradation linked to translation include sequestration of 
Ago-bound mRNAs in P-bodies (Djuranovic et al., 2011) and nonsense-mediated decay 
triggered by the presence of exon junction complexes in 3’UTRs where they are not 
displaced during the pioneer round of translation (Giorgi et al., 2007).  Although our 
earlier microarray analysis did not detect changes in the steady-state polysome pool in the 
absence of FMRP, subsequent identification of FMRP targets by CLIP allows productive 
interrogation of candidate mRNAs by QPCR, which is considerably more sensitive.  To 
reduce possible functional compensation by FMRP’s paralogs, Fxr2
+/-
 mice were 
compared to Fmr1/Fxr2 DKO mice (Fxr2
+/-
 mice were chosen to use as a control instead 
of wt mice in order to increase the number of usable litters, and of the available 
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heterozygous genotypes were judged least likely to have phenotypes similar to Fmr1 KO 
mice).  To further increase our chances of establishing statistical significance for subtle 
alterations, ten littermate pairs were used and samples were handled blind to genotype.  
Total RNA was prepared from cortex in the second postnatal week.  To establish the best 
possible normalization controls, a panel of 16 housekeeping genes from diverse 
metabolic pathways was screened against the full set of 20 samples and the GeNorm 
program was used to rank the control mRNAs according to expression stability.  The 
GeNorm program is designed to overcome the circular problem of how to chose stably 
expressed internal controls without a previously established baseline against which to 
normalize (Vandesompele et al., 2002).  In an ideal scenario (ie one in which samples are 
identical), the ratio of two internal control genes will not change from sample to sample.  
In real life, this ratio will change, and the more variable the ratio is, the less stable one or 
both of the control genes are.  However, it cannot be known from just two control genes 
whether variation is inherent in the samples (ie one sample is more concentrated that the 
other) or whether one or both of the control genes is/are differentially expressed between 
the samples.  The GeNorm program addresses this problem by starting with a large set of 
potential control genes and comparing each control gene to all other control genes in 
pairwise fashion, assigning a stability measure, M, based on the average pairwise 
variation of each gene with all other genes.  The worst performing control gene (ie with 
the highest M value) is then removed from the set and the analysis is repeated, ultimately 
ranking all control genes according to their relative stabilities.  Furthermore, it is 
recognized that use of more than one internal control will improve normalization 
accuracy.  In order to determine the optimal point at which inclusion of additional control 
genes only minimally improves accuracy (or even decreases accuracy, if poorly 
performing controls with high M value are included), the program calculates 
normalization factors based on stepwise inclusion of additional control genes and then 
assesses the impact on normalization accuracy from the inclusion of each additional gene.  
To do this, it calculates the pairwise variation, Vn/n+1, between the normalization factors 
for n control genes and n+1 control genes.  If Vn/n+1 is large compared to Vn+1/n+2, it means 
that inclusion of the (n+1)
th
 control gene will significantly improve normalization 
accuracy.  Based on Genorm analysis, the three most stable control genes, Hprt1, TBP 
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and B2M, were used to normalize the data.  Four additional control mRNAs not included 
in calculation of the normalization factor were also examined, and –RT controls were 
performed for all genes.  Analysis of the seven nontargets plus nine strong FMRP target 
mRNAs showed no significant changes in steady state mRNA levels upon loss of FMRP 
and FXR2P expression (Figure 1). 
 
Steady state polysome profiles of target mRNAs are unaffected in Fmr1 KO or 
I304N brain 
We next looked at steady state polysome distributions of target mRNAs, to investigate 
FMRP’s effect on translational status.  In order to perceive possible small shifts in 
gradient distribution that would be missed by pooling polysomes, individual fractions 
were analyzed.  Brains from littermate pairs of wt and Fmr1 KO or wt and I304N 
knockin mice in the third postnatal week were homogenized in a cycloheximide-
containing buffer, which stabilizes polysomes.  Lysates were fractionated over 20-50% 
sucrose gradients and RNA was extracted from each fraction, reverse transcribed, and 
analyzed by QPCR.  It was found that column-based RNA purification suffered from 
high levels of technical variation, even when using columns designed to recover 
picogram-quantity amounts of RNA, so RNA was purified using liquid phase extraction.  
Considerable effort was made to determine the most accurate way to normalize the data.  
The fractions could not be normalized to total RNA, because rRNA levels vary 
enormously across polysome gradients.  The fractions also could not be normalized to the 
profile of a control mRNA, because housekeeping genes are not typically under 
translational control and thus nearly all the QPCR signal is consolidated in two or three 
fractions (ie most molecules of that mRNA have a similar number of ribosomes).  Thus, 
fractions not overlapping with this “peak” would be normalized to values close to zero, 
which is not very meaningful or accurate.  An effort was made to use spiked-in luciferase 
mRNA for a normalization control, adding 8pg of Luc mRNA to each fraction after 
addition of Trizol LS.  While this method should work in principle, in practice we found 
that technical duplicates (ie, a single gradient with each fraction split into two) 
normalized in this manner were less identical than those simply prepared starting with an 
equal volume of each fraction and carried through with careful volumetric pipetting.  In 
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the end, it was found that liquid-phase extraction of equal volumes of samples gave 
highly reproducible results without further normalization.  QPCR measurements were 
made for each of 16 gradient fractions, for 9 control genes and 9 target genes, with each 
fraction plotted as a percentage of the sum of the gradient fractions for a given gene 
(Figure 2).  It was also confirmed that each primer pair generated a single product of 
expected size on a gel (Figure 3).  In agreement with previous microarray analysis of 
pooled polysomes (Darnell 2011), there were no significant changes in the steady state 
polysome profiles of target mRNAs in the absence of FMRP. 
 
Runoff of polysomes with puromycin in live cells shows that FMRP is associated 
with mRNAs containing both active and stalled ribosomes  
Although presence of mRNA in heavy polysome fractions is commonly considered a 
direct measure of translational output, these fractions can also contain transcripts on 
which ribosomes are engaged but not translocating.  For example, binding of the miRNA 
let-7a to the lin-41 3’UTR repressed expression of reporter mRNAs without affecting 
migration of the mRNA on sucrose gradients (Nottrott et al., 2006).  As discussed above, 
one method of distinguishing actively translating polysomes from stalled polysomes is to 
remove translocating ribosomes from mRNA using puromycin.  Treatment of 
neuroblastoma (N2A) cells with puromycin revealed that while FMRP-associated 
polysomes were partially sensitive to puromycin, these transcripts remained associated 
with 3 or 4 ribosomes after runoff, even after treatment with a high concentration of 
puromycin (1mM) (Stefani et al., 2004).  The fact that these ribosomes remain associated 
with mRNA after puromycin treatment suggests that they are nontranslocating, as 
puromycin can only be incorporated by actively translating ribosomes.  Since FMRP 
remained in heavier fractions after puromycin treatment than other RBPs such as polyA 
binding protein (PABP) and Hu (Darnell et al., 2011), this suggests that polysomes 
associated with FMRP are less sensitive to puromycin than the general polysome 
population.   
 
Gradient fractions containing FMRP after puromycin runoff should also contain FMRP 
target transcripts.  Furthermore, if these transcripts are less sensitive to puromycin 
 51 
because FMRP causes ribosomes to stall, then removal of FMRP from its target 
transcripts might allow stalled ribosomes to resume translocation, rendering them 
sensitive to puromycin.  To test this, puromycin runoff was performed in N2A cells in 
which expression of FMRP, FXR1P and FXR2P was simultaneously knocked down.  
Cells were treated with pools of four siRNAs for each protein, for five hours on each of 
two consecutive days.  On the third day, cells were treated with puromycin for 1 hour and 
then arrested with cycloheximide.  All three FXRPs were successfully knocked down by 
approximately 90%.  Lysates were loaded over 20-50% sucrose gradients and analyzed 
by Western and QPCR as before. Interestingly, the triple knockdown increased the 
sensitivity of target transcripts to puromycin, without affecting puromycin sensitivity of 
nontarget transcripts (Figure 4).  This suggests that ribosome stalling is a reversible 
phenomenon regulated by FMRP (and/or its paralogs) that is limited to a particular set of 
mRNAs. 
 
FMRP target transcripts are resistant to puromycin in an in vitro translation system 
programmed with endogenous brain polysomes  
The results from N2A cells suggest that FMRP stalls ribosomal translocation on target 
mRNAs.  However, since N2A cells do not express many of the FMRP target transcripts 
and the physiology of cultured cells is not reflective of that of neurons in brain, their 
usefulness for investigating FMRP’s role in brain is limited.  In particular, development 
of a functional assay for FMRP in mouse brain, the same system in which FMRP’s 
targets were identified by HITS-CLIP (Darnell et al., 2011), would allow direct 
comparison of results from binding and functional assays.  However, freshly prepared 
mouse brain lysate does not support translation.  In order to examine FMRP’s effects on 
its endogenous mRNA targets while preserving normal FMRP:RNA stoichiometry, 
Jennifer Darnell developed the IVT-EBP assay (in vitro translation of endogenous brain 
polysomes).  In this assay, freshly homogenized postnuclear mouse brain lysate is mixed 
with amino acids, ATP and rabbit reticulocyte lysate (in which globin and other 
reticulocyte mRNAs have been destroyed by micrococcal nuclease).  Incubation of the 
mixture with puromycin resulted in ribosome runoff evident by 2 minutes and complete 
by 20 minutes, as measured by A254 trace of ribosome distribution and 
35
S-methionine 
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incorporation into new protein (Darnell et al., 2011).  Increasing the incubation to 45 
minutes or increasing the concentration of puromycin by 10-fold did not induce 
additional loss of ribosomes from mRNA.  If puromycin’s effect was blocked by 
inclusion of cycloheximide in the reaction, polysomes remained intact, indicating that the 
decrease in A254 signal corresponds to ribosome runoff and not degradation of mRNA 
during the incubation.  Finally, blockade of initiation using hippuristanol, an inhibitor of 
the helicase eIF4A, had no significant effect on incorporation of 
35
S-methionine during 
elongation in the absence of puromycin, indicating that new initiation is limited in this 
system and therefore suggesting that observed runoff primarily involves ribosomes that 
initiated translation in vivo.  Importantly, distributions of FMRP and other RBPs after 
puromycin runoff in the IVT-EBP system appeared extremely similar to their 
distributions after puromycin runoff in N2A cells: in both systems, FMRP was retained in 
heavier sucrose fractions after runoff than other polysome-associated RBPs, and in both 
systems FMRP and other RBPs migrated at the top of the gradient after EDTA treatment.  
Collectively, these results suggest that the IVT-EBP system offers a valid approach to 
studying ribosomal translocation on endogenous brain polysomes. 
 
We next investigated the effect of FMRP loss-of-function in the IVT-EBP system on the 
sensitivity of target transcripts to puromycin.  Lysates from wt/Fmr1 KO and wt/I304N 
littermate pairs in the third postnatal week were incubated with puromycin in the IVT-
EBP system and then separated over 20-50% gradients.  The gradient distribution of 
FMRP was assayed by Western blot before and after runoff, confirming that FMRP 
remained in relatively heavy fractions after puromycin treatment (Figure 5).  Fractions 
were collected and analyzed by QPCR as before, and the gradient distributions of nine 
target and nine nontarget mRNAs were assayed.  In both Fmr1 KO and I304N lysates, 
target mRNAs were more sensitive to puromycin than in wt lysates (Figure 6).  This 
suggests that FMRP inhibits ribosomal translocation on endogenous brain transcripts, and 
suggests that it is specifically the polysome-binding activity of FMRP (which is 
abrogated in the I304N mouse) that is responsible for this effect.  Nontarget transcripts 
did not exhibit significant increases in puromycin sensitivity in the absence of polysome 
association by FMRP, further strengthening the argument that physical association of 
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FMRP with transcripts (as assayed by CLIP) is the key factor that determines the 
differential puromycin sensitivity. 
 
Because the IVT-EBP system experiences little translational initiation, it primarily assays 
runoff of ribosomes previously engaged on transcripts in vivo.  We were interested to 
know whether FMRP’s inhibition of ribosomal translocation could be acutely relieved, to 
show that observed effects are due directly to FMRP loss-of-function, rather than to 
possible secondary consequences of long-term loss of FMRP function in animal models 
(for example, FMRP targets the elongation factor eEF2, which would be predicted to 
chronically inhibit global elongation).  Treatment of polysomes with kcRNA, an aptamer 
for FMRP identified in SELEX experiments, has been shown to effectively and 
specifically remove FMRP and its paralogs FXR1P and FXR2P from polysomes without 
affecting polysome integrity (Darnell et al., 2005a), (Darnell et al., 2009).  Wt brain 
lysate from the third postnatal week was treated with 1uM kcRNA or kcRNAC50G (a point 
mutant that does not bind to FMRP) immediately prior to addition of the other 
components of the IVT-EBP system. Reactions were terminated with cycloheximide, 
fractionated over 20-50% sucrose gradients and analyzed by QPCR as before, for the 
same set of 9 targets and 9 nontargets.  As expected, kcRNA released FMRP from 
polysomes in the IVT-EBP system, while treatment with kcRNAC50G did not affect 
migration of FMRP on sucrose gradients compared to puromycin treatment alone (Figure 
5).  We found that acute removal of FXRPs from polysomes relieved ribosome stalling, 
increasing sensitivity of target but not nontarget transcripts to puromycin (Figure 7).  In 
fact, there was a significantly greater effect on the target mRNAs compared to runoff in 
Fmr1 KO or I304N brain (Figure 9 and related text), which may be due to the fact that 
kcRNA removes both FMRP and its paralogs from polysomes.   
 
One important control concerns the fact that the stoichiometry between FMRP and 
associated mRNAs is unknown.  In theory, if enough molecules of FMRP associated with 
individual transcripts, loss of FMRP alone could cause transcripts to migrate at lower 
densities on sucrose gradients.  FMRP’s molecular weight (75kD) is roughly 1/50
th
 that 
of a eukaryotic ribosome (4000kD).  Loss of FMRP during puromycin runoff causes 
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mRNA migration shifts consistent with loss of approximately 4-8 ribosomes.  Although 
migration on a sucrose gradient is not strictly proportional to molecular weight, it can be 
estimated that loss of 200-400 molecules of FMRP from a transcript in theory could 
produce such a shift in its gradient migration.  To test whether the observed migration 
shift of target mRNAs to lower gradient densities in presence of kcRNA during 
puromycin runoff is associated with loss of translocating ribosomes or is due solely to 
loss of FXRPs, removal of FXRPs by kcRNA was delayed until after puromycin runoff 
was complete.  To ensure that elongation was completely halted before addition of 
kcRNA, reactions were placed on ice slush and treated with both cycloheximide and 
anisomycin, inhibitors of elongation that target the translocation and peptidyl bond 
formation steps, respectively.  Under these conditions, kcRNA removed approximately 
80% of FMRP from polysomes (Figure 8).  Reassuringly, removal of FXRPs from 
polysomes after the runoff reaction was stopped had almost no effect on the gradient 
migration of target transcripts (Figure 8).  This suggests that the FMRP-dependent shift 
of target mRNAs to lighter gradient fractions during puromycin runoff is indeed due to 
increased loss of translocating ribosomes and does not simply reflect loss of FMRP mass 
from polysomes. 
 
The specificity of the above findings for transcripts targeted by FMRP suggested there 
might be a correlation between the magnitude of the FMRP-dependent puromycin shift 
and the degree of FMRP binding as assayed by CLIP.  In order to make statistical 
comparisons between the two experiments, the IVT-EBP kcRNA dataset was expanded 
to 22 targets and 17 nontargets (Figure 7).  Because some mRNAs with the highest 
numbers of tags have long coding sequence lengths, a number of target mRNAs with 
shorter coding sequence lengths were purposefully selected, as well as several nontargets 
with long coding sequence lengths (Table 1).  Nontargets were also well expressed in 
neurons, according to a published database of neuron-specific gene expression in mice of 
similar age to those used in our experiments (Table 1, Cahoy 2008).  In order to quantify 
the increase in ribosome runoff upon removal of FMRP from polysomes, transcript 
abundance in each fraction was weighted for the number of ribosomes per transcript in 
that fraction (Figure 9A).  To do this, the linearity of the sucrose gradients was first 
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established by measurement of the sucrose concentration in each fraction of a blank 
gradient using a sucrose refractometer.  Next, the number of ribosomes per transcript was 
counted for the first nine fractions of a cycloheximide-treated gradient based on peaks in 
the UV254 profile.  The number of ribosomes per transcript in fractions 10-16 was then 
extrapolated using a best-fit curve.  Weighting transcript abundance according to 
ribosome loading in this way transforms each QPCR data point into a measure of 
translational potential.  The sum of the ribosome-weighted values for each fraction of the 
gradient thus represents the total translational potential of a transcript, in this case 
reflective of the number of ribosomes retained on the transcript after puromycin runoff.  
The difference in this final value after puromycin runoff in the presence versus absence 
of FMRP is a metric we call the retained ribosome score (RRS).  The RRS is thus a 
measure of how much FMRP-dependent ribosome stalling occurs on target transcripts.   
 
The RRS was significantly higher for targets compared to nontargets in all three loss-of-
function models used in the puromycin runoff assay (Figure 9B).  The difference was 
particularly significant for the expanded kcRNA dataset of 22 targets and 17 nontargets 
(p=9.7x10
-8
) (Figure 9D).  RRS was not correlated with transcript abundance or steady-
state ribosome loading.  There was a correlation of RRS with coding sequence length, 
mainly due to an effect of the targets (R
2
=0.17 for nontargets, 0.56 for targets and 0.41 
overall) (Figure 9E), consistent with the idea that since longer transcripts tend to be 
associated with more ribosomes, more ribosomes are potentially available for stalling.  
Importantly, however, RRS was still significantly increased for 7 targets of moderate 
coding sequence length (1000-2000nt) compared to a matched set of 6 nontargets within 
the same CDS length window (Figure 9F).  RRS also correlated well with FMRP target 
specificity as assayed by FMRP polysome CLIP, both in terms of chi-square score 
(R
2
=0.53) and tags per gene (R
2
=0.39) (Figure 9C and data not shown), providing 
further evidence that the magnitude of ribosome stalling depends on the extent of FMRP 
interaction with specific targets.   
 
Inspection of the kcRNA runoff results shows that even nontarget mRNAs contain some 
residual ribosomes after runoff is complete (with peaks in fractions 5-8), though these 
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residual ribosomes do not become sensitive to puromycin in the absence of FMRP.  
While we do not understand why these residual ribosomes are present, the number of 
residual ribosomes reflects the original number of ribosomes loaded on transcripts in the 
steady state, and such an effect has previously been observed by others (Maroney et al., 
2006).  Removal of residual ribosomes by inclusion of 30mM EDTA during puromycin 
runoff caused mRNAs to migrate in lighter fractions, usually fractions 4-5 (Figure 10), 
consistent with puromycin-resistant complexes containing ribosomes.  For a few genes, 
EDTA treatment revealed that a large portion of mRNA was not associated with 
ribosomes in steady state, for example Bsn, Adcy1 and Pabpc1, suggesting additional 
mechanisms of translational control based on inhibition of initiation or sequestration of 
mRNAs from translational machinery.  Overall, most transcripts migrated in somewhat 
heavier fractions after EDTA treatment than had been expected based on the canonical 
view that transcripts shift to the lightest gradient fractions (eg, fraction 2) after EDTA 
treatment (Matthews et al., 2007).  However, these original findings were based on 
analysis of housekeeping mRNAs that have short coding sequences and are likely under 
little regulatory control by associated RBPs (Fagan et al., 1991), both factors that would 
be predicted to result in migration in lighter fractions.  In agreement with this prediction, 
we did find that the mRNA of the short housekeeping gene Hprt1 migrated in fraction 2 
after EDTA treatment. 
 
Complexes retained in heavy fractions after runoff contain ribosomes and FMRP 
The facts that FMRP-associated transcripts are partially sensitive to puromycin and that 
puromycin-resistant complexes can be further shifted by EDTA suggest that these 
transcripts are in polysomal complexes.  However, more direct evidence that the FMRP 
migrating in dense fractions after puromycin treatment is associated with polysomes is 
desirable.  There are examples of large RNPs that cosediment with polysomes on sucrose 
gradients but are not actually polysomes (for example see (Thermann and Hentze, 2007)).  
Immunoprecipitation experiments do suggest that FMRP is buried in some sort of 
complex, as it is largely inaccessible to antibodies under native conditions.  
Immunoprecipitation of FMRP from mouse brain is limited unless lysate is treated in 
ways that disrupt RNPs, such as with RNAse, EDTA, or kcRNA (Figure 11).  These 
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results are consistent with disruption of FMRP-polysome interactions, but could also be 
consistent with disruption of other kinds of RNPs.  To directly visualize complexes 
present in fractions containing FMRP and puromycin-resistant transcripts, puromycin 
runoff of brain polysomes was performed in the IVT-EBP system and lysates were 
separated over sucrose gradients.  Fraction 9 (which contains FMRP after runoff) from 
both puromycin-treated and cycloheximide-treated gradients was examined by electron 
microscopy using negative staining with uranyl acetate.  Both samples were richly 
populated with structures of approximately 100nm in diameter containing multiple 
globules of a size consistent with that of eukaryotic ribosomes (Figure 12).  Importantly, 
these structures appear extremely similar to previously published electron micrographs of 
polysomes (for example see (de Petris, 1970)), suggesting that they are indeed 
polysomes.  Markedly fewer polysomes were visible by EM after puromycin runoff, 
consistent with disassembly of most polysomes during runoff.  To assess whether 
polysomes that survive runoff are compact RNPs, an additional sample was treated with 
micrococcal nuclease after puromycin runoff to cleave any RNA not protected by RBPs.  
Micrococcal nuclease treatment caused no apparent differences in the appearance or size 
of the residual polysomes compared to puromycin runoff alone, suggesting that 
polysomes remaining after puromycin runoff do not contain freely accessible RNA and 
consistent with a model of tightly stacked stalled ribosomes (see discussion).  No other 
large structures such as granules were obvious in any of the preparations.  Polysomes 
were further characterized by immuno-electron microscopy (IEM).  Because previous 
evidence suggested that it might be difficult to achieve antibody binding to FMRP on 
intact polysomes (Figure 11), we piloted IEM conditions using EGFP-tagged ribosomal 
protein L10a.  Polysomes were prepared from cerebella of Pcp2-promoter driven EGFP-
tagged rpL0a BAC transgenic mice, which express EGFP-tagged ribosomes in Purkinje 
cells (Heiman et al., 2008).  Fractions were fixed with 4% paraformaldehyde and 0.08% 
glutaraldehyde to preserve polysome structure during immunolabeling and probed with 
an EGFP antibody coupled to 6nm gold particles.  Although images were less distinct due 
to antibody incubation and limitations of fixation procedures, they appeared similar in 
composition to those previously seen.  We observed antibody binding to a minority of the 
polysomes (roughly 1%), consistent with the fact that EGFP-rpL10a is expressed in a 
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subpopulation of neurons (Figure 13).  Although most polysomes were unlabeled, 
multiple gold particles were often observed on those that were labeled, consistent with 
multiple EGFP-tagged ribosomes existing on polysomes from Purkinje cells.  Together, 
these results support the morphologic evidence that the observed structures are 
polysomes, although lack of an EGFP-negative control in this pilot study precludes 
definitive conclusions based on the immunolabeling.  We next attempted IEM of 
polysomal FMRP, using EGFP-tagged FMRP expressed in 293T cells in hopes of 
presenting a more accessible antigen.  Polysomes were compared from lysates containing 
either N-terminally or C-terminally tagged FMRP constructs and it was found that better 
signal was obtained with the N-terminal tag.  Direct probing for FMRP using the 
antibody 17722, which recognizes an epitope in the C-terminal, also failed to produce 
labeling.  Together these results are consistent with the C-terminal of FMRP being less 
accessible in vivo than the N-terminal.  293T cells transfected with N-terminally tagged 
EGFP-FMRP or EGFP alone (which is not expected to associate with polysomes) for 2 
days were treated with puromycin for 1 hour and then arrested with cycloheximide as 
before.  As a control, cells expressing each construct were treated with cycloheximide 
alone.  Lysates from the four conditions were separated over 20-50% sucrose gradients 
and fraction 10 was fixed in 4% paraformaldehyde and 0.1% glutaraldehde and processed 
for IEM using an EGFP antibody coupled to 12nm gold.  500 polysomes were counted 
from each condition and the number of gold particles per polysome was noted.  A greater 
percentage of polysomes were positive for EGFP labeling after puromycin runoff 
compared to the cycloheximide control, indicating enrichment for FMRP-containing 
complexes after runoff of actively translating polysomes (Figure 16).  Overall, 13.4% of 
polysomes from cells expressing EGFP-FMRP were labeled after puromycin runoff, 
compared with 7.2% of polysomes from cells treated with cycloheximide and 0.02% of 
polysomes from cells expressing EGFP alone.  In sum, these results show that fractions 
containing target transcripts resistant to puromycin also contain structures with the 
morphologic appearance of polysomes that include both ribosomes and FMRP.  
Together, these results support the assertion that target transcripts are associated with 
both FMRP and stalled ribosomes. 
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Discussion: 
Recent identification of hundreds of FMRP-associated mRNAs by HITS-CLIP (Darnell 
et al., 2011) provided a critical clue about FMRP regulatory function – that FMRP 
associates with the entire coding sequence of target mRNAs.  Historically, attempts to 
elucidate FMRP’s function have produced a jumble of results, with descriptions of FMRP 
directing miRNA-mediated translational repression (Muddashetty et al., 2011), (Edbauer 
et al., 2010), FMRP regulating mRNA stability via 3’UTR interactions (Zalfa et al., 
2007), (Schutt et al., 2009), FMRP inhibiting translation initiation via interaction with the 
eIF4E-binding protein Cyfip1 (Napoli et al., 2008), FMRP potentiating translation by 
binding the novel SoSLIP RNA motif (Bechara et al., 2009), and even a report of a 
FMRP binding site functioning as a splicing enhancer (Didiot et al., 2008).  While in 
general, consensus seemed to be that FMRP was a negative regulator of translation, in 
vivo evidence of such was limited and somewhat inconsistent (see Introduction).  In 
retrospect, much of the difficulty in ascertaining the mechanistic function of FMRP 
appears to stem from the fact that loss of FMRP does not cause obvious, easy-to-detect 
changes in the translational status or protein levels of its targets, as well as from frequent 
reliance on overexpressed recombinant proteins (which can have nonphysiologic RNA 
association properties) (Laggerbauer et al., 2001), (Coffee et al., 2012), (Gross et al., 
2011) and reporter transcripts (which are not FMRP targets and are often designed to 
assay FMRP association with 3’UTRs rather than coding sequence) (Wang et al., 2004), 
(Edbauer et al., 2010).  Here, we used the finding from the unbiased, rigorous HITS-
CLIP assay that FMRP associates with the coding sequence of particular mRNAs to 
guide the design of a functional assay for FMRP’s role in translation.  Through use of 
puromycin-induced ribosome runoff assays in multiple genetic, molecular and 
biochemical FMRP loss-of-function models, we demonstrate that FMRP inhibits 
ribosome translocation on a specific set of mRNAs shown to physically associate in vivo 
with FMRP by HITS-CLIP. 
 
FMRP stalls ribosomes on target transcripts 
Early translational runoff assays found that disassembly of translating polysomes was 
associated with FMRP migration at lighter densities on sucrose gradients (Stefani et al., 
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2004), (Feng et al., 1997a), (Wang et al., 2008).  These experiments were interpreted as 
evidence that FMRP was associated with actively translating polysomes that were 
disrupted during runoff.  However, various other findings suggested that FMRP inhibited 
translation, apparently inconsistent with a role on actively translating polysomes 
(Laggerbauer et al., 2001), (Li et al., 2001), (Qin et al., 2005), (Lu et al., 2004), (Zhang et 
al., 2001).  In particular, loss of FMRP was associated with increased incorporation of 
35
S-methionine in hippocampal slices and in vitro translation systems (Darnell et al., 
2011), (Osterweil et al., 2010), consistent with negative regulation of protein synthesis by 
FMRP.  Together, these results created an apparent paradox as to how FMRP could be 
associated with actively translating polysomes and yet inhibit protein synthesis. 
 
Resolution of this paradox was set in motion by the realization that FMRP-associated 
transcripts are only partially sensitive to translational runoff.  Examination of sucrose 
gradients after puromycin runoff in cells showed that FMRP migrated in fractions 
containing polysomes that still retained some ribosomes after runoff (Stefani et al., 2004), 
(Darnell et al., 2011).  These results are consistent with a model in which FMRP 
associates with polysomes on which some ribosomes are sensitive to puromycin and 
some ribosomes are not.  Since only translocating ribosomes are sensitive to puromycin, 
this suggests that FMRP-associated mRNAs contain some translocating and some stalled 
(nontranslocating) ribosomes.  However, it does not necessarily follow that FMRP causes 
reduced sensitivity to puromycin.  To address whether FMRP directly causes polysomes 
to be less sensitive to puromycin, it must be demonstrated that acute loss of FMRP results 
in increased puromycin sensitivity and that this effect is limited to FMRP target 
transcripts.  In other words, loss of FMRP should result in resumption of ribosome 
translocation on a set of specific FMRP-associated mRNAs. 
 
To investigate whether FMRP directly causes ribosome stalling, puromycin runoff assays 
were first performed in N2A cells in which expression of the FXRPs was knocked down.  
In this system, loss of FXRP expression resulted in increased runoff of ribosomes from 
target mRNAs but did not affect runoff of nontarget mRNAs, consistent with inhibition 
of ribosome translocation on specific mRNAs in vivo by FXRPs.  In order to extend this 
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result to mouse brain, the system in which FMRP-associated mRNAs were identified by 
HITS-CLIP and the system most relevant to FXS pathology, Jennifer Darnell developed 
the IVT-EBP system, in which endogenous brain polysomes are used to program a 
puromycin runoff assay performed in reticulocyte lysate.  Although the IVT-EBP assay is 
an in vitro system, because it is based on freshly prepared mouse brain lysate it maintains 
several advantages reminiscent of in vivo assays: endogenous levels and stoichiometries 
of all RBPs and mRNAs are maintained, posttranslational modifications of FMRP or 
other RBPs are established in vivo, and initiation of translation and FMRP association 
with mRNAs occurs in vivo.  In agreement with previous results in N2A cells, polysomes 
from Fmr1 KO brains exhibited quantifiably increased puromycin sensitivity compared 
to polysomes from wt brains, and the increased puromycin sensitivity was limited to 
FMRP target transcripts.  Importantly, this effect was due specifically to the RNA-
binding function of FMRP: the I304N point mutation that abolishes FMRP polysome 
association and recapitulates major aspects of FXS in mice (Zang et al., 2009) also 
resulted in increased puromycin sensitivity of the same set of target transcripts but not 
nontarget transcripts.  Finally, FMRP-dependent ribosome stalling was found to be an 
acutely reversible effect, since removal of FXRPs from polysomes by kcRNA treatment 
at the beginning of the puromycin runoff assay recapitulated the findings from runoff 
assays using Fmr1 KO and I304N brains.  Acute reversibility of FMRP-dependent 
ribosome stalling is an important point, since it demonstrates that the increased sensitivity 
to puromycin during runoff is directly due to loss of FMRP and is not a secondary effect 
of long-term loss of function of FMRP (for example, via downregulation of targets with 
roles in translation, such as the elongation factor eEF2).  Notably, the kcRNA-dependent 
effects on target mRNAs were quantifiably greater than those observed using genetic 
models, presumably because kcRNA treatment also removes the FXRPs, which likely 
provide some functional redundancy to FMRP (Spencer et al., 2006), (Darnell et al., 
2009).  Together, these results constitute a coherent set of assays in four models that 
reproducibly demonstrate increased puromycin sensitivity of ribosomes on target but not 
nontarget mRNAs upon FMRP loss of function.  Since puromycin specifically affects 
translocating ribosomes, these results are consistent with a model in which FMRP 
represses translation by stalling ribosomes during elongation.  
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Results from puromycin runoff assays were quantified by weighting measurements of 
transcript abundance to reflect ribosome loading in each gradient fraction.  This approach 
transformed measurements of mRNA distributions into measurements of protein 
producing capacity, since polysomes contain varying numbers of ribosomes but all 
polysomes contain a single molecule of mRNA.  Transforming the data in this way more 
accurately reflects the effect of FMRP on protein production; since polysome 
fractionation is nonlinear with respect to polysome size, small shifts in mRNA 
distribution in dense fractions represent a much greater change in total ribosome loading 
than do small shifts in mRNA distribution in light fractions.  We developed a metric 
called the Retained Ribosome Score (RRS) that defines the magnitude of FMRP’s effect 
on ribosome stalling as the difference in total ribosome loading of transcripts after 
puromycin runoff in the presence versus absence of FMRP.  Thus, a positive RRS 
indicates that more ribosomes are stalled in the presence FMRP than in the absence of 
FMRP.  An RRS of zero indicates that FMRP has no effect on ribosome stalling. 
 
RRS was significantly increased for target mRNAs compared to nontargets for all three 
platforms assayed in the IVT-EBP system (wt/Fmr1 KO, wt/I304N and kcRNA/ 
kcRNAC50G), with the greatest increases seen for the kcRNA platform, in which both 
FMRP and its paralogs were removed from polysomes.  There was a correlation of RRS 
with coding sequence length of target transcripts (RRS was only weakly correlated with 
coding sequence length of nontargets).  This finding is consistent with the facts that 
FMRP associates with the entire length of the coding sequence of target transcripts and 
that long transcripts tend to be more heavily loaded with ribosomes (and thus may have 
more stalled ribosomes).  Importantly, we controlled for coding sequence length by 
intentionally assaying both short targets and long nontargets.  Within a restricted set of 
CDS-matched targets and nontargets, RRS was still significantly increased for the targets.  
RRS also correlated well with HITS-CLIP ranking of target mRNAs, linking physical 
association of FMRP with specific mRNAs to increased ribosome stalling on the same 
transcripts.  Overall, although the RRS findings are highly significant, there were some 
outliers.  Adcy1 and Bassoon are top FMRP targets as assayed by CLIP, and yet had low 
 63 
RRS scores.  Interestingly, comparison of the EDTA and cycloheximide control gradients 
showed that most Adcy1 and Bassoon mRNA was not associated with ribosomes in the 
steady state.  In the case of Bassoon, there was a subset of ribosome-loaded transcripts 
that did exhibit increased puromycin sensitivity in the absence of FMRP.  The finding 
that these mRNAs are largely translationally silent is consistent with a literature 
describing translational repression of specific mRNAs under certain conditions, for 
example during transport to synapses (Wang et al., 2010), and explains the low RRS 
scores of these strong targets.  Another outlier, Atp1a3, was originally predicted to be a 
strong target based on its high number of CLIP tags, yet exhibited a low RRS in the IVT-
EBP assay.  In retrospect, Atp1a3 mRNA is extremely abundant and therefore may not in 
fact be highly FMRP-associated.  A third set of outliers (Dlg4, Pctk1, and Gnb1) had 
almost no residual ribosomes left after runoff even when FMRP was present.  The fact 
that these mRNAs experienced more complete runoff than other genes may be related to 
the fact that they were somewhat more lightly loaded with ribosomes in steady state.  
However, we do not fully understand why stalled ribosomes were not detectable for these 
mRNAs.  Finally, there was a small FMRP-dependent effect on nontargets.  In most cases 
this effect was minimal and may reflect a minor degree of nonspecific reassociation of 
FMRP with nontarget transcripts in vitro.  In a few cases (Vldlr and Npepps), nonspecific 
effects were larger even though these mRNAs have very few FMRP CLIP tags.  Since 
these mRNAs were assayed in the kcRNA platform but not the FMRP-specific loss-of-
function platforms, it is possible that they could be targets of FXR1P or FXR2P but not 
FMRP. 
 
The evidence from puromycin runoff assays supporting a model of ribosome stalling by 
FMRP is augmented by results from 
35
S-methionine incorporation assays performed by 
Jennifer Darnell (Darnell et al., 2011).  In these experiments, mRNAs from mouse brain 
lysate in the IVT-EBP system were allowed to elongate in the absence of puromycin and 
incorporation of 
35
S-methionine into growing peptide chains was monitored by gel 
separation and phosphorimaging.  
35
S-methionine was incorporated into proteins of all 
molecular weights and removal of FMRP from polysomes by kcRNA treatment had no 
effect on global 
35
S-methionine incorporation.  However, immunoprecipitation of Lingo1 
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or CamKIIa polypeptides using N-terminal antibodies showed increased 
35
S-methionine 
incorporation into these proteins when FMRP was removed from polysomes.  In contrast, 
immunoprecipitation of Pabpc1, whose mRNA is not associated with FMRP, did not 
show increased 
35
S-methionine incorporation when FMRP was removed from polysomes.  
These results are consistent with the target specificity demonstrated in the puromycin 
runoff and HITS-CLIP assays and support the assertion that FMRP inhibits protein 
synthesis. 
 
Physical properties of FMRP-stalled transcripts 
Electron microscopy was used to visualize RNPs present in fractions containing FMRP 
and residual polysomes after puromycin runoff.  The morphology and size of observed 
RNPs before and after puromycin runoff closely resembled previously published electron 
micrographs of polysomes (de Petris, 1970), a conclusion also supported by the findings 
that the majority of purported polysomes were dismantled by puromycin treatment and 
that immunolabeling of EGFP-tagged ribosomes was observed.  Importantly, EGFP-
FMRP immunolabeling was detected on a subset of polysomes and this subset was 
enriched after puromycin runoff.  This finding provides evidence that FMRP physically 
associates with the polysomes remaining in dense gradient fractions after puromycin 
treatment, a conclusion that cannot be drawn simply from comigration on gradients.   
 
Treatment with micrococcal nuclease after runoff did not noticeably alter the morphology 
of polysomes remaining in dense fractions.  Micrococcal nuclease preferentially cleaves 
single stranded RNA, so treatment with this enzyme will digest unprotected mRNA while 
leaving ribosomes and mRNA segments protected by ribosomes intact.  The finding that 
micrococcal nuclease treatment did not dissociate polysomes remaining in heavy 
fractions after puromycin runoff suggests that ribosomes on these transcripts are closely 
packed such that the nuclease cannot cleave in between them.  Biochemical experiments 
conducted by Jennifer Darnell support this conclusion (Darnell et al., 2011).  In these 
experiments, dense fractions from gradients after puromycin runoff were treated with 
micrococcal nuclease and surviving polysomes were pelleted under a sucrose cushion.  
This treatment freed nearly all polyA binding protein, as expected for a protein associated 
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with 3’UTRs.  However, this treatment freed very little FMRP, consistent with a model in 
which most FMRP is associated with regions protected by packed ribosomes.  Notably, a 
small amount of FMRP was released by micrococcal nuclease treatment, consistent with 
HITS-CLIP evidence of some FMRP binding in 3’UTRs.  Remarkably, even after 
exposure of nuclease concentrations of 20U/uL a significant fraction of FMRP remained 
in dense fractions.  Overall, these results suggest that FMRP is associated with transcripts 
on which multiple, closely packed ribosomes are present. 
 
 
 
  
Figure 1.  Measurement of steady state mRNA levels from Fmr1
+/+
, Fxr2
+/-
 and 
Fmr1
-/-
, Fxr2
-/- 
littermate pairs.   
mRNA levels of 16 genes were measured total mouse brain extract prepared from 20 
animals (10 littermate pairs) by QPCR; the data were then averaged by genotype.  
Normalization was carried out using GeNorm analysis as described in the text.  No 
significant differences were observed for any mRNAs. 
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Figure 2.  FMRP loss-of-function does not affect mRNA steady-state polysome 
distribution.   
Polysome profiles of target and nontarget mRNAs from wt (black), Fmr1 KO (red) and 
I304N (orange) mouse brains are shown, measured by QPCR.  Brain lysates were treated 
with cycloheximide to stabilize polysomes.  Both FMRP target and nontarget mRNAs are 
shown (following pages).  FMRP loss-of-function did not affect the distribution of target 
or nontarget mRNAs on sucrose gradients.  Error bars represent technical triplicates of 
QPCR measurements. 
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Figure 3.  RT-PCR reactions performed with the QPCR primers used to analyze 
mRNA distributions on polysome gradients.   
cDNA was prepared from pooled brain polysomes.  All QPCR primer pairs produced a 
single product of expected size (indicated in parentheses after gene symbols). Products 
were separated by agarose gel. 
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Figure 4.  Puromycin runoff of polysomes in N2A cells after triple knockdown of 
FXRs.   
Following knockdown of FMRP, FXR1P and FXR2P, N2A cells were treated with 
puromycin to induce ribosome runoff.  Remaining polysomes were stabilized with 
cycloheximide after 1 hour of puromycin treatment and cells were lysed and subjected to 
sucrose gradient fractionation.   
 
A) UV254 traces of sucrose gradients showing polysome runoff with puromycin treatment.  
Slightly more polysome runoff was observed after knockdown of FXRPs.   
 
B) Western blot analysis shows all three FXRPs were successfully knocked down.   
 
C) Runoff of individual mRNAs was measured by QPCR.  Triple knockdown of FXRPs 
resulted in increased ribosome runoff of target mRNAs Map1B and Huwe1 (as evidenced 
by a shift to lighter gradient fractions) but did not affect runoff of a nontarget mRNA 
(Hprt1). 
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Figure 5.  Distribution of FMRP on sucrose gradients in steady state and after 
runoff.   
Brain polysomes were separated on sucrose gradients after puromycin runoff in the IVT-
EBP system and fractions were analyzed by Western blot.  FMRP was associated with 
heavy polysomes in the steady state (cycloheximide treated; CHX) and was associated 
with the heaviest remaining polysomes after puromycin runoff in the IVT-EBP system 
(puro).  Treatment with kcRNA during puromycin runoff removed FMRP from 
polysomes, allowing it to migrate with free proteins in light fractions.  The inactive 
mutant kcRNAC50G did not affect FMRP distribution on polysomes during runoff. 
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Figure 6.  Ribosome stalling on FMRP target transcripts was relieved in two genetic 
models of FMRP loss-of-function.   
Brain lysates from littermate pairs of wt/Fmr1 KO (black/red) or wt/I304N 
(black/orange) mice were subjected to ribosome runoff using puromycin in the IVT-EBP 
system.  Reactions were separated over sucrose gradients and the mRNA levels of 
individual genes were measured by QPCR for each fraction.  A cycloheximide control 
(light blue) indicates original steady-state distributions of transcripts.  FMRP loss-of-
function in both models was associated with increased ribosome runoff of target 
transcripts, as evidenced by migration of target transcripts in lighter gradient fractions.  
FMRP loss-of-function did not alter runoff of nontarget transcripts.  Error bars represent 
technical triplicates of QPCR measurements. 
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Figure 7.  Ribosome stalling on FMRP target transcripts was relieved by acute 
FXRP loss-of-function.  
Brain lysates from wt mice were treated with kcRNA or inactive mutant kcRNAC50G to 
acutely remove FXRPs from polysomes during ribosome runoff using puromycin in the 
IVT-EBP system.  Reactions were separated over sucrose gradients and the mRNA levels 
of individual genes were measured by QPCR for each fraction.  A cycloheximide control 
(light blue) indicates original steady-state distributions of transcripts.  Acute FXRP loss-
of-function was associated with increased ribosome runoff of FMRP target transcripts, as 
evidenced by migration of target transcripts in lighter gradient fractions.  FXRP loss-of-
function did not alter runoff of nontarget transcripts.  In the right-hand column, QPCR 
signal was weighted to reflect ribosome loading of transcripts, as described in the text.  
This representation more realistically reflects the protein-producing capacity of 
polysomes, since mRNAs in heavy fractions are associated with more ribosomes than 
mRNAs in light fractions.  Error bars represent technical triplicates of QPCR 
measurements.    
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Table 1: 39 FMRP target mRNAs assayed in the IVT-EBP system.   
Number of CLIP tags per gene for whole brain and polysome CLIP experiments is shown, along 
with coding sequence length (CDS Length), neuronal mRNA abundance (Cahoy 2008), Retained 
Ribosome score (RRS) and Ribosome Loading score (a measure of the total number of 
ribosomes associated with transcripts on polyribosome gradients before run-off, calculated by 
summation of the ribosome-weighted QPCR values for all 16 fractions of a CHX-treated 
gradient).  
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 Gene Common Name 
Tags: 
Whole 
Brain 
Tags: 
Poly-
some 
CDs 
Length 
mRNA 
RRS 
Ribosome 
Abund Loading 
 TARGETS 
 
            
Mtap1b Map1b 5959 797 7395 1038 178 15.7 
Kif1a Kinesin 1A 3256 565 5094 240 224 16.2 
Bsn Bassoon 2067 568 11829 3738 176 10 
Adcy1 Adenylate cyclase 1 1630 414 3357 3795 175 6.8 
Cyfip2 
Cytoplasmic FMRP-
interacting protein 2 
1225 355 3762 3029 211 12.5 
Nisch Nischarin 970 261 4782 6435 263 15.7 
Pde2a 
Phosphodiesterase 
2a 
925 192 2808 6392 167 11.5 
Camk2a 
Ca/Calmodulin dep. 
kinase IIa 
662 143 1437 1624 112 14.7 
Dlg4 PSD-95 587 157 2175 NA 39 7.5 
Pctk1 
PCTAIRE protein 
kinase 1 
587 95 1491 2711 75 5.4 
Bat2 
HLA-B associated 
transcript 2 
538 187 6477 1360 259 11.1 
Bai2 
Brain-specific 
angiogenesis 
inhibitor 2 
531 213 4650 NA 183 8.8 
Grin2b NMDAR subunit 2B 422 143 4449 903 134 11.2 
Lingo1 Lingo1 355 101 1845 1879 161 11.4 
Grik5 
Kainate receptor 5, 
KA5 
298 111 2940 679 102 7.4 
Dlgap3 SAPAP3 269 86 2934 267 126 7.9 
Atp1a3 
ATPase, Na+/K+ 
transporting, alpha 
3  
246 161 3162 5499 91 17.8 
Gnb1 
G protein, beta 
polypeptide 1 
221 83 1023 3804 29 8.9 
Grin2a NMDAR subunit 2A 205 86 4395 35 220 11.3 
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Gene Common Name 
Tags: 
Whole 
Brain 
Tags: 
Polys 
CDs 
Length 
mRNA 
RRS 
Ribosome 
Abund Loading 
 NON-
TARGETS  
            
Eif3a 
Eukaryotic initiation 
factor 3a 
104 11 4035 2674 49 12.5 
Ndrg4 
NDRG family 
member 4 
79 62 1020 12009 94 13.4 
Ttyh3 Tweety homolog 3  58 41 1575 2831 92 8 
Npepps 
Aminopeptidase 
puromycin sensitive 
55 11 2763 1861 107 13.8 
Pabpc1 PABP 53 11 1911 3161 0 4.9 
Gria1 
AMPAR subunit 
GluR1 
51 29 2724 1710 113 12.3 
Gria2 
AMPAR subunit 
GluR2 
40 17 2652 3090 47 12.4 
St8sia3 
ST8 a-N-Ac-
neuraminide a-2,8-
sialyltransf. 3 
31 8 1143 926 35 10.3 
Glrb 
Glycine receptor, 
beta 
30 8 1491 2573 46 10.8 
Tcerg1 
Transcription 
elongation 
regulator 1 
28 5 3303 1344 47 12 
Canx Calnexin 16 14 1776 3584 68 14.7 
Vldlr 
Very low density 
lipoprotein receptor 
14 0 2622 NA 148 12.2 
Clcn6 Chloride channel 6 12 1 2613 1478 88 11.7 
Arc Arg3.1/Arc 11 9 1191 903 114 10.8 
Sae1 
SUMO1 activating 
enzyme subunit 1 
10 2 1053 1759 45 10.2 
Hyou1 
Hypoxia up-
regulated 1 
9 3 3000 1272 83 17 
Atp6ap2 
ATPase, H+ transp., 
lysosomal acc. prot. 
2 
9 1 1053 10196 64 14.5 
Hprt1 
Hypoxanthine 
phosphoribosyltran
s.1 
4 5 657 4553 29 10.7 
Slc35f1 
Solute carrier family 
35, member F1 
3 6 1227 2092 56 11.6 
Tmem65 
Transmembrane 
protein 65 
2 4 705 1264 21 8.8 
 
 
 
!7
Figure 8.  Removal of FMRP from polysomes after completion of puromycin runoff 
had no effect on mRNA migration on sucrose gradients.   
Wt brain lysate was subjected to ribosome runoff using puromycin in the IVT-EBP 
system and treatment with kcRNA or kcRNAC50G was delayed until after runoff was 
complete.   
 
A) Removal of FXRPs from polysomes by kcRNA treatment after completion of runoff 
did not affect migration of target mRNAs (for comparison to the effect of kcRNA 
addition during runoff, see Figure 7).  This indicates that the FMRP-dependent migration 
shift of target mRNAs on sucrose gradients is due to loss of ribosomes and not to loss of 
FMRP.   
 
B) Western blot of FMRP from heavy polysome fractions.  kcRNA treatment is usually 
performed at 30°C.  To ensure that kcRNA treatment at 4°C was also effective at 
removing FMRP from polysomes, the amount of FMRP remaining in heavy polysomes 
was compared after kcRNA treatment at the two temperatures.  kcRNA was largely 
effective at 4°C (removing ~80% of FMRP from polysomes). 
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Figure 9.  Quantitation of FMRP-mediated ribosome stalling 
A) Characterization of sucrose gradients used in retained ribosome score  (RRS) 
calculations. Top: the percent sucrose (w/w) measured in each gradient fraction using a 
refractometer was linear with fraction number (R
2
 = 0.99). Fractions 1 and 2 correspond 
to lysate.  Bottom: determination of the approximate number of ribosomes (open circles) 
in sucrose gradient fractions by extrapolation from those that can be directly counted 
(black circles), using linear regression analysis (R
2
 = 0.999), based on the linearity 
determined in the top panel.  Figures reflecting the number of ribosomes per transcript in 
each fraction were used to weight mRNA measurements from QPCR analysis of gradient 
fractions (as in Figure 7, right-hand column). 
B) Bar graphs plotting RRS scores in three different FMRP loss of function models 
(I304N, Fmr1 KO, kcRNA) for nine target (gold) and nine nontarget (red) transcripts. 
Significant differences were evident between targets and nontargets in all three systems, 
as well as a significantly greater effect of kcRNA than either genetic FMRP loss of 
function model. Error bars depict the standard error of the mean (SEM). 
C) FMRP binding to target mRNAs (chi-square score of polysome CLIP targets, see 
Darnell 2011) compared with ribosome retention scores from puromycin runoff assays in 
the IVT-EBP system showed a significant correlation for 39 tested transcripts. Target 
transcripts (shaded gold) showed high chi-square values and RRS scores relative to 
nontargets (shaded red), with some outliers. 
D) Twenty FMRP targets and 16 nontargets showed a significant difference in RRS 
(RRSAvg(target) = 148.1 +/- 14.6; RRSAvg(nontarget) = 58.3 +/- 8.9; p = 9.7 x 10
-6
). This 
analysis includes every mRNA tested except Arc and Gria1. 
E) RRS was highly correlated with coding sequence (CDS) length for FMRP targets 
(excluding an outlier, Bsn; CDS 11,829 nts), consistent with FMRP stalling ribosomes 
across the length of the CDS of its target transcripts. 
100
F) Six FMRP targets and seven nontargets matched for length (in the 1000-2000nt 
window) showed a significant difference in RRS (RRSAvg(target) = 93.7 +/- 17.6; 
RRSAvg(nontarget) = 44.8 +/- 8.6; p = 0.040). 
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Figure 10.  EDTA profiles of FMRP target and nontarget transcripts after 
puromycin runoff.   
Ribosome runoff of brain polysomes using puromycin in the IVT-EBP system was 
conducted in the presence of kcRNA (red) or kcRNA plus 30mM EDTA (green).   
Samples were separated over sucrose gradients and QPCR was used to measure the levels 
of the indicated mRNAs in each fraction. Individual mRNAs and their “ribosome loading” 
scores are indicated on each graph. Ribosome loading is a measure of the total number of 
ribosomes associated with transcripts on polyribosome gradients before runoff. Graphs 
are arranged in order of descending ribosome loading, and illustrate the dependence of 
the number of residual ribosomes (the difference between the red and green traces) on the 
number of ribosomes initially associated with each transcript.  EDTA treatment caused 
mRNAs to migrate in lighter gradient fractions, consistent with removal of residual 
ribosomes.  Note that while only FMRP target mRNAs were further shifted by FMRP 
loss-of-function during runoff (Figure 7), residual ribosomes from both target and 
nontarget mRNAs were removed by EDTA treatment. 
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Figure 11.  Immunoprecipitation of FMRP from mouse brain.   
FMRP was immunoprecipitated from mouse brain using the FMRP monoclonal antibody 
7G1.  Treatment with 200nM kcRNA, RNAse A/T1 cocktail or 30mM EDTA markedly 
improved pulldown of FMRP compared to untreated lysate.  The Western blot was 
probed with FMRP monoclonal antibody 2F5.  These results suggest that FMRP’s 
epitopes are masked in vivo by association with an RNA-containing complex, and that 
removal of FMRP from this complex facilitates immunoprecipitation. 
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Figure 12.  Electron micrographs of polyribosomes from mouse brain.   
Polysomes purified on sucrose gradients were examined using uranyl acetate negative 
staining.   
 
Top row: Steady-state polyribosomes treated with cycloheximide.  
 
Middle row: Some intact polyribosomes remained in heavy fractions after puromycin 
runoff (puro), suggesting that they contain ribosomes not sensitive to puromycin.  
 
Bottom row: Some polyribosomes remained in heavy fractions even after both 
puromycin runoff and micrococcal nuclease (MN) treatment, suggesting that remaining 
ribosomes are tightly packed in vivo, protecting underlying mRNA from nuclease 
digestion.  Two different magnifications are shown. 
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Figure 13.  Immunoelectron micrographs of polyribosomes containing EGFP-tagged 
ribosomal protein L10a.   
Sucrose gradients were prepared from cerebellum of the Purkinje cell-specific Pcp2-
promoter driven EGFP-tagged rpL10a BAC transgenic mice (Heiman et al 2008), and 
polyribosome fractions were processed for IEM using an EGFP antibody and a secondary 
antibody labeled with 6nM gold. Specific staining on clustered structures is indicated 
(white arrows); nearby unlabeled polysomes are also shown. Only ~1% of polysomes 
showed labeling, consistent with the use of whole cerebellum for analysis, yet most that 
were labeled had multiple labels, consistent with polysomes from Purkinje cells carrying 
multiple EGFP-tagged ribosomes.   
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Figure 14.   Immunoelectron micrographs of EGFP-FMRP associated with stalled 
polyribosomal complexes after puromycin run-off in vivo in transfected 293T cells.   
 
A) Constructs expressing N-terminally tagged EGFP-FMRP or EGFP alone were 
transiently transfected into 293T cells.  Cells were treated with puromycin for 1 hour to 
induce ribosome runoff and then treated with cycloheximide (CHX) to stabilize 
remaining polysomes.  As a control, some cells were treated only with CHX.  A Western 
blot for EGFP shows each protein was expressed at sufficient levels and was of expected 
size.   
 
B) Cell lysates were then fractionated over sucrose gradients, and fractions from EGFP-
FMRP transfected cells were analyzed by Western blot.  EGFP-FMRP associated with 
normal distribution on polysomes, compared with the endogenous form of FMRP (which 
migrates at 75kD).  Puromycin runoff caused both EGFP-FMRP and endogenous FMRP 
to shift to somewhat lighter gradient fractions, but in both cases FMRP remained 
associated with polysomes.  A sample of sucrose gradient fraction #10 was processed for 
immunoelectron microscopy (IEM) using an EGFP antibody and a secondary antibody 
labeled with 12nM gold (see images on following page).    
 
C) Quantification of IEM data (from the following page).  7.2% of polyribosomes were 
labeled in the presence of EGFP-FMRP in steady state (CHX), while 13.5% of residual 
polyribosomes were labeled in the presence of EGFP-FMRP after ribosome runoff (puro), 
indicating an enrichment of stalled polysomes carrying FMRP after runoff of translating 
polysomes.  Only 0.02% of polyribosomes from EGFP-expressing cells were associated 
with gold, indicating specificity of the labeling.  500 polysomes were counted for each 
treatment.  
 
D) (Following page) EGFP-FMRP was detected on polysomes by IEM in both steady 
state (CHX; top panel) and following puromycin runoff (puro; bottom panel).  Gold 
particles are indicated by white arrows. 
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Chapter IV. Efforts to identify origin of FMRP target specificity 
 
Introduction: 
Data from the previous chapters suggest that FMRP is associated with a specific subset of 
mRNAs.  There is little correlation between number of FMRP polysome CLIP tags per 
gene and transcript abundance on polysomes as measured by exon array, indicating that 
FMRP selectively binds a subset of translated mRNAs (Darnell et al., 2011).  Although 
such a result could arise if the polysomal mRNA pool included abundant glial-specific 
mRNAs to which FMRP does not bind, there is also no correlation between number of 
tags per gene in FMRP polysome CLIP and abundance of neuronal mRNAs, supporting 
the view that FMRP selectively interacts with particular transcripts.  However, the 
polysome CLIP data also show that that FMRP associates with target mRNAs relatively 
evenly along the full length coding sequence without evident sites of specific binding, 
leading one to wonder how specific association with target mRNAs arises.  CLIP 
experiments on other RBPs such as Nova, Argonaute and Fox2 have revealed discrete 
“peaks” or clusters of tags, indicating specific binding of proteins at these sites (Chi et al., 
2009), (Licatalosi et al., 2008), (Yeo et al., 2009).  In the case of Nova and Fox2, binding 
sites identified by CLIP contain sequence motifs that, in combination with other data, can 
be used to greatly increase the confidence of binding site identification (Zhang et al., 
2010).  In this light, the broad distribution of tags observed in FMRP polysome CLIP is 
somewhat unusual.  Interestingly, the FMRP tag distribution profile appears similar to 
that observed in ribosome profiling experiments (Ingolia et al., 2011).  Together with the 
finding that FMRP induces ribosome stalling, these observations support the hypothesis 
that FMRP may associate directly with ribosomes, and that the coding sequence tags 
observed in CLIP may arise due to transient contacts between FMRP and the mRNA as 
FMRP travels along with the ribosome during elongation. 
 
In such an FMRP-ribosome association model, specificity for the mRNA could arise 
prior to the onset of elongation.  One might imagine several scenarios in which this could 
occur.  For example, FMRP could directly bind mRNA at specific sites in 5’UTRs and 
then be packaged into the ribosome as the preinitiation complex matures.  Tags from this 
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sort of interaction would be represented in the polysome CLIP data, since mature mRNAs 
loaded with multiple ribosomes still receive newly initiating ribosomes.  However, if 
direct FMRP binding to mRNA occurs only briefly before FMRP is picked up by the 
scanning 60S preinitiation complex, then there might be only a few tags generated from 
direct mRNA binding compared to those that reflect 60S scanning.  FMRP could also 
interact with the preinitiation complex via binding to 3’UTRs.  This type of looped-
polysome model has precedent; for example, the protein CBEP binds cytoplasmic 
polyadenylation elements in 3’UTRs and inhibits translation via interaction with Maskin, 
an eIF4E binding protein (Stebbins-Boaz et al., 1999). 
 
Initial specific contact with the mRNA could also be mediated through another protein or 
a small RNA.  If selectivity were mediated via a protein-protein interaction, CLIP tags 
might not be generated because FMRP would be less likely to be positioned within bond 
length of the mRNA.  While FMRP has been reported to interact with a number of 
proteins (Bardoni et al., 1999), (Bardoni et al., 2003), (Schenck et al., 2001), (Davidovic 
et al., 2006), the only proteins that are solidly established as interacting partners are its 
paralogs FXR1P and FXR2P (Zhang et al., 1995), (Siomi et al., 1996), (Tamanini et al., 
1999).  Furthermore, a point mutation in the KH2 domain causes FXS phenotypes in 
mouse and human and completely abrogates the polysome association of FMRP (Zang et 
al., 2009), (Darnell et al., 2005b), (De Boulle et al., 1993), indicating the primacy of 
FMRP-RNA interaction in FMRP function.  Nonetheless, it remains a possibility that 
FMRP could be initially recruited to specific mRNAs via a protein-protein interaction, 
and is thereafter associated with ribosomes or mRNA in a KH2 domain-dependent 
manner.  In the case of mediation via a small RNA, a model has been proposed in which 
FMRP inhibits translation via the small RNA BC1 (Zalfa et al., 2003), (Zalfa et al., 
2005), (Napoli et al., 2008).  Wang et al found BC1 bound to eIF4A and PABP and 
proposed a mechanism of nonspecific control whereby BC1 could inhibit translation of 
most/all mRNAs during initiation by inhibiting assembly of eIF4F (Wang et al., 2005).  
However, Zalfa et al proposed that BC1 mediates association between FMRP and its 
targets via binding directly to the 3’UTRs of particular mRNAs (Zalfa et al., 2003), 
(Zalfa et al., 2005).  Later, this same group proposed a new model in which BC1 
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mediates interaction between FMRP and a newly discovered 4EBP, Cyfip1, instead of 
binding mRNA directly (Napoli et al., 2008).  In this model, FMRP is predicted to 
repress initiation by promoting Cyfip1 binding to eIF4E, although Cyfip1 and eIF4E 
remain associated in the Fmr1 KO.  However, while this group claimed that FMRP 
bound BC1 under conditions of 750mM salt in an electromobility shift assay (Zalfa et al., 
2003), others could only recapitulate the binding under conditions of 100mM salt and 
found it was completely abrogated by nonspecific competitor RNA, indicating the 
purported binding underlying the entire mechanism was weak and nonspecific 
(Iacoangeli et al., 2008).  Furthermore, the assumption that translation is stalled at 
initation was based on a moderate reduction in polysome association of target mRNAs in 
the presence of FMRP and the fact that FMRP was observed only in initiation complexes 
and not on polysomes (Zalfa et al., 2003).  We and others find that the vast majority of 
FMRP is in fact on polysomes under similar buffer conditions (Stefani et al., 2004), 
(Khandjian et al., 2004), (Davidovic et al., 2005).  This calls into question the findings of 
shifted polysome association of target mRNAs, further weakening the premise of the 
BC1 model.  However, even though a role for BC1 in FMRP function seems doubtful, it 
is still conceivable that FMRP could select its targets using small RNAs as guides. 
 
Another possibility is that a subset of ribosomal subunits carry FMRP prior to mRNA 
docking, and somehow these ribosomes engage a particular set of transcripts due to some 
unrecognized feature shared by the target mRNAs.  One possibility is simply that FMRP 
is loaded onto ribosomes locally, perhaps in response to neuronal activity, and any 
transcripts in the vicinity of FMRP-carrying ribosomes become targets.  Alternatively, 
target transcripts could somehow actively recruit an FMRP-carrying subclass of 
ribosomes during translation initiation, for example via a specialized initiation factor.  
Interestingly, it was recently shown that mutation of ribosomal protein L38 resulted in 
decreased translation of a specific set of Hox genes in the mouse embryo without a 
change in global protein synthesis (Kondrashov et al., 2011).  Rpl38 sits near an 
evolutionarily recent, conformationally dynamic expansion segment of rRNA, and the 
authors suggest that Rpl38 binding near this region could alter ribosome conformation 
and thus somehow affect the ability of ribosomes to initiate on particular mRNAs.   
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Finally, we must consider the possibility that the coding sequence tags do not arise from 
FMRP moving along transcripts during elongation, but rather reflect association of 
stationary FMRP at random intervals along the coding sequence.  Since CLIP data 
represent population averages, the fact that mapped tags appear to coat the coding 
sequence does not mean that FMRP must coat the coding sequence of individual 
transcripts.  However, the fact that treatment of polysomes with micrococcal nuclease 
releases very little FMRP suggests that the majority of FMRP must associate with 
mRNAs in some sort of RNAse-protected protein complex large enough to pellet with 
ribosomes (Darnell et al., 2011).  In theory, FMRP could extensively multimerize along 
transcripts to produce this effect.  However, data presented in this thesis show that 
removing the FXRs from polysomes by kcRNA treatment after puromycin runoff did not 
change the gradient migration of FMRP target transcripts, suggesting that 
multimerization extensive enough to protect a fragment that cosediments with ribosomes 
is unlikely.  Nonetheless, this does not rule out the possibility that FMRP could exist on 
polysomes as part of some other large, nonribosomal multiprotein complex.  This 
scenario would still require some kind of mechanism to generate specificity for target 
mRNAs.  One theoretical possibility is that FMRP could associate with a transcription 
factor (thus generating specificity for a subset of transcripts) and then be deposited along 
premRNAs during transcription.  An example of an RBP that is deposited in the nucleus 
but still associates with polysomes is Hrp36, which associates with premRNAs during 
transcription and is then exported to cytoplasm, where it associates with polysomes along 
the length of the mRNA coding sequence (Visa et al., 1996).  Or, FMRP could associate 
with all transcripts in a particular location; for example, FMRP associated with the 
endoplasmic reticulum could in theory make contact with mRNAs as they are docked at 
translocons.  Importantly, models in which FMRP associates directly with coding 
sequence could still be consistent with a stalling effect on ribosomes. 
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Results: 
FMRP HITS-CLIP in total mouse brain and purified brain nuclei 
The above scenarios suggest various ways in which FMRP could specifically associate 
with a subset of mRNAs.  We hypothesized that specific FMRP binding sites could exist 
on RNA species not abundant or not included in the pool used for polysome CLIP; for 
example, pre-mRNAs, noncoding RNAs or transcripts undergoing a pioneer round of 
initiation.  To look for possible FMRP associations with RNAs other than mature 
mRNAs, a renewed attempt was made to perform FMRP HITS-CLIP in whole cell lysate.  
Whole brains from a P14 WT and Fmr1 KO littermate pair were chopped and 
immediately crosslinked before homogenization.  Homogenates were processed 
according to the standard CLIP protocol (see Methods) using the polyclonal antibody 
17722.  CLIP tag DNA was recovered from the wt sample after 26 cycles of PCR, while 
no signal was observed in the KO sample until 32 cycles (Figure 15).  Illumina 
sequencing of the wt products resulted in 497,050 unique mappable tags.  1740 mRNAs 
were identified that had at least 50 exonic CLIP tags (Table 2).  Importantly, target 
specificity was still observed: of 16286 mRNAs with measurable neuronal expression 
values (Cahoy et al., 2008), no correlation was found with number of exonic CLIP tags 
per gene (R
2
 = 0.03) (Figure 16).  
 
Of the 497,050 unique tags, 84.6% mapped to exonic sequences (either coding sequence 
or UTRs) (Figure 17).  Only 5.6% mapped to introns, and of these, most corresponded 
either to ncRNA sequences within introns (eg rRNA or tRNA genes) or to misannotated 
exons (eg, Ank2 and Ank3 each have a short isoform with an apparent misannotation of 
the first exon).  The remaining intronic tags were sparsely distributed with no discernable 
pattern in distribution.  The number of exonic tags per gene observed in whole brain 
CLIP correlated highly with that observed in the polysome CLIP experiments (R
2
 = 0.87) 
(Figure 16).  In addition, tag distributions on exonic sequence appeared similar to that 
previously documented for polysome CLIP (Figure 18 and (Darnell et al., 2011)).  
Together, these observations suggest that the majority of FMRP:RNA interactions 
involve mature mRNA. 
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Under our lab’s standard tag mapping pipeline, CLIP tags are not mapped if they match 
more than one genomic locus.  However, many ncRNAs exist in multiple copies in the 
genome; for example, rRNA genes are present in hundreds of copies on multiple 
chromosomes.  In order to more carefully analyze whether FMRP significantly interacts 
with ncRNA, the whole brain CLIP data was remapped using the alignment program 
Bowtie, using parameters under which any given tag was allowed to map to up to 100 
locations in the genome.  Although some ncRNAs exist in more than 100 copies, this 
ceiling was selected due to limits in computational power.  To reduce noise, single tags 
not overlapping with another tag were discarded.  When the data were reanalyzed in this 
manner, the percentage of deep intergenic tags in clusters of 2+ rose from 3.7% to 29.3% 
(Figure 17).  Of the deep intergenic tag clusters, 32% were in unannotated regions, while 
64.6% were repetitive or low complexity regions such as LINEs, SINEs, LTRs, simple 
repeats, or satellite DNA.  The remaining 3.4% of clusters mapped to ncRNAs of 
potential interest, such as rRNA (222 clusters), tRNA (175 clusters), snRNA (166 
clusters), scRNA (120 clusters), srpRNA (7 clusters), or other ncRNAs (19 clusters).  In 
general, the number of tags in individual clusters was low, with a maximum of about 200 
tags per cluster and most clusters containing fewer than 100 tags (with the exception of 
rRNAs, which had high tag numbers in agreement with the extremely high representation 
of rRNAs on polysomes).  Two non-rRNA clusters stood out as having relatively high 
numbers of tags.  The first, with 216 tags, mapped to Y RNA, a ncRNA of poorly 
characterized function that exists as an RNP with the Ro autoantigen and may play a role 
in degradation of misfolded RNAs (Fuchs et al., 2006).  Human Y RNAs are highly 
abundant, within an order of magnitude of 5S rRNA abundance (Christov et al., 2006).  
The second example, with clusters of 118, 118 and 138 tags on three different 
chromosomes, mapped to 7SK RNA, another highly abundant ncRNA with a role in 
transcription (Diribarne and Bensaude, 2009).  Tellingly, nearly all HITS-CLIP studies 
performed in our lab show high numbers of tags at both of these loci, including HITS-
CLIP experiments for Nova, Hu, Ago, brPTB, Mbn13 and Fus.  The fact that several 
RBPs of disparate functions have tags on highly abundant ncRNAs suggests that these 
tags may represent nonspecific “sampling” protein:RNA interaction events.  Overall, at 
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this time we cannot show that FMRP interacts with ncRNAs in a functionally significant 
manner. 
 
Although FMRP has a predominantly cytoplasmic localization in steady state, it contains 
both an NLS and an NES and can be observed in the nucleus if the NES is inactivated by 
point mutation (Fridell et al., 1996) or deleted by truncation construct (Eberhart et al., 
1996).  This suggests that FMRP could bind pre-mRNAs and remain associated with 
them during translation.  Although few intronic tags were observed in the whole brain 
CLIP dataset, this does not rule out the possibility that FMRP has discrete binding sites 
on pre-mRNAs, either in introns or in exons, since half-lives of pre-mRNAs are on the 
order of minutes (Rabani et al., 2011) while half lives of most mRNAs are on the order of 
hours (Sharova et al., 2009).  To investigate whether the specificity of FMRP for its 
mRNA targets arises at the pre-mRNA level, we enriched the pre-mRNA population by 
performing CLIP on purified brain nuclei. 
 
In a first attempt, brains from mice in the first postnatal week were crosslinked and 
homogenized in low salt buffer containing 0.32M sucrose.  After homogenization, lysate 
was brought to either 1% NP-40 or 1% Triton-X100 to solubilize the outer nuclear 
envelope, which is continuous with the polysome-containing rough ER, without lysing 
the nuclei.  Lysates were then spun over a column of 1.8M sucrose to pellet the nuclei 
and strip off any remaining rough ER fragments.  Nuclei appeared as a small, clear flat 
pellet.  Crosslinking reduced the size of the nuclear pellet by approximately half, 
indicating that this process lysed some nuclei.  Western blot analysis of resuspended 
pellets and total lysate showed that FMRP was present in both fractions, while the 
neuronal nuclear marker NeuN (Fox3) was highly enriched in the nuclear pellet and the 
cytosolic marker GAPDH was entirely absent from the pellet (Figure 19).  Importantly, 
the integral membrane ER protein calnexin was also entirely absent from the nuclear 
pellet, indicating successful removal of ER membranes from nuclei.  Resuspended pellets 
were DNAse treated and processed according to the standard CLIP protocol using the 
17722 FMRP antibody.  The wash series after IP was amended to include a second high 
salt and omit the low salt washes, in an attempt to reduce clumping of beads (thought to 
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be due to hydrophilic interactions between DNA and Dynabeads).  Unfortunately, 
although FMRP was efficiently depleted in the IP, no FMRP-specific signal was seen 
after separating products by urea-PAGE, indicating a high level of background in the IPs 
(Figure 20).  Several attempts to reduce background in Fmr1 KO samples were 
unsuccessful, including increasing the time of a preclearing step, increasing stringency of 
washes, and on-bead DNAse treatment after IP. 
 
Because other members of the lab had successfully performed CLIP on nuclei prepared 
by simple low speed pelleting, we decided to try this approach.  Although nuclei prepared 
according to this method are not are pure as those fractionated through sucrose, a high 
level of enrichment for pre-mRNAs compared to whole lysate should still be achieved.  
Nuclear lysate was prepared in a similar manner as above, homogenizing in the same 
buffer and dissolving ER membranes in 0.8% NP-40.  Lysates were spun at 2000xg for 
10 minutes and pellets were gently washed twice in the homogenization buffer by stirring 
with a pipette tip.  Bradford assays indicated the final pellet contained about 8% of total 
cellular protein.  Western analysis showed that GAPDH was present only in the cytosolic 
fraction, while histones, hnRNP C1/C2 and NeuN were present only in the nuclear 
fraction (Figure 21).  Again, calnexin was only present in the cytosolic fraction, 
indicating dissolution of ER membranes.  As expected, both the cytoplasmic and nuclear 
fractions contained ribosomes.  FMRP was also present in both fractions, with 
approximately 11% of total cellular FMRP in the nuclear fraction (in agreement with 
previous observations by Jen Darnell in our lab).  In a pilot CLIP experiment, the 17722 
antibody unexpectedly recognized a nonspecific band of the same molecular weight as 
FMRP which was not seen in whole brain or polysome CLIP experiments (Figure 22).  
However, a different FMRP antibody, 27455, specifically recognized FMRP in nuclear 
lysates (Figure 22).  Comparison of FMRP pulldown by 17722 and 27455 found that 
27455 also IPed FMRP much more strongly.  Therefore, nuclear FMRP CLIP was 
repeated using the 27455 antibody (Figure 23).  Encouragingly, separation of PCR 
products revealed that the nonspecific signal from the Fmr1 KO control was lighter than 
the wt sample and had a more banded (rather than smeared) distribution.  Since this type 
of banded signal is often the result of linker-linker ligation reactions that can predominate 
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in the absence of CLIP tags, products from this sample were TOPO cloned and 
sequenced.  Of the 17 sequences obtained, 7 were indeed primer artifacts and 4 mapped 
to repetitive regions.  Although the remaining 5 tags did map to genic regions, it is 
expected that IPs performed in the absence of antigen will be more susceptible to 
nonspecific antibody interactions.  The wt sample was then submitted for Illumina 
sequencing. 
 
102,698 unique mappable tags were sequenced in the nuclear CLIP experiment.  More 
intronic tags were observed in nuclear CLIP (17.9% of total tags) than in whole brain 
CLIP (5.6% of total tags) (Figure 24).  Nonetheless, overall tag distributions on 
individual transcripts were highly similar to those observed for whole brain CLIP (Figure 
25) and the number of exonic tags per gene observed in nuclear CLIP was well correlated 
with that observed in whole brain CLIP (R
2
=0.68) (Figure 26).  Of the 18,430 intronic 
tags, 63.5% did not overlap with any other tag and were discarded to reduce noise.  Of 
the remaining 6735 tags, 27% mapped to repetitive/low complexity regions and were not 
examined further.  2.5% mapped to rRNA, while 1.6% mapped to other ncRNAs, mainly 
snRNAs.  7.1% mapped to large misannotated exons in Ank2 and Ank3; these were also 
discarded.  Of the clusters not in the above categories, 55% mapped to introns in genes 
with Entrez ID numbers.  The 3734 intronic tags mapped to 1023 genes, and 524 were in 
clusters containing at least 5 tags (80 clusters, with the top cluster containing 20 tags).  
The number of intronic tags per gene did not correlate with mRNA abundance in neurons 
from mice of similar age (R
2
=0.004, Cahoy 2008) or to the number of exonic tags per 
gene as measured in the same experiment (R
2
=0.0005) (Figure 26).  The clusters did not 
appear to be distributed in any discernable pattern.  Since it did not appear that FMRP 
associated with intronic sequence in any consistent manner, the increased number of 
intronic tags in the nuclear CLIP experiment may reflect higher nonspecific background 
in the IP resulting from enrichment of pre-mRNAs in nuclear lysate, and most exonic 
tags sequenced in this experiment may reflect presence of perinuclear polysomes. 
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FMRP HITS-CLIP after seizure: 
Thus far, we have only looked for specific binding sites for FMRP in the steady state.  
However, gene expression in neurons can be highly dynamic in non-resting states, with 
rapid changes in transcription and translation underwriting changes in learning and 
memory.  There is a broad assumption that FMRP is likely to respond to synaptic 
activity, but evidence directly linking synaptic activity to differential translation of target 
mRNAs in an FMRP-dependent manner is limited.  The best examples may be a report 
that mGluR activity results in increased translation of two major FMRP targets, Map1B 
and CamKIIa, in wt hippocampal slices, while synthesis of these proteins is constitutively 
elevated in Fmr1 KO slices, consistent with chronic overtranslation of target mRNAs in 
the absence of FMRP (Hou et al., 2006), and a similar recent report for Arc (Niere et al., 
2012).  In addition, a number of studies have suggested that FMRP levels and/or 
phosphorylation state may respond to synaptic activity induced by a variety of stimuli, 
including pharmacological activation of mGluR and NMDA receptors, whisker 
stimulation, or exposure to light (Narayanan et al., 2007), (Zhao et al., 2011), (Weiler et 
al., 1997), (Nalavadi et al., 2012), (Lee et al., 2011), (Todd et al., 2003), (Gabel et al., 
2004).  We hypothesized that if FMRP binds specific sites on target mRNAs after 
transcription or in early stages of translation, CLIP tags mapping to these sites might be 
enriched after a synchronized transcriptional burst, for example on early immediate genes 
(IEGs) that are induced by seizure, because this situation would temporarily enrich the 
pre-mRNA populations of these genes.  In addition, such an experiment would offer the 
first glimpse of how FMRP association with target mRNAs might be affected by changes 
in synaptic activity, and whether FMRP plays a role in regulating gene expression in 
response to synaptic activity. 
 
Brief seizure activity induced by a single maximal electroconvulsive shock (MECS) is an 
established model for induction of immediate early genes (IEGs) (Cole et al., 1990), 
(Lyford et al., 1995), (Wallace et al., 1998).  Mice exposed to a current via ear-clip 
electrodes experience a short tonic-clonic seizure that results in rapid transcriptional 
upregulation of a number of genes including Arc, c-Fos, zif268/Egr1 and c-Jun.  Many of 
these IEGs are transcription factors, which initiate cascades of further gene expression.  
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Others, such as Arc, have direct roles at the synapse important for synaptic plasticity.  
Collectively, expression of IEGs is a central element in the dynamic response of neurons 
to stimuli.  Importantly, many of the IEGs identified using seizure models have 
subsequently been shown to be similarly upregulated in response to more natural stimuli, 
such as spatial learning (Marrone et al., 2008).  In particular, two IEGs with low numbers 
of FMRP CLIP tags in the steady state drew our attention as possible important targets. 
 
The first, Arc, stood out among other IEGs in early studies because its mRNA is 
transported to dendrites after induction (Wallace et al., 1998). Arc plays a critical role in 
consolidation of memory, as Arc KO mice exhibit deficits in long term memory yet have 
normal short term memory (Plath et al., 2006).  Arc KO mice also have defects in long-
term synaptic plasticity (both LTP and LTD) at Schaffer collateral – CA1 synapses in the 
hippocampus, suggesting that abnormal plasticity at these synapses underlie the defects in 
memory consolidation.  Arc is also essential for the expression of mGluR-LTD, a form of 
plasticity abnormally enhanced in Fmr1 KO mice (Waung et al., 2008), (Park et al., 
2008).  While activation of mGluRs normally causes a rapid increase in Arc protein 
levels, the Fmr1 KO was shown to have constitutively upregulated Arc levels that were 
not further increased upon stimulation (Niere et al., 2012).  Interestingly, Arc expression 
is tightly controlled at both the mRNA and protein levels.  Arc mRNA contains an intron 
within its 3’UTR, rendering it susceptible to exon junction complex-mediated decay after 
the pioneer round of transcription (Giorgi et al., 2007).  Additionally, Arc protein is 
ubiquitinylated by the activity-regulated ubiquitin ligase Ube3a  (Greer et al., 2010).  
Both of these mechanisms limit Arc levels after an initial short burst of expression.  If 
Arc were a target of FMRP (which is difficult to assess under steady state conditions, 
when Arc mRNA levels are very low), release of FMRP-mediated translational inhibition 
could facilitate the rapid Arc translation observed at synapses after mGluR activition.  
Limiting derepression of FMRP to a short window could then confine translation of Arc 
to a short burst. 
 
Another IEG, Homer1a, is of interest because it physically interacts with group I mGluRs 
(Brakeman et al., 1997).  Homer proteins interact with one another through C-terminal 
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coiled-coil domains and are abundant PSD scaffolding proteins, interacting with Shanks 
and various receptors (Hayashi et al., 2009).  Homer1a is the only isoform that is 
upregulated by synaptic activity, and it is the only isoform lacking coiled-coil domains 
(Xiao et al., 1998).  Since mGluRs that bind Homer1a do not participate in scaffolding 
with long Homer isoforms, Homer1a was predicted to have a dominant negative effect on 
mGluR activity (Xiao et al., 1998).  This was demonstrated by expression of either 
Homer1a or a point mutant of Homer1a incapable of binding mGluRs in neurons 
stimulated with DHPG.  Expression of Homer1a disrupted mGluR-mediated inhibition of 
EPSCs, while expression of the point mutant did not (Kammermeier and Worley, 2007).  
Interestingly, Homer1a-mGluR interaction was increased in the Fmr1 KO mouse, which 
suggests that Homer1a might be upregulated by FMRP loss-of-function (Ronesi et al., 
2012). 
 
To characterize FMRP association with target mRNAs after synaptic activity and look for 
potential specific binding sites that might be present under these conditions, we 
performed HITS-CLIP in mice subject to MECS compared to resting mice.  Briefly, mice 
were exposed to a 25mA current for 1s via ear clips and allowed to recover in their home 
cages for different periods of time before sacrifice.  To minimize stimulation due to 
transport from the animal facility, all mice were carried by hand to the lab and rested in a 
quiet space for at least several hours prior to the experiment.  To confirm that the MECS 
protocol was successful, RNA was prepared from cortices and hippocampi from resting 
and MECS mice and Arc mRNA levels were analyzed by QPCR.  As expected, Arc 
levels were increased several fold by 30 minutes in both brain regions (Table 3).  Mice in 
the third postnatal week were stimulated by MECS and sacrificed 5 min, 15 min or 30 
min after seizure, with resting controls.  This shorter timepoints were chosen to maximize 
the chances of catching mRNAs immediately after transcription or during the pioneer 
round of translation, while the longer timepoint reflects a point of more substantial Arc 
upregulation, as observed by QPCR and reported in the literature (Guzowski et al., 1999), 
(Lyford et al., 1995).  Cortices plus hippocampi were rapidly dissected under ice-cold 
buffer, chopped and crosslinked.  Tissues were then homogenized and processed for 
CLIP using the standard whole brain protocol (Figure 27).  Although good results were 
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obtained for all four samples, only the resting and 15 minute samples were submitted for 
Illumina sequencing, as a cost-saving measure given the status as a pilot experiment.   
 
Similar numbers of total unique tags were mapped for resting and MECS samples 
(1,105,165 tags for resting and 820,939 tags for MECS).  The tag ratio (resting/MECS) 
was calculated for each gene, normalized to the total number of tags sequenced in each 
sample to control for differences in sequencing depth.  Of 4949 mRNAs with a total of at 
least 50 tags between the two samples, 117 had at least a 50% increase in tag ratio 
(indicating more tags in the MECS sample), while only 18 had more than a 50% decrease 
in tag ratio (Table 4).  The maximal tag ratio observed in this set of mRNAs was 7.2.  
Although we did not perform RNA Seq due to cost considerations for a pilot experiment, 
it is likely that at some level, increases or decreases in the number of FMRP CLIP tags 
reflect changes in mRNA abundance due to transcriptional regulation.  In keeping with 
this possibility, GO analysis of the 117 mRNAs with increased tags after MECS showed 
enrichment for categories including PolII transcription (biologic process), transcription 
factor complex (cellular component) and DNA binding (molecular function), as well as 
an enrichment for proteins containing leucine zipper domains (UniProt sequence feature) 
(Table 5).  Overall, this is consistent with upregulation of transcription factors (especially 
leucine zipper transcription factors, such as c-Fos and c-Jun) in response to MECS and is 
consistent with the literature on IEGs.  We observed at least a 2X increase in tags on 
three canonical IEGs: c-Fos, zif268/Egr1 and c-Jun, while Arc had a 1.5X increase in 
tags (Table 4).  Two possible models suggest themselves in this situation.  Given the 
extensive literature on IEGs, it is safe to assume that at least some of these genes are 
transcriptionally upregulated after MECS.  In one model, FMRP could reduce its 
association with these mRNAs, in order to facilitate their increased expression (ie, if a 2X 
increase in FMRP CLIP tags was observed but the mRNA in question increased 10X in 
abundance, what appeared to be increased FMRP association could in reality be the 
opposite).  In an alternative model, FMRP could exert a counterbalance at the 
translational level on the expression of IEGs at the transcriptional level.  In order to 
examine whether any mRNAs had decreased tags after MECS, the threshold for total tags 
between the two samples was lowered to 25.  Of the 6791 mRNAs in this set, 102 had 
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more than a 50% decrease in tag ratio.  GO analysis of these mRNAs showed enrichment 
in categories including monovalent cation transport (biologic process) and alkali metal 
ion binding (molecular function) (Table 5).  A logical supposition would be that neurons 
might respond to high levels of synaptic activity by decreasing expression of genes 
involved in membrane excitability, which would be consistent with decreased numbers of 
FMRP CLIP tags on these transcripts.  
 
The number of exonic tags per gene was extremely similar between the resting and 
MECS conditions (R
2
=0.99) and tag distributions were also extremely similar, both 
overall and on individual transcripts (Figures 28 and 29).  In particular, transcripts with 
increased numbers of tags after MECS did not show obvious changes in the distribution 
of the tags, suggesting that newly transcribed mRNAs were rapidly engaged in translation 
(Figure 29).  We had guessed that Homer1a might have an increased number of FMRP 
tags after MECS, based on its status as an IEG with a dominant negative effect over 
mGluR scaffolding interactions with long Homer isoforms.  In fact, we found no 
difference in the number or distribution of Homer1a tags after MECS.  However, due to 
the markedly improved sequencing depth obtained in this experiment, we were able to 
observe a number tags mapping immediately downstream of the annotated ends of the 
3’UTRs for both short and long Homer1 isoforms, suggesting unannotated 3’UTR 
extensions exist.  Binding of an RBP to unannotated extensions of 3’UTRs has been 
previously described, (Licatalosi et al., 2008) and suggests that HITS-CLIP maps can 
inform gene annotation under certain circumstances.  However, the lack of change in 
FMRP:Homer1a association 15 minutes after MECS does not rule out the possibility that 
FMRP may dynamically regulate Homer1a.  Fluorescent in situ hybridization studies 
using riboprobes to 5’ and 3’ ends of the 50kB Homer1a gene have shown that although 
Homer1a transcription begins within minutes of MECS stimulus, transcription does not 
finish until nearly 30 minutes later (Vazdarjanova et al., 2002), (Bottai et al., 2002).  
Therefore, translation of newly transcribed Homer1a would not be expected to be 
observable at the 15 minute timepoint used in this pilot study. 
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Analysis of FMRP target mRNA distribution on cytosolic versus ER-associated 
polyribosomes 
As discussed earlier in this chapter, specificity of FMRP for target mRNAs could in 
theory arise not due to specific binding sites on mRNAs but due to FMRP association 
with all mRNAs in some common location.  For example, FMRP could associate with 
translocons on ER membranes and make contact with ER-associated mRNAs during 
translation.  Interest in this possible mechanism was piqued by a report that ER-
associated polysomes are less sensitive to puromycin than free polysomes (Unsworth et 
al., 2010).  In theory, FMRP recruitment of polysomes to ER membranes could explain 
the observed reduction in puromycin sensitivity of targets discussed in the previous 
chapter.  Although the canonical model dictates that ER-associated transcripts primarily 
encode secreted proteins or integral membrane proteins, there are reports of a number of 
ER-associated mRNAs encoding soluble proteins, which could be translated on the 
surface of the ER (Lerner et al., 2003), (Diehn et al., 2006), (Kraut-Cohen and Gerst, 
2010).  Thus, it could be plausible for mRNAs targeted by FMRP to associate with ER 
membranes even if they encode soluble proteins. 
 
We purified free polysomes and membrane-associated polysomes from mouse brain and 
analyzed mRNAs associated with each fraction in order to assess the potential correlation 
between membrane association of polysomes and FMRP association with transcripts.  
Several methods of purification were tried.  In the first attempt, brain from the third 
postnatal week was homogenized in low salt buffer containing 320mM sucrose using a 
Potter-Elvehjem homogenizer.  Microsomes were pelleted from post-mitochondrial 
supernatants at 140,000xg for 2 hours. Western blot analysis for the ER integral 
membrane marker calnexin and the cytosolic marker GAPDH revealed that while this 
method successfully pelleted microsomes, the pellet was contaminated by substantial 
amounts of cytosolic protein (Figure 30).  In a second attempt, lysate prepared similarly 
to above was layered between a 2.5M sucrose cushion and overlying 2.05M and 1.3M 
layers of sucrose.  After spinning at 90,000xg for 5 hours, free polysomes remained 
below the 2.05M sucrose layer, while a portion of microsomes floated into the 1.3M 
sucrose layer as expected.  However, Western blots showed much calnexin remained 
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stuck below the 2.05M sucrose layer, indicating substantial microsome contamination of 
free polysomes (Figure 30).  In a third attempt, brain was homogenized in physiologic 
buffer containing 250mM sucrose.  Post-mitochondrial supernatant was loaded over a 
discontinuous gradient consisting of 0.8M and 1.3M sucrose layers over a 2.5M sucrose 
cushion.  After spinning at 140,000xg for 2.5hrs, free polysomes migrated in the 1.3M 
sucrose layer, while microsomes (which are less dense) were contained within the 0.8M 
sucrose layer and cytosol floated above the 0.8M sucrose layer (Figure 31).  150uL from 
fractions 3-9 was pooled as an “ER-associated” fraction, while 150uL from fractions 11-
15 was pooled as a “free polysomes” fraction.  The two pooled fractions were brought to 
equal volumes and Westerns were repeated to quantify the relative amount of FMRP in 
each pool.  Although in the FMRP blot of the full gradient it appeared that FMRP was 
associated primarily with free polysome fractions, re-analysis of pooled fractions showed 
that FMRP was present in both pools in roughly equal amounts.  Separate linkers were 
ligated to RNA from each pool and the two pools were sequenced in the same run by 
Illumina RNA-Seq. 
 
24,905,839 mappable unique tags were sequenced from the ER-associated fraction, while 
23,098,197 were sequenced from the free polysome fraction.  RPKM (reads per kilobase 
of exon model per million mapped reads) was calculated for each gene, so that the ER-
associated and free polysome fractions could be directly compared despite different 
sequencing depths.  Results were filtered to eliminate very low abundance mRNAs with 
total RPKM values (the sum of RPKM in both pools) of less than 10.  The fractional 
distribution of each mRNA in ER-associated and free polysome pools was calculated by 
dividing the RPKM value for each pool by the sum of the RPKMs for both pools.  The 
maximal enrichment observed in the ER-associated fraction in this filtered set was 96% 
(for neurensin-1, a neuron-specific vesicular transmembrane protein (Kadota et al., 1997), 
indicating that it is possible to achieve near-complete separation of mRNAs into the ER-
associated fraction (Figure 32).  The maximal enrichment observed in the free polysome 
fraction was 85%.  Assuming there are some mRNAs that are strictly cytosolic, this 
suggests there was about 15% crosscontamination from the free polysome fraction into 
the ER-associated fraction, consistent with free polysomes having to pass through the 
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ER-associated layer during the purification.  Overall, most mRNAs had split distributions 
in both fractions: out of 8356 genes with total RPKM scores of at least 10, only 2126 
were at least 70% enriched in one fraction (Figure 32).  The ER-associated and free 
polysome pools were further characterized by gene ontology (GO) analysis.  Out of 1644 
mRNA enriched at least 70% in the ER-associated fraction, 856 coded for integral 
membrane proteins  (Table 6).  106 were secreted proteins and 367 had a characterized 
signal peptide.  Furthermore, the categories of N-linked glycosylation and disulfide bond 
formation, both protein maturation events associated with the ER, had 494 genes and 249 
genes, respectively.  Of the 481 mRNAs enriched at least 70% in the free polysome 
fraction, the most enriched categories were nucleoside binding (molecular function), 
cytosol (cellular compartment) and cellular carbohydrate catabolic process (biologic 
process), indicating a general role for these mRNAs in basic metabolic processes, in 
particular glycolysis (Table 6).  Interestingly, 213 mRNAs from the free polysome 
fraction encoded acetylated proteins, a modification that can occur cotranslationally on 
N-terminal peptides and actively directs translation to the cytosolic compartment (Forte 
et al., 2011).  Finally, we found the subset of mRNAs enriched at least 70% in the ER-
associated fraction contained 71% of the mRNAs coding for ribosomal proteins (35 out 
of 49 genes with RPKM of at least 10), although only 20% of all mRNAs are ER-
associated to this degree.  Although ribosomal proteins do not exist within the ER, this 
result is consistent with the finding discussed above that proteins required in the nucleus 
(in this case, for ribosome biogenesis) may be translated nearby, eg on ER membranes. 
 
Importantly, we found no correlation between the fraction of a transcript associated with 
the ER and the number of exonic CLIP tags on that transcript in whole brain CLIP 
(R
2
=0.002) (Figure 33).  There was also no correlation between the fraction of a 
transcript associated with the ER and the ribosome retention score (RRS) of the 39 
mRNAs whose polysome profiles were assayed by QPCR after puromycin runoff 
(R
2
=0.05) (Figure 33).  Finally, outlier control genes (Vldlr and Npepps) from puromycin 
runoff assays were not preferentially ER-associated (68% and 32% ER association, 
respectively).  Together, these analyses suggest that the FMRP-dependent reduction in 
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puromycin sensitivity observed in Chapter 2 is not caused by target mRNA association 
with ER membranes. 
 
Although we hypothesized that FMRP tags in nuclear CLIP derive mainly from 
polysomes associated with perinuclear ER, there was no correlation between the fraction 
of a transcript associated with the ER and the number of exonic CLIP tags on that 
transcript in nuclear CLIP (R
2
=0.001) (Figure 33).  However, the method used to purify 
ER membranes by necessity cannot include detergent, so it is expected that ER 
membranes closest to the nucleus would be removed during nuclear pelleting.  Since the 
nuclear envelope is a recognized subdomain of the ER with a distinct set of associated 
proteins (Voeltz et al., 2002), it would not be surprising if it also contained a distinct 
complement of mRNAs.  Therefore, we would not necessarily expect nuclear CLIP 
results to be correlated with ER association measurements. 
 
Discussion: 
Data from previous chapters show that FMRP interacts with a specific set of mRNAs.  
Broadly, FMRP regulates many mRNAs involved with specialized aspects of neuronal 
function such as glutamateric signaling and small GTPase regulation, and in general is 
not a strong regulator of housekeeping genes.  However, the question of how FMRP’s 
specificity for certain mRNAs arises is currently one of the major unanswered questions 
in the field.  HITS-CLIP studies performed on purified polysomes showed that FMRP 
interacts with the entire coding sequence of target mRNAs, in addition to a lesser degree 
of association with 5’ and 3’ UTRs (Darnell et al., 2011).  Together with puromycin 
runoff assays showing decreased ribosome runoff from target transcripts in the presence 
of FMRP, a model was formulated in which FMRP stalls ribosomes during elongation.  
The data suggest, but do not show, that FMRP might associate directly with ribosomes, 
making transient contacts with the length of the mRNA coding sequence as ribosomes 
progress.  However, certain aspects of the data are not explained by this model, in 
particular how FMRP associates with 3’UTRs, which are not in contact with the 
ribosome (Ingolia et al., 2011).  Together with the fact that the ribosome stalling model 
does not explain the origin of FMRP’s specificity for its targets, this suggests that there 
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are elements of FMRP function that we do not understand, some of which are perhaps 
unobservable in polysome HITS-CLIP, in which only mature, translating mRNAs are 
assayed.  In an attempt to more fully understand FMRP’s function and understand how 
target specificity arises, pilot HITS-CLIP studies were performed on whole cell lysate 
and purified nuclear lysate, in order to examine possible FMRP interactions with earlier 
stages in the lifecycle of mRNAs, such as pre-mRNAs and mature mRNAs undergoing a 
pioneer round of translation, as well as examine possible FMRP interactions with 
ncRNAs. 
 
Results from the pilot whole brain CLIP experiment were highly correlated with those 
from earlier polysome CLIP studies, both in terms of the number CLIP tags per gene and 
the tag distributions.  Importantly, the same degree of target specificity was also 
maintained, with no correlation between abundance of neuronal mRNAs and number of 
CLIP tags per gene.  Very few intronic tags were observed, and we did not find 
convincing evidence of specific FMRP association with non-ribosomal ncRNAs.  
Together, these results suggest that the majority of functional FMRP:RNA interactions 
are indeed with translating polysomes.  However, these results do not rule out the 
possibility that functionally important but transient FMRP interactions with mRNAs or 
pre-mRNAs might still occur, since transient interactions are more difficult to observe.  
Interestingly, FMRP is predicted to have a nuclear function, based on functional 
characterization of NLS and NES sequences (Willemsen et al., 1996), (Eberhart et al., 
1996), (Fridell et al., 1996), (Kim et al., 2009).  Immunogold electron microscopy 
experiments have detected FMRP in neuronal nuclei but not glial nuclei (FMRP is not 
expressed in glia) (Feng et al., 1997b) (Bakker et al., 2000).  Although these reports are 
not entirely convincing due to sparse labeling and lack of Fmr1 KO controls, if only a 
small fraction of FMRP exists in the nucleus in steady state, it might very well be 
difficult to observe.  To explore the possibility that target specificity might arise during 
FMRP association with pre-mRNAs, which are typically very short-lived compared to 
mature mRNAs, a pilot FMRP HITS-CLIP study was performed on nuclear lysates from 
mouse brain.  We hypothesized that CLIP tags arising from potential FMRP:pre-mRNA 
interactions would be likely to have a different distribution than tags arising from FMRP 
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interactions with mature mRNAs; for example, pre-mRNA tags might be present in 
introns or be enriched in UTRs.  While we did observe more intronic tags in the nuclear 
CLIP experiment than in the whole brain CLIP experiment, there did not appear to be a 
relationship between the number of intronic tags and the number of exonic tags for a 
given gene, as might be expected if binding to intronic sequences gave rise to association 
with exonic sequences.  Furthermore, intronic tags were not distributed in any noticeable 
pattern (eg, always in the first intron, etc).  Therefore, it seems most likely that intronic 
tags represent nonspecific background due to high enrichment of intronic sequences in 
nuclear lysate. 
 
Although the number of exonic tags per gene observed in nuclear CLIP was fairly well 
correlated with that observed in whole brain CLIP, several mRNAs were highly enriched 
for exonic tags in the nuclear CLIP experiment.  Interestingly, most of these genes coded 
for cytoskeletal proteins, including ankyrins 2 and 3, spectrins a2, b2 and b3, AHNAK, 
macf1 and dystonin.  The simplest explanation for why these mRNAs were enriched for 
tags in nuclear CLIP compared to whole brain CLIP would be that these mRNAs are 
enriched around the nucleus.  The encoded proteins could be used locally, either inside 
the nuclei as part of the nuclear matrix, or as part of the cytoskeleton anchoring the 
nucleus within the cell.  Since the targets enriched in this experiment are extremely large 
(on the order of hundreds of kD), they are expected to have limited diffusion capability 
and thus local translation is likely an efficient cellular strategy.  Interestingly, proteomic 
studies have indeed identified spectrins, dystonin and AHNAK as components of the 
nuclear matrix or the nuclear envelope (Albrethsen et al., 2009), (Ocampo et al., 2005), 
(Kallappagoudar et al., 2010), (Young and Kothary, 2005), (Young et al., 2006), (Young 
and Kothary, 2008).  The nuclear pore can accommodate molecules up to 39nm in 
diameter (Pante and Kann, 2002), which is large enough to export ribosomes and should 
easily accommodate proteins of this size.  We also observed a strong enrichment in tags 
per gene for Akap6, which is a 254kD protein that anchors PKA to the nuclear membrane 
(Dodge-Kafka et al., 2008), further supporting the possibility that certain large proteins 
with nuclear roles may be locally translated near the nucleus.  FMRP therefore appears to 
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regulate local translation in the perinuclear compartment in addition to its much-studied 
role in local translation in neurites.   
 
An alternative possible origin for target specificity would be if FMRP associated with 
mRNAs with a common localization.  For example, it has been shown that ER-associated 
mRNAs exhibit reduced puromycin sensitivity in runoff assays (Unsworth et al., 2010).  
If FMRP actively recruited transcripts to the ER, this could potentially account for the 
observed reduction in puromycin sensitivity in the absence of FMRP.  Previous ER 
purifications from cells have found that ER-association is a broadly represented 
characteristic of many transcripts, including many that do not code for secreted or 
integral membrane proteins (Lerner et al., 2003), (Diehn et al., 2006).  Together, these 
findings suggested it was at least conceivable that ER-association might be a general 
characteristic of FMRP target mRNAs, and that this might explain both the reduced 
sensitivity of target mRNAs to puromycin in runoff assays and how FMRP comes to be 
associated with a particular set mRNAs.  To address this possibility, we purified 
populations of ER-associated and free polysomes from mouse brain and characterized 
them by high throughput sequencing.  Western blot and GO analyses confirmed that our 
purification was successful, with very high enrichment for known ER-associated and 
cytoplasmic proteins and mRNAs in respective pools.  Interestingly, we did not observe a 
bimodal separation of ER-associated and free mRNAs, as might be predicted if presence 
of a signal peptide were the sole arbitrator of ER localization.  Rather, we found that the 
majority of mRNAs were represented in both pools, a finding consistent with a recent 
purification of membrane-associated versus free polysomes from 11 human cell lines, in 
which 40% of UniGene clusters were not enriched one fraction versus the other (using a 
cutoff of 74% enrichment) (Diehn et al., 2006).  While no purification is ever absolute, 
there are bona fide biological reasons why a given mRNA might associate with both ER 
and free polysome pools.  For example, alternative splice isoforms may differentially 
associate with the ER (Li et al., 2003).  In addition, since mRNAs begin translation in the 
cytosol and canonically do not become membrane-associated until after membrane-
targeting peptide sequences have been translated, the free polysome fraction should 
contain some mRNAs ultimately destined for ER association.  Finally, it has been shown 
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in vitro that post-termination ribosomes can remain associated with the ER and initiate a 
new round of translation with mRNAs encoding soluble proteins (Seiser and Nicchitta, 
2000), (Potter and Nicchitta, 2000).  Importantly, we observed no correlation between the 
fraction of a transcript associated with the ER and the number of exonic CLIP tags on 
that transcript or the RRS score for that transcript, suggesting that mRNAs regulated by 
FMRP are not enriched on ER membranes.  Unexpectedly, we did find a strong 
enrichment for mRNAs encoding ribosomal proteins in the ER pool, an example of 
mRNAs encoding cytosolic proteins associating with ER membranes.  Local translation 
of mRNAs encoding ribosomal proteins on ER membranes would ensure production of 
ribosomal proteins near the nucleus, where they must be imported for ribosome 
biogenesis.  Together with our previous finding that FMRP targeting of mRNAs 
encoding cytoskeletal proteins was enriched in the perinuclear compartment, these results 
hint that the ER might have a role in directing local translation of mRNAs whose protein 
products do not enter the canonical ER-Golgi pathway. 
 
A second major outstanding question in the field concerns how FMRP function is linked 
to neuronal activity.  Synaptic plasticity defects are among the best-characterized FXS 
phenotypes (Bear et al., 2004), (Volk et al., 2007), and FMRP regulates many genes 
involved with the expression of synaptic plasticity (Darnell et al., 2011).  We 
hypothesized that FMRP:RNA associations might be altered in response to synaptic 
activity; for example, FMRP might increase or decrease its association with particular 
mRNAs in response to neuronal signaling.  To explore the role of neuronal activity in 
FMRP function, HITS-CLIP was performed after induction of a single tonic-clonic 
seizure by MECS, a well-characterized paradigm that was instrumental in early study of 
IEGs (Yamagata et al., 1994b), (Yamagata et al., 1994a), (Lyford et al., 1995), (Wallace 
et al., 1998).  We found that the number of FMRP CLIP tags increased on a number of 
mRNAs after MECS, including several canonical IEGs such as c-Fos, c-Jun, zif268/Egr1 
and Arc.  Interestingly, many of the mRNAs with the greatest increase in tags have 
functions with potential tie-ins to known FMRP biology.  For example, gene with the 
greatest increase in FMRP tags after MECS, Ddx3, is a DEAD box RNA helicase which, 
at physiologic levels, appears to facilitate translation of mRNAs with long and/or 
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structured 5’UTRs, although it can inhibit translation when overexpressed (Tarn and 
Chang, 2009).  In another example, three genes with at least 2X increase in tags have 
potential links to autism.  One of these, Dhcr7, encodes a dihydrocholesterol reductase 
(catalyses final step in cholesterol synthesis), deficiency of which causes Smith-Lemli-
Opitz syndrome, which is associated with autistic-like symptoms (Tierney et al., 2000), 
(Tierney et al., 2001).  Two others, Uty and Jarid1d, are histone demethylases.  Several 
histone demethylases were recently linked to autism in a whole-exome sequencing study 
(Iossifov et al., 2012), and a child with autism was found to have a missense mutation in 
Jarid1c (Adegbola et al., 2008).  Two ubiquitin ligases, Ube2q2 (Melner et al., 2006) and 
Rnf180 (Ogawa et al., 2008), also had more than 2X increase in tags.  The ubiquitin 
system has emerged as an important player in synaptic plasticity, underlying the 
importance of protein expression levels in neuronal function (for review see (Hegde, 
2010).  Finally, we observed a 4X increase in FMRP tags for a newly characterized IEG, 
Npas4.  Unlike other activity-dependent transcription factors, Npas4 is only upregulated 
in response to calcium signaling, not neurotrophin or PKA signaling (Lin et al., 2008).  
Npas4 plays an important role in the balance of network excitability, upregulating 
expression of genes involved in the formation and/or maintenance of inhibitory synapses 
in response to excitatory stimulation of neurons in culture.   Npas4 is upregulated in the 
visual cortex by exposure of dark-reared animals to light (Lin et al., 2008) and in 
hippocampal area CA3 by learning paradigms such as contextual fear conditioning 
(Ramamoorthi et al., 2011).   In an elegant study, acute deletion of Npas4 in CA3 by 
injection of virally expressed Cre-recombinase into the Npas4 cKO mouse impaired 
contextual learning, while reintroduction of Npas4 to CA3 in the global KO by similar 
strategy rescued the defect (Ramamoorthi et al., 2011).  Overall, this pilot study points to 
a potential role for FMRP in the active modulation of translational bursts from acutely 
expressed genes important for neuronal function. 
 
It should be noted that regulation of genes important for neuronal function and plasticity 
does not necessarily imply that FMRP mainly functions at synapses.  While it is clear that 
some FMRP is indeed localized postsynaptically and does appear to locally regulate 
translation at these sites (Antar et al., 2005), (Muddashetty et al., 2007), the fact is that 
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most FMRP is somatic.  Models of FMRP function often propose that somatic FMRP 
associates with translationally repressed mRNP particles and is trafficked out to dendrites 
in this state (Antar et al., 2005), (Dictenberg et al., 2008).   There is good evidence that 
some FMRP targets such as Arc are indeed translationally repressed during dendritic 
transport (Steward et al., 1998b), so it is reasonable to suppose that FMRP might be 
cotransported in these cases, although FMRP appears not to be required for transport 
(Steward et al., 1998a).  However, the facts that the vast majority of FMRP is somatic 
and at least 90% of FMRP is on heavy polysomes indicate that most somatic FMRP must 
be engaged on polysomes.  This is consistent with our finding that FMRP is associated 
with the coding sequence of perinuclear polysomes and with our finding that the mRNAs 
of many FMRP targets (for example those encoding receptors, Bassoon and Piccolo) are 
associated with the ER, and suggests that FMRP could locally regulate translation of 
certain mRNAs in one cellular compartment (eg synapses) and of other mRNAs in 
another compartment (eg perinuclear sites).  Alternatively, FMRP could play a role in 
neuron-wide regulation of translation.  In addition to various forms of Hebbian plasticity 
that increase or decrease the strength of individual synapses in response to local 
signaling, neurons must undergo cell-wide adjustment of excitability to maintain synaptic 
strengths within a physiologically appropriate dynamic range, a form of homeostatic 
plasticity called synaptic scaling (Turrigiano, 2008).  FMRP could contribute to synaptic 
scaling through somatic regulation of mRNAs important for neuronal excitability.  Hints 
at such processes have begun to be reported in the literature.  For example, synaptic 
scaling induced by concurrent blockade of action potentials and NMDAR activity in 
hippocampal slices was impaired in the Fmr1 KO (Soden and Chen, 2010).  In another 
example, the synaptic reweighting that occurs during sleep after a period of wakefulness 
was defective in dfmr1 KO flies (Bushey et al., 2011).  These findings suggest that FMRP 
plays a broader role in neuronal plasticity than previously appreciated, and, together with 
results from the MECS CLIP pilot study, suggest that regulation of translation by FMRP 
is a dynamic process that actively responds to changes in neuronal signaling and gene 
expression. 
 
 
Figure 15.  FMRP HITS-CLIP from whole mouse brain.   
 
A) Autoradiogram of labeled RNA:protein complexes immunoprecipitated after limited 
RNAse digest.  Gel was transferred to nitrocellulose and membrane was cut at regions 
indicated by brackets.   
 
B)  RNAs purified from nitrocellulose were reverse transcribed, amplified by PCR and 
further purified by urea-PAGE.  DNAs of correct size are visualized as a smear between 
100-150nt. DNA was recovered from the gel cut at bracketed regions.  No signal was 
observed in Fmr1 KO or (-)RT lanes.   
 
C) Agarose gel showing final CLIP products.  Gel was cut at regions indicated by dots 
and DNA was sent for high throughput sequencing. 
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Table 2: Top 50 FMRP targets identified by whole brain HITS-CLIP.   
The number of exonic tags per gene is shown. 
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Gene Name Exonic Tags 
  
Gene Name Exonic Tags 
Apc 5959   Cyfip2 1225 
Mtap1b 5083   Mtap2 1196 
Kif1a 3256   Akap6 1176 
Kif5a 3158   Usp34 1169 
Mtap1a 2886   Birc6 1142 
Huwe1 2368   Wdfy3 1142 
Ank2 2162   Centg1 1110 
Bsn 2067   Spna2 1075 
Dync1h1 1903   Lphn1 1060 
Kif1b 1858   Wnk1 1046 
Spnb2 1852   Itpr1 1044 
Pclo 1790   Nbea 1038 
Macf1 1741   Kif5c 1035 
2610507B11Rik 1673   Grit 1033 
Adcy1 1630   Nisch 970 
Hivep2 1592   Dennd5a 953 
Ttc3 1574   Shank1 933 
Ank3 1528   Dmxl2 928 
Spnb3 1497   Pde2a 925 
Mycbp2 1481   Unc13c 913 
Herc2 1378   Myo5a 897 
Nf1 1363   Nckap1 893 
Usp9x 1356   Clasp2 864 
Dst 1353   Herc1 861 
Ubr4 1240   Fry 852 
 
!41
Figure 16.  Correlation of whole brain FMRP CLIP data with polysome FMRP 
CLIP data and with neuronal mRNA abundance.   
 
A) The number of exonic CLIP tags per gene was highly correlated between whole brain 
FMRP CLIP and polysome FMRP CLIP experiments (Darnell 2011).  The top 5000 
targets were included in the analysis.   
 
B) The number of exonic CLIP tags per gene from the whole brain CLIP experiment was 
not correlated to abundance of neuronal mRNAs (Cahoy 2008).  All mRNAs with 
measurable expression levels were included in the analysis. 
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Figure 17.  Genomic distributions of FMRP CLIP tags.   
 
A) Whole brain CLIP, all tags.   
 
B) Exclusion of single, nonoverlapping tags from whole brain CLIP slightly reduced 
intronic and intergenic signal.   
 
C) For comparison, distribution of FMRP polysome CLIP tags (Darnell 2011, all tags).  
Polysome CLIP had proportionally more intergenic tags than whole brain CLIP because 
sample was dissociated more harshly during resuspension of the polysome pellet (boiled 
in 2% SDS), exposing more rRNA.   
 
D) Whole brain CLIP, allowing up to 100 alignments for each tag to facilitate mapping of 
sequences derived from ncRNAs.  Single, nonoverlapping tags were excluded.   
 
E) Breakdown of tags aligning to noncoding regions from (D). 
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Figure 18.  FMRP CLIP tag distributions on mature mRNA transcripts.  
Representative transcripts have high tag numbers and a single major isoform.   
 
Top panel: Cumulative tag distribution.  Tags mapping to the 5‘UTR are plotted in red, 
those mapping to coding region are plotted in blue, and those mapping to the 3‘UTR are 
plotted in green.   
 
Bottom panel: Relative distribution of CLIP tags.  In general, FMRP CLIP tags are 
distributed evenly along the coding sequence, with fewer tags observed in UTRs. 
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Figure 19.  Purification of cellular nuclei from mouse brain by sedimentation 
through sucrose.   
Nuclei were isolated from detergent-treated brain extracts by centrifugation over a 
column of 50% w/w sucrose.  Total lysate (T) and the nuclear fraction (N) were analyzed 
by Western blot, loading equal milligram amounts of protein from each fraction.  
GAPDH is a marker of the cytosolic fraction, NeUN (Fox3) is a marker of neuronal 
nuclei, and calnexin is an integral membrane protein that is a marker of the endoplasmic 
reticulum.  No calnexin copurified with the nuclear fraction, indicating that ER 
membranes were largely dissolved or stripped during purification.  FMRP was present in 
both cytoplasmic and nuclear fractions. 
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Figure 20.  FMRP CLIP of brain nuclei pelleted under sucrose.   
 
A) Autoradiogram of labeled RNA:protein complexes immunoprecipitated after a titrated 
RNAse digest (RNAse dilution indicated over each lane).  Gel was transferred to 
nitrocellulose and membrane was cut at regions indicated by dots.   
 
B) Western blot showing successful depletion of FMRP from extracts after the CLIP 
immunoprecipitation step.   
 
C) RNAs purified from nitrocellulose were reverse transcribed, amplified by PCR and 
further purified by urea-PAGE.  DNAs of correct size are visualized as a smear between 
100-150nt.  However, in this experiment the signal was not specific to the wt lanes.  
Although the water control indicated some level of reagent contamination, the Fmr1 KO 
lanes also contained additional background signal that gained in intensity with increasing 
PCR cycles, suggesting that the contaminating DNA contains linker sequences 
recognized by the PCR primers and indicating that the IP may contain RNAs crosslinked 
to proteins other than FMRP. 
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Figure 21.  Purification of cellular nuclei from mouse brain by pelleting extracts at 
2000xg.   
Nuclei were isolated from brain extracts treated with 0.8% NP-40 by centrifugation at 
2000xg, with two gentle washes.  Total extract (T), the cytoplasmic fraction (C) and the 
nuclear fraction (N) were analyzed by Western blot, loading 6uL of each fraction (by 
Bradford, the nuclear fraction was 5X less concentrated than the other fractions).  Gapdh 
is a marker of the cytosolic fraction; hpRNP C1/C2, NeUN (Fox3) and histones are 
markers of the nuclear fraction; calnexin is an integral membrane protein that is a marker 
of the endoplasmic reticulum.  No calnexin purified in the nuclear fraction, indicating 
that the majority of ER membranes were removed from nuclei by the detergent treatment.  
FMRP was present in both cytoplasmic and nuclear fractions. 
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Figure 22.  Comparison of two different antibodies in immunoprecipitation of 
FMRP from mouse brain nuclear extracts.   
 
A) Western blot of inputs (I) and post-IP supernatants (P) from immunoprecipitations of 
FMRP with antibody 17722, blotted with the same antibody.  A nonspecific band of the 
same size as FMRP was observed in nuclear extracts from Fmr1 KO mice (this band was 
not observed in Fmr1 KO samples from whole brain extracts).   
 
B) Western blot of nuclear extracts from wt and Fmr1 KO mouse brain using FMRP 
antibody 27455.  No nonspecific bands were observed.   
 
C) Western blots showing input, post-IP supernatants and IP eluates from 
immunoprecipitations using antibodies 27455 or 17722, blotted with 17722.  The 27455 
antibody immunoprecipitated much more FMRP than an equivalent amount of the 17722 
antibody. 
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Figure 23.  FMRP CLIP of brain nuclei pelleted at 2000xg using antibody 27455.   
 
A) Autoradiogram of labeled RNA:protein complexes immunoprecipitated after a titrated 
RNAse digest (RNAse dilution indicated over each lane).  More signal in the bracketed 
region was observed in wt lanes than in RNAse overdigest, no-crosslink or Fmr1 KO 
control lanes.  The gel was transferred to nitrocellulose and membrane was cut at regions 
indicated by brackets.   
 
B) RNAs purified from nitrocellulose were reverse transcribed, amplified by PCR and 
further purified by urea-PAGE .  DNAs of correct size are between 100-150nt.  DNA was 
recovered from the gel cut at bracketed regions.   
 
C) Agarose gel showing final CLIP products.  Gel was cut at bracketed regions and DNA 
was sent for high throughput sequencing. 
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Figure 24.  Genomic distributions of FMRP nuclear CLIP tags.   
 
A) All tags.   
 
B) Exclusion of single, nonoverlapping tags reduced intronic and intergenic signal.   
 
C) Breakdown of tags aligning to intronic sequences. 
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Figure 25.  Comparison of FMRP CLIP tag distributions from CLIP experiments 
performed on whole brain, brain polysomes, and brain nuclei.   
Tags are plotted as RPKM (Reads Per Kilobase of exon model per Million mapped reads) 
in order to visually compare results from experiments with different sequencing depths.  
Read depth is indicated for each track on the Y-axis.  Four examples of genes are shown.  
On this page: Map1B in upper panel, Huwe1 in lower panel.  On next page: Apc in upper 
panel, Bassoon in lower panel.  The tag tracks are represented in the following order (top 
to bottom within panels): nuclear CLIP, whole brain CLIP, polysome CLIP. 
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Figure 26.  Analysis of nuclear FMRP CLIP data.   
 
A) The number of exonic CLIP tags per gene was fairly well correlated between nuclear 
FMRP CLIP and whole brain FMRP CLIP experiments.  The top 5000 targets were 
included in the analysis.   
 
B) The number of exonic CLIP tags per gene from the whole brain CLIP experiment was 
not correlated to abundance of neuronal mRNAs (Cahoy 2008).  All mRNAs with 
measurable expression levels and at least two overlapping intronic CLIP tags were 
included in the analysis.   
 
C) The number of intronic tags per gene was not correlated with the number of exonic 
tags per gene.  All 1023 genes with at least 2 overlapping intronic tags were included in 
the analysis. 
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Table 3: Fold Arc mRNA induction in mouse brain after seizure, compared to resting 
animals.   
Single tonic-clonic seizures were induced by the MECS protocol as described in text.  At the 
indicated times after induction of seizure, mice were sacrificed and RNA was isolated from brain 
lysates (from hippocampus or cortex, as indicated).  Arc mRNA levels were measured by QPCR.  
In Experiment 1, only hippocampus was assayed.  In Experiment 2, both hippocampus and 
cortex were assayed.  Values were normalized to Arc levels in resting animals.  Three animals 
were used per timepoint and for resting controls. 
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Minutes 
Post-
Seizure 
!"#$%!"#%&'$()*+"'%
Expt1 Expt2 Expt2 
Hp Hp Cx 
5 3.4     
10 5.4 
  
30 8.8 10 2.6 
90   7.5 1 
! ! ! ! 
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Table 4:  mRNAs with increased whole brain FMRP CLIP tags after seizure.   
Single tonic-clonic seizures were induced by the MECS protocol as described in text.  Mice were 
sacrificed 15 minutes after the induction of seizure, in addition to resting controls.  FMRP HITS-
CLIP was performed on total brain.  All mRNAs with at least a 50% increase in FMRP CLIP 
tags (normalized to the total number of tags sequenced per condition) are listed.  The number of 
tags per gene after seizure and the fold increase in tags compared to the resting control are shown. 
 
  
!"5
 Gene Name 
Tags 
after 
MECS 
Fold 
Increase 
in Tags   
Gene Name 
Tags 
after 
MECS 
Fold 
Increase 
in Tags 
Ddx3y 43 7.24   Tpcn1 54 1.77 
Fos 49 6.60   Klhdc8a 35 1.75 
Uty 92 5.38   Ppp2r3c 31 1.74 
Jarid1d 69 4.42   Isyna1 31 1.74 
Npas4 85 3.95   Phf17 36 1.73 
Mirnlet7i 63 3.14   Kat2b 59 1.73 
Sall3 41 2.51   Tmco3 41 1.72 
Ube2q2 39 2.50   Pcdh15 32 1.72 
Mirn153 67 2.37   1810013L24Rik 32 1.72 
Fmo1 37 2.37   BC017647 37 1.72 
Rnf180 43 2.32   Snx1 33 1.71 
Mirn30a 120 2.31   Mirn340 29 1.70 
Mirn708 110 2.24   Nrbp2 34 1.70 
Notch3 31 2.20   2310061I04Rik 34 1.70 
Mrpl3 31 2.20   Amot 44 1.69 
Egr1 93 2.12   Scg5 30 1.68 
Mirn26a-2 138 2.11   4930504E06Rik 30 1.68 
Dhcr7 31 2.09   Edem1 45 1.68 
Jun 34 2.08   Pcbp1 41 1.67 
Htatsf1 34 1.99   Ldb1 36 1.67 
Tlr4 31 1.99   Stk24 31 1.67 
Mirn9-3 192 1.96   Shroom4 31 1.67 
Scg3 46 1.94   Tex15 47 1.67 
Mirn181a-2 46 1.94   Nudt4 89 1.66 
Dusp6 33 1.93   Fem1c 85 1.66 
Gnl2 31 1.90   Nr4a1 70 1.65 
Tubb3 43 1.87   Zfp426 44 1.65 
Mirn9-2 54 1.86   Wars 28 1.64 
Mtss1 47 1.86   Tcfe3 28 1.64 
Mtf2 29 1.86   Nbn 28 1.64 
Creb1 40 1.86   Arhgap18 28 1.64 
Setdb2 33 1.85   A930017M01Rik 45 1.64 
Atad5 33 1.85   Me2 51 1.63 
C130039O16Rik 37 1.84   Rock1 177 1.63 
Mdh2 38 1.83   Mirn30d 63 1.63 
Lta4h 31 1.81   Nrg1 29 1.63 
Trim25 36 1.79   1110067D22Rik 35 1.62 
Tmem135 37 1.78   Frmpd4 957 1.62 
Api5 33 1.78   Dock8 49 1.61 
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Gene Name 
Tags 
after 
MECS 
Fold 
Increase 
in Tags 
Gab1 69 1.60 
41154 44 1.60 
Gpx1 32 1.60 
Mirn30e 112 1.59 
Cops3 33 1.59 
AF529169 33 1.59 
Myt1 27 1.58 
Ppp1r7 34 1.58 
Casp8ap2 130 1.58 
Mtmr10 104 1.57 
Cpne5 35 1.57 
0610007P08Rik 85 1.57 
Nup88 43 1.56 
Zfx 58 1.56 
Uba3 58 1.56 
Cops5 29 1.56 
Arc 29 1.56 
Smek1 131 1.55 
Dscaml1 87 1.54 
Zmat4 32 1.54 
Zfp385a 32 1.54 
Maml1 32 1.54 
Myh14 41 1.53 
Rnf103 75 1.53 
Ntng1 50 1.53 
Tiparp 92 1.53 
Aldh3a2 34 1.53 
Tjp2 77 1.52 
Ric8b 43 1.52 
Cyc1 35 1.52 
Hrb 142 1.52 
Tmeff1 36 1.51 
Rp2h 27 1.51 
Fn1 73 1.51 
Tfg 46 1.51 
Pik3c3 46 1.51 
Mfsd4 29 1.50 
Cggbp1 29 1.50 
Ik 39 1.50 
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Table 5: GO analyses of mRNAs with increases or decreases in FMRP CLIP tags after 
seizure.   
mRNAs with at least a 50% increase or 50% decrease in CLIP tags (and meeting minimum 
thresholds for total tags – see text) were used for analysis.  Terms with p<0.01 are shown.  The 
GO categories for biologic process, cellular compartment and molecular function are shown, as 
well as UniProt sequence features. 
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 Increased FMRP CLIP tags after MECS 
  
Category Term Count PValue 
UP_SEQ_FEATURE domain:Leucine-zipper 5 0.005 
UP_SEQ_FEATURE DNA-binding region:Basic motif 5 0.008 
    
GOTERM_BP_FAT 
GO:0045944~positive regulation of 
transcription from RNA polymerase II 
promoter 
9 0.004 
GOTERM_BP_FAT GO:0055114~oxidation reduction 9 0.004 
GOTERM_BP_FAT 
GO:0010557~positive regulation of 
macromolecule biosynthetic process 
10 0.008 
GOTERM_BP_FAT 
GO:0031328~positive regulation of 
cellular biosynthetic process 
10 0.010 
GOTERM_BP_FAT 
GO:0045893~positive regulation of 
transcription, DNA-dependent 
9 0.010 
GOTERM_BP_FAT 
GO:0051173~positive regulation of 
nitrogen compound metabolic process 
10 0.010 
    
GOTERM_CC_FAT 
GO:0005667~transcription factor 
complex 
6 0.008 
    
    GOTERM_MF_FAT GO:0003677~DNA binding 22 0.009 
    
 Decreased FMRP CLIP tags after MECS 
  
Category Term Count PValue 
GOTERM_BP_FAT 
GO:0015672~monovalent inorganic 
cation transport 
8 0.002 
GOTERM_BP_FAT GO:0055085~transmembrane transport 8 0.007 
GOTERM_BP_FAT GO:0006812~cation transport 9 0.008 
    
GOTERM_MF_FAT GO:0031420~alkali metal ion binding 6 0.010 
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Figure 27.  FMRP HITS-CLIP from whole mouse brain after seizure.   
Mice were subjected to a single tonic clonic seizure using MECS as described in text.  
Brains were harvested 15 minutes after induction of the seizure.  Resting animals were 
used for controls.   
 
A) Autoradiogram of labeled RNA:protein complexes immunoprecipitated after limited 
RNAse digest.  Gel was transferred to nitrocellulose and membrane was cut at regions 
indicated by brackets.   
 
B) RNAs purified from nitrocellulose were reverse transcribed, amplified by PCR and 
further purified by urea-PAGE.  DNAs of correct size are visualized as a smear between 
100-150nt.  DNA was recovered from the gel cut at bracketed regions. 
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Figure 28.  Analysis of FMRP HITS-CLIP from mouse brain after seizure 
compared to resting mice.   
 
A) The number of exonic tags per gene was highly correlated between seizure and resting 
samples.  2966 genes with at least 50 tags post-seizure were included for analysis.  
 
B) The overall genomic distribution of CLIP tags was unchanged by seizure. 
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Figure 29.  Comparison of FMRP CLIP tag distributions in resting mice and mice 
subjected to seizure by MECS.   
CLIP tags are represented as small rectangles above the RefSeq gene map.  Two tag 
tracks are plotted; the name of each is above the track (resting versus 15 minutes post-
seizure).  The lengths of the tags are all similar; note that the scale of the middle panel is 
decreased to accommodate the longer sequence of Jarid1.  The genes shown here (from 
top to bottom on this page: Egr1, Jarid1d and Fos; from top to bottom on next page: 
Npas4 and Homer1 (3’ end only)) all have increased numbers of FMRP CLIP tags after 
seizure.  However, tag distributions appear unchanged.  On the following page, the 3’ end 
of Homer1 is shown to illustrate that FMRP CLIP tags map to regions downstream of 
both 3‘UTRs, suggesting that these 3‘UTRs may have unannotated extensions. 
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Figure 30.  Purification of free (cytosolic) and membrane-associated polyribosomes 
from mouse brain, pilot methods.   
Calnexin was used as a marker of ER membranes and Gapdh was used as a cytosolic 
marker.   
 
A) Pelleting of microsomes from postmitochondrial supernatant.  Western blots of pellet 
and supernatant show substantial contamination of the microsome pellet with cytosolic 
protein.   
 
B) Isopycnic floatation of microsomes from 2.15M sucrose into 1.3M sucrose (extract 
was layered under the 2.0M sucrose layer).  Western blot of gradient fractions showed 
that while some microsomes floated to the 1.3M layer, a large portion of microsomes 
remained stuck in the 2.15M layer. 
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Figure 31.  Purification of free (cytosolic) and membrane-associated polyribosomes 
from mouse brain, final method.   
Calnexin was used as a marker of ER membranes; GAPDH was used as a cytosolic 
marker.   
 
A) Separation of free polysomes and microsome-associated polysomes on a 
discontinuous sucrose gradient (extract was layered on the top of the gradient).  Western 
blots of gradient fractions showed good separation of cytosol, microsomes and free 
polysomes.  Polysomes were present in both microsome and free polysome fractions, as 
indicated by presence of ribosomal protein P0.   
 
B) Pooled, volume-normalized microsome-associated and free polysome fractions were 
reprobed by Western blot to more accurately quantify FMRP and calnexin association 
with each fraction.  Approximately equal amounts of FMRP were present in each pool. 
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Figure 32.  Fractions of individual mRNAs associated with membranes.   
mRNAs from membrane-associated and cytosolic fractions (see previous figure) were 
analyzed by RNA Seq and the relative fraction of each mRNA in the membrane-
associated pool was calculated.  The values for all 8355 mRNAs with total (free + 
membrane associated) RPKM values of at least 10 are plotted.  Most mRNAs were 
present in both membrane-associated and cytosolic fractions. 
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Table 6: GO analyses of mRNAs enriched in membrane and cytosolic fractions isolated 
from mouse brain.   
All mRNAs enriched at least 70% in either fraction were analyzed.  The top terms from each 
category are shown.  The GO categories for biologic process, cellular compartment and 
molecular function are shown, as well as UniProt keywords. 
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  Membrane-associated mRNAs 
  Category Term Count PValue 
GOTERM_MF_FAT 
GO:0022803~passive transmembrane 
transporter activity 65 1.5E-13 
GOTERM_MF_FAT GO:0015267~channel activity 65 1.5E-13 
GOTERM_MF_FAT 
GO:0022838~substrate specific 
channel activity 63 9.8E-13 
GOTERM_MF_FAT GO:0046873~metal ion 
transmembrane transporter activity 56 2.2E-12 
GOTERM_MF_FAT GO:0005216~ion channel activity 62 2.5E-12 
GOTERM_MF_FAT GO:0015293~symporter activity 30 3.3E-10 
GOTERM_MF_FAT GO:0022836~gated channel activity 51 3.8E-09 
GOTERM_MF_FAT GO:0031420~alkali metal ion binding 39 9.0E-09 
    GOTERM_CC_FAT GO:0031224~intrinsic to membrane 856 3.6E-153 
GOTERM_CC_FAT GO:0016021~integral to membrane 829 1.2E-152 
GOTERM_CC_FAT GO:0005576~extracellular region 128 8.7E-14 
GOTERM_CC_FAT GO:0005783~endoplasmic reticulum 182 9.1E-13 
GOTERM_CC_FAT GO:0044421~extracellular region part 63 4.1E-09 
GOTERM_CC_FAT GO:0005615~extracellular space 43 2.8E-06 
GOTERM_CC_FAT 
GO:0005887~integral to plasma 
membrane 56 3.0E-06 
GOTERM_CC_FAT 
GO:0031226~intrinsic to plasma 
membrane 58 3.8E-06 
        GOTERM_BP_FAT GO:0006811~ion transport 122 2.8E-20 
GOTERM_BP_FAT GO:0030001~metal ion transport 80 7.4E-15 
GOTERM_BP_FAT GO:0006812~cation transport 89 8.5E-14 
GOTERM_BP_FAT GO:0048878~chemical homeostasis 68 3.3E-10 
GOTERM_BP_FAT GO:0043413~biopolymer glycosylation 26 2.4E-09 
GOTERM_BP_FAT GO:0070085~glycosylation 26 2.4E-09 
GOTERM_BP_FAT 
GO:0006486~protein amino acid 
glycosylation 26 2.4E-09 
GOTERM_BP_FAT GO:0009100~glycoprotein metabolic 
process 36 2.8E-09 
    SP_PIR_KEYWORDS transmembrane 820 1.9E-218 
SP_PIR_KEYWORDS membrane 915 1.4E-143 
SP_PIR_KEYWORDS glycoprotein 507 2.9E-135 
SP_PIR_KEYWORDS signal peptide 367 8.5E-89 
SP_PIR_KEYWORDS disulfide bond 249 3.4E-54 
SP_PIR_KEYWORDS endoplasmic reticulum 161 1.7E-22 
SP_PIR_KEYWORDS Signal-anchor 82 9.2E-22 
SP_PIR_KEYWORDS ion transport 104 2.6E-19 
SP_PIR_KEYWORDS Secreted 106 9.9E-19 
SP_PIR_KEYWORDS receptor 108 2.0E-15 
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       Cytosolic mRNAs 
Category Term Count PValue 
GOTERM_MF_FAT GO:0001882~nucleoside binding 100 7.00E-10 
GOTERM_MF_FAT GO:0000166~nucleotide binding 135 8.00E-10 
GOTERM_MF_FAT GO:0030554~adenyl nucleotide binding 99 9.80E-10 
GOTERM_MF_FAT GO:0001883~purine nucleoside binding 99 1.30E-09 
GOTERM_MF_FAT GO:0005524~ATP binding 94 2.10E-09 
GOTERM_MF_FAT 
GO:0032559~adenyl ribonucleotide 
binding 
94 4.20E-09 
GOTERM_MF_FAT GO:0017076~purine nucleotide binding 115 7.10E-09 
GOTERM_MF_FAT GO:0032553~ribonucleotide binding 110 2.90E-08 
 
  
  GOTERM_CC_FAT GO:0005829~cytosol 49 1.40E-07 
GOTERM_CC_FAT GO:0030684~preribosome 6 8.20E-05 
GOTERM_CC_FAT GO:0031980~mitochondrial lumen 21 1.00E-04 
GOTERM_CC_FAT GO:0005759~mitochondrial matrix 21 1.00E-04 
GOTERM_CC_FAT 
GO:0031974~membrane-enclosed 
lumen 
73 2.10E-04 
GOTERM_CC_FAT GO:0043233~organelle lumen 71 2.20E-04 
GOTERM_CC_FAT 
GO:0070013~intracellular organelle 
lumen 
70 3.50E-04 
GOTERM_CC_FAT 
GO:0030529~ribonucleoprotein 
complex 
36 6.60E-04 
 
  
  
GOTERM_BP_FAT 
GO:0044275~cellular carbohydrate 
catabolic process 
22 4.70E-17 
GOTERM_BP_FAT GO:0006007~glucose catabolic process 20 7.80E-16 
GOTERM_BP_FAT 
GO:0046365~monosaccharide catabolic 
process 
20 7.80E-16 
GOTERM_BP_FAT GO:0019320~hexose catabolic process 20 7.80E-16 
GOTERM_BP_FAT 
GO:0016052~carbohydrate catabolic 
process 
22 1.20E-15 
GOTERM_BP_FAT GO:0046164~alcohol catabolic process 21 2.40E-15 
GOTERM_BP_FAT GO:0006096~glycolysis 17 5.10E-14 
GOTERM_BP_FAT 
GO:0006006~glucose metabolic 
process 
26 4.40E-12 
 
  
  SP_PIR_KEYWORDS phosphoprotein 313 6.70E-17 
SP_PIR_KEYWORDS acetylation 213 1.60E-31 
SP_PIR_KEYWORDS cytoplasm 168 6.20E-10 
SP_PIR_KEYWORDS nucleus 147 8.50E-03 
SP_PIR_KEYWORDS nucleotide-binding 104 1.10E-10 
SP_PIR_KEYWORDS atp-binding 86 4.00E-11 
SP_PIR_KEYWORDS hydrolase 54 2.70E-02 
SP_PIR_KEYWORDS transferase 54 9.50E-02 
SP_PIR_KEYWORDS mitochondrion 47 2.10E-02 
SP_PIR_KEYWORDS transit peptide 40 9.00E-05 
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Figure 33.  mRNA association with membranes is not correlated with FMRP 
association or retained ribosome score (RRS).   
 
A) The fractional enrichment of mRNAs in the membrane-associated pool was not 
correlated with the number of exonic tags per gene in nuclear FMRP CLIP.  444 mRNAs 
with at least 25 exonic tags in nuclear FMRP CLIP were included in the analysis.   
 
B) The fractional enrichment of mRNAs in the membrane-associated pool was not 
correlated with the number of exonic tags per gene in whole brain FMRP CLIP.  1625 
mRNAs with at least 50 exonic tags in whole brain FMRP CLIP were included in the 
analysis.  
 
C) The fractional enrichment of mRNAs in the membrane-associated pool was not 
correlated with the retained ribosome score.  The 39 mRNAs for which RRS was 
measured were included in the analysis. 
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Chapter V. Design and construction of a new mouse model, the FMRP cTAG mouse 
 
Introduction: 
HITS-CLIP results define a set of approximately 1000 mRNAs regulated by FMRP.  
However, these results are based on immunoprecipitation of transcripts from total brain, 
reflecting a mixture of mRNAs from all cells expressing FMRP.  The brain contains an 
incredible diversity of neurons, and a more nuanced picture of which mRNAs are 
regulated by FMRP in individual neuron types is lacking.  It is likely that many of the 
mRNAs targeted by FMRP exhibit restricted expression patterns.  For example, PSD-95 
and Syngap1 are both strong targets that associate with one another and mediate NMDA 
receptor signaling (Kim et al., 1998).  However, detailed in situ analysis revealed that 
expression of Syngap1 is much more restricted than that of PSD-95, both temporally and 
spatially (Porter et al., 2005).  More generally, the heterogeneity of translational profiles 
from different neuronal cell types has been demonstrated using immunoprecipitation of 
GFP-tagged ribosomes (Doyle et al., 2008).  Results showed that translatomes from 
different classes of neurons are highly diverse, and that highly specialized cell types, such 
as Purkinje neurons, have translational profiles with relatively low similarity to other cell 
types.  Importantly, many mRNAs that were of low abundance in whole cell lysate were 
enriched in rare cell types, emphasizing the point that analysis at the level of individual 
cell types is critical for understanding the ramifications of gene expression in local 
context.  Furthermore, the authors found that a large fraction of translational diversity 
was driven by expression of cell-surface proteins such as receptors and ion channels, 
transcription factors, and calcium-binding proteins, a set that overlaps the population of 
mRNAs regulated by FMRP.  Additional observations underscoring the importance of 
cell type-specific molecular analysis include preliminary data from cell-specific HITS-
CLIP results in motor neurons for the splicing factor Nova (see below), as well as results 
from cell type-specific miRNA profiling experiments that reveal distinct complements of 
miRNAs in different populations of neurons (He et al., 2012).  Cell type-specific 
molecular targeting has also been used to label discrete populations of dorsal root ganglia 
neurons, allowing complex anatomies of axonal endings to be visually resolved and 
mapped (Li et al., 2011), and to acutely inhibit activity of individual populations of 
neurons in conscious mice (Ray et al., 2011).  Collectively, these studies show that 
 199 
analysis at the level of individual cell types can uncover biology unobservable in whole-
tissue studies due to heterogeneity of gene expression and diversity of neuronal 
physiology.  
 
We are most interested in the FMRP targets that significantly contribute to FXS 
phenotypes.  Not all mRNAs regulated by FMRP can be expected to make equal 
contributions to the pathology of the syndrome.  Regulatory effects of FMRP have to 
compete with other drivers of protein dynamics, including other mechanisms of 
translational control as well as transcriptional control and protein turnover.  Furthermore, 
targets must be dose-dependent enough in local context for the net outcome to matter to 
the cell.  It is likely that exact dosage of certain proteins is indeed critical for neuronal 
function.  For example, Shank3, a strong FMRP target closely linked to autism, is 
degraded via ubiquintylation when not in complex with Homer proteins, suggesting that 
the amount of existing Shank3 is titrated to fit local scaffolding needs (Bangash et al., 
2011).  The reduction in Shank3 levels was associated with defects in synaptic plasticity 
and social interaction in mice, demonstrating functional consequences of degradation.  In 
a second example, a screen for protein-level changes at PSDs during activity identified 
ten proteins whose local abundance was decreased during synaptic activity (Ehlers, 
2003).  Three of these, Shank, GKAP and AKAP79, were ubiquitinylated, suggesting 
local degradation of scaffolding proteins might be a general driver of changes in overall 
PSD composition during activity.  In support of this finding, Bingol et al also observed 
increased ubiquitinylation of synaptic substrates during activity, and found that this was 
associated with proteasomal movement into dendritic spines (Bingol and Schuman, 
2006).  Overall, these results support the assertion that dose-dependence of many proteins 
is critical to neuronal function, and thus translational regulatory actions of FMRP are 
predicted to be of significant importance.  However, we must be able to define which 
expression changes are most relevant to FXS phenotypes. 
 
To do this, we must link phenotypes to the regulation of particular mRNAs with the 
highest possible degree of resolution.  The barrel cortex has been a useful system for 
characterization of very specific developmental defects in Fmr1 KO mice.  For example, 
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development of the thalamocortical synapse that mediates input to the barrel is delayed in 
Fmr1 KO mice, resulting in an increased number of silent synapses persisting through the 
first postnatal week and a commensurately extended window of LTP at these synapses 
(Harlow et al., 2010).  Fmr1 KO mice also exhibit a significant delay in the next stage of 
barrel cortex development, formation of the major ascending projection from layer 4 onto 
layer 3 (Bureau et al., 2008).  As for defects seen during thalamocortical synapse 
development, defects in development of the L4:L3 synapse are transient:  they are evident 
during the second postnatal week but normalized by the third postnatal week.  Together, 
these papers show that FMRP function is of particular importance during discrete critical 
periods at specific synapses, and future work will likely further elucidate such roles.  
However, it has not yet been shown that cell-autonomous loss of FMRP in layer 4 
neurons results in the observed phenotypes.  Use of the conditional Fmr1 KO to establish 
that loss of FMRP in specific cells results in particular phenotypes will be crucial to 
efforts to identify functionally important FMRP:RNA interactions. 
 
Two such uses of the conditional Fmr1 KO have been published.  The most recent 
investigated the role of FMRP in adult neurogenesis in the dentate gyrus.  The authors 
found that loss of FMRP in adult neural stem cells (aNSCs) resulted in multiple abnormal 
phenotypes in stem cell progenitors, including defects in proliferation, differentiation and 
dendritic arbor complexity (Guo et al., 2011).  Importantly, these phenotypes were 
associated with behavioral consequences and were correctable by conditional expression 
of FMRP in aNSCs in Fmr1 KO mice.  Although this would be an obviously attractive 
system for the study of cell-autonomous mRNA regulation by FMRP, HITS-CLIP is not 
sufficiently sensitive at this time to support analysis of such a small population of cells.  
An appealing alternative system is offered by the first published use of the conditional 
Fmr1 KO mouse, in which it was found that loss of FMRP in Purkinje neurons resulted 
in defects in eyeblink conditioning, a form of classical conditioning that reflects the 
ability of an animal to learn to anticipate a puff of air to the eye when it is preceded by 
playing of a tone (Koekkoek et al., 2005).  Defects in eyeblink conditioning were also 
observed in FXS patients, underscoring the relevance of this phenotype to human disease 
(Koekkoek et al., 2005).  Knockout of FMRP in Purkinje neurons also resulted in 
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increased mGluR-LTD at Purkinje cell – parallel fiber synapses, a form of LTD that is 
depended on protein synthesis (Karachot et al., 2001) and for which the molecular 
underpinnings are fairly well understood (Kano et al., 2008), and elongation of dendritic 
spines at these synapses.  Together, these phenotypes are extremely relevant to FXS 
biology and promise to be informative with respect to FMRP function. 
 
Recent experiments in our lab offer proof in principle that cell type-specific HITS-CLIP 
is a productive approach generating novel results not discernable by general HITS-CLIP.  
HITS-CLIP performed on AcGFP-Nova driven from the motor neuron-specific choline 
O-acetyltransferase (Chat) promoter, using AcGFP as an IPable tag, successfully 
identified a set of motor neuron-enriched transcripts regulated by Nova (Y. Yuan, 
unpublished).  However, the design of this experiment has one potentially significant 
drawback, which is that protein expressed from a BAC is likely to be overexpressed and 
may not exhibit normal expression patterns compared to wt protein.  In the case of FMRP, 
this may constitute a serious problem.  Overexpression of FMRP has been shown to 
result in aberrant phenotypes, including hypoactivity, increased anxiety and reduced 
mGluR-LTD in mice and defects in flying, rough eyes, underelaboration of 
neuromuscular junction synapses and increased death in flies ((Peier and Nelson, 2002), 
(Hou et al., 2006), (Zhang et al., 2001)).  More subtly, activation of group I mGluRs in 
hippocampal slices results in a burst of Fmr1 translation that raises FMRP levels by 40% 
(Hou et al., 2006).  This increase is transient (lasting approximately 5 minutes), due to 
ubiquitinylation and degradation of FMRP shortly after the translational burst.  Together, 
these actions produce a rapid, sharp increase and decrease of FMRP levels in response to 
synaptic activity.  There have also been reports of FMRP levels increasing in response to 
activity in vivo.  In one study, dark-reared rats were acutely exposed to light, resulting in 
a transient increase in FMRP in visual cortex after 15 minutes (Gabel et al., 2004).  In 
another study, whisker stimulation resulted in increased FMRP levels in barrel cortex, 
although over a longer timescale (4 hours) (Todd et al., 2003).  Together, these results 
suggest that FMRP levels are tightly regulated in response to synaptic activity, indicating 
that maintenance of wildtype expression levels for tagged constructs may be of 
paramount importance.  
 202 
Results: 
Construct design and targeting 
We engineered a new mouse model, the conditionally tagged AcGFP-FMRP (“cTAG”) 
mouse, to allow cell type-specific HITS-CLIP of AcGFP-FMRP expressed at endogenous 
levels while also maintaining normal wt FMRP expression in cells not expressing 
AcGFP-FMRP.  Based on the reports discussed above that FMRP levels are acutely 
regulated in response to activity and overexpression of FMRP results in aberrant 
phenotypes, we opted to create a knock-in mouse in order to maintain normal expression 
levels and patterns of FMRP.  We also wished to maintain normal wt FMRP expression 
in neurons not expressing AcGFP-FMRP, so that synaptic inputs from these cells onto 
neurons expressing the tagged allele would be normal.  To meet these criteria, we 
designed a bifunctional construct in which either wt FMRP or AcGFP-FMRP can be 
expressed from the same allele, based on floxing the endogenous terminal exon of Fmr1 
(exon 17) and adding an alternative, downstream AcGFP-tagged terminal exon (Figure 
34).  In the presence of Cre, the endogenous terminal exon, including the entire 3’UTR, is 
excised, and the downstream, tagged terminal exon (which also includes the entire 
3’UTR) is used.  In the absence of Cre, the endogenous terminal exon is used, resulting in 
wt expression of FMRP.   
 
AcGFP was selected for use as an IPable tag because protein tags can generally be IPed 
with higher efficiency than peptide tags such as HA (personal communication, Mike 
Rout).  AcGFP is a monomeric alternative to EGFP, avoiding potential problems arising 
from nonphysiologic dimerization of AcGFP-FMRP via the tag.  Sucrose gradient 
analysis was performed on 293T cells transfected with AcGFP-FMRP, to confirm that 
tagging FMRP with AcGFP does not alter its polysome association (Figure 35).  A 
conservative point mutation was made in AcGFP to destroy a Bsu36I site for cloning 
purposes.  Finally, AcGFP was cloned in-frame with Fmr1 exon 17, replacing the Fmr1 
stop codon with the same Gly-Pro-Val swivel as used in pFMRP-AcGFP in Figure 35, 
using overlap extension PCR (Nelson and Fitch, 2011).   
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The cTAG targeting vector was constructed using a hybrid approach of recombineering 
plus standard cloning.  Recombineering offers an efficient method of cloning based on 
homologous recombination in E. coli that does not require use of restriction 
endonucleases or DNA ligases (Copeland et al., 2001).  We used a modified version of 
the BAC host strain DH10B called SW106, in which the lambda phage Red system is 
integrated into the host genome.  The Red system encodes three proteins, Exo, Beta and 
Gam, under a temperature-sensitive promoter.  Exo is a 5’-to-3’ exonuclease that creates 
overhangs on linear dsDNA targeting cassettes.  Beta then binds these ssDNA overhangs 
and promotes recombination with homologous regions in host plasmids, assisted by Gam, 
which inhibits the endogenous recombinase recBCD.  Expression of the Red proteins is 
undetectable at 32°C, yet reaches high levels after 15 minutes at 42°C.  Together with 
inhibition of endogenous recombinase activity by Gam, this results in a system in which 
the potential for homologous recombination is restricted to a discrete induction window, 
limiting unwanted recombination events.  Overall, this system offers highly efficient rates 
of recombination with as little as 50nt of homology.  14.3kB of sequence of Fmr1 was 
subcloned into PL253 from the BAC RP23-149C7 (which is derived from C56BL/6 
mice) in the SW106 recombineering strain, taking advantage of the gap repair activity 
inherent in this system.  Briefly, 500nt “arms” homologous to either end of the Fmr1 
fragment were cloned into PL253, which was then cut between the arms, resulting in a 
linearized plasmid with one homology arm on each end.  This vector was electroporated 
into SW106 cells carrying the RP23-149C7 BAC and induction of the Red genes resulted 
in efficient retrieval of the 14.3kB sequence by recombination of the PL253 arms with 
homologous regions of the BAC (in 10 out of 12 miniprepped clones) (Figure 36).  A 
correct clone was purified by re-transformation and sequenced. 
 
Next, targeting of the upstream “lone” lox site was achieved by PCR amplification of a 
neomycin cassette from PL452 using primers containing the 34nt loxP sequence and 
short 5’ sequences homologous to the flanking regions of the targeting locus (Figure 36).  
The PCR product was transfected into SW106 cells containing PL253 with the retrieved 
Fmr1 sequence.  Induction of the Red genes resulted in insertion of the lox-neo-lox 
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sequence 439nt upstream of Fmr1 exon 17, in 14 out of 14 miniprepped clones.  The lox-
neo-lox cassette was then reduced to a single lox site by arabinose induction of Cre. 
 
The remainder of the insert (see below) was assembled in pCR4-TOPO and then 
subcloned into PL253 using a native unique restriction site, Bsu36I, that exists 0.8kB 
downstream of the Fmr1 3’UTR (Figure 37).  This insert could not be targeted by 
recombineering due to extensive homology between the two copies of exon 17.  Use of 
this native site allowed homology to be uninterrupted downstream of AcGFP, so that the 
downstream copy of the Fmr1 3’UTR, which is 2.4kB, contributed to the total 5.9kB 
length of the 3’ homology arm used for embryonic stem cell (ES cell) targeting.  This 
limited the total nonhomologous length of the targeting construct to 7kB, and limited 
total plasmid size (including left and right homology arms of 7.9kB and 5.9 kB, 
respectively) to 26.2kB.  If we had not used this strategy, the nonhomologous region 
would have been 9.4kB and we would have also needed to increase the length of the 
homology arms, resulting in a final plasmid size of approximately 34kB, which would 
have been much more difficult to handle. 
 
The insert assembled in pCR4-TOPO consisted of a Proudfoot minimal polyadenylation 
sequence (Levitt et al., 1989), an Frt-Neo-Frt-lox cassette and the AcGFP-tagged version 
of Fmr1 exon 17 generated by overlap extension PCR (Figure 37).  We positioned the 
Proudfoot polyA sequence downstream of the native polyA site as a backstop to prevent 
transcriptional read-through and ensure that splicing to the downstream, tagged exon 
would not occur in the absence of Cre.  The Frt-Neo-Frt-lox cassette allows selection in 
ES cells and also introduces the second lox site.  Overall, elements (including the 
upstream lox site described earlier) were placed well away from annotated exons and 
conserved regions.  This is important to avoid placing elements in unannotated extensions 
of 3’UTRs and to avoid interference with potential splicing factor binding sites.  Final 
cloning into PL253 involved ligation of a 6.5kB insert into a 19.7kB vector.  This ligation 
was achieved after significant optimization of conditions using a 3:1 molar ratio of insert 
to vector with a 25ng/uL total DNA concentration and overnight incubation of the ligase.  
Although such a high DNA concentration typically causes ligation to result only in end-
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to-end linear products, in this case because the fragments were so large, their molar 
concentrations were appropriate.  Ultimately, one correct ligation product was obtained 
out of 28 miniprepped clones.  The cloning junctions were sequenced and three different 
restriction digests generating 7-10 bands each were performed, confirming that the 
construct was correct (Figure 38). 
 
The construct was targeted in male albino C57BL/6 ES cells by the Genome Targeting 
Resource Center and one correct clone was identified out of 200 based on Southern blots.  
The Southern blotting strategy is described in Figure 39a-e.  Probes were less than 300nt 
in length and had specific activities on the order of 10
9
.  The primary Southern screen 
identified seven out of 200 clones containing the Neo selection cassette (Figure 39a).  
These seven clones were then further tested by Southern blotting to confirm presence of 
the lone lox and AcGFP elements (Figure 39b,c).  Three of seven clones contained both 
these elements.  However, two of the three (#70 and #89) also contained bands that 
appeared as if the clones were mixed with wt cells.  Upon repurification, these clones did 
not appear correct.  This left clone #189 as the only clone containing all three elements 
(lone lox site, FNF cassette and AcGFP-tagged exon).  To check for internal duplications 
or rearrangements, the clones were subjected to further Southern blotting using internal 
probes (Figure 39d,e).  Clone #189 again appeared correct in both blots. 
 
To test for correct Cre-dependent recombination, ES cells from clone #189 were 
transfected with pPAC-Cre to induce expression of AcGFP-FMRP.  A portion of the 
transfected cells were selected with puromycin to enrich for cells expressing Cre, since 
the Gene Targeting facility typically observes transfection rates for ES cells on the order 
of 1%.  RNA was prepared from –Cre, +Cre and +Cre/+puro cells and reverse transcribed 
products were PCR amplified using primers in exon 16 and the 3’UTR.  This resulted in a 
0.6kB or 1.3kB product depending on whether or not AcGFP was included in the mRNA.  
The 1.3kB product was expected to be rare due to low Cre transfection rates.  To 
facilitate detection of rare products, 
32
P-dCTP was added to the last two cycles of the 
PCR reaction and products were visualized by urea-PAGE.  A high molecular weight 
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band consistent with the expected size for AcGFP inclusion was observed in the +Cre 
samples, with expected enrichment in the puromycin-selected sample (Figure 40). 
 
ES cells from clone #189 were then injected into C57BL/6 blastocysts with successful 
production of 12 chimeric males (3 grade A, 3 grade B, 6 grade C and 2 grade D).  Use of 
albino C57BL/6 ES cells allowed chimeras to be graded on coat color even though both 
the ES cells and the blastocyst were of the same genetic background (thus eliminating the 
need for backcrossing).  The ten best chimeras were mated to female albino C57BL/6 
mice (Jackson Labs #000058).  Because Fmr1 is on the X chromosome, every white, 
female pup should carry a copy of the cTAG allele (Figure 41).  Two of the chimeras 
repeatedly produced all-white litters, indicating that the cTAG allele was fully germline 
in these animals and providing a reliable source of cTAG het pups.  Presence of the 
cTAG allele was confirmed by genotyping.  The Neo selection cassette was removed by 
crossing the cTAG+/- females to males expressing Flp recombinase under an actin 
promoter (Jackson Labs #005703). 
 
Characterization of cTAG mice 
To confirm correct expression of AcGFP-FMRP, a germline cTAG male chimera was 
crossed with a female expressing Cre driven by the adenovirus EIIa promoter, which is 
expressed early in development (before implantation to the uterine wall) and in a wide 
variety of tissues including brain.  This cross resulted in Cre+, cTAG/+ mice that 
expressed both tagged and untagged versions of FMRP, allowing direct comparison of 
the two.  As a control, a germline chimera was also bred to a female albino C57BL/6 
mouse, resulting in Cre-, cTAG/+ mice.  Brain lysates from each were fractionated over 
20-50% sucrose gradients and blotted with an antibody against FMRP that recognizes 
both wt FMRP and AcGFP-FMRP.  Both forms of FMRP were of anticipated molecular 
weights and were present in roughly equal ratios in +Cre mice (Figure 42).  No AcGFP-
FMRP was observed in –Cre lysate.  Although expression of AcGFP-FMRP did not 
appear to result in a commensurate decrease in expression of wt FMRP compared to the  
–Cre mouse, the +Cre mouse used in this experiment was six days younger than the –Cre 
mouse, and thus expressed higher levels of FMRP overall.  Importantly, wt FMRP and 
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AcGFP-FMRP were identically distributed on polysome gradients (Figure 43).  No 
AcGFP-FMRP was observed on polysomes from –Cre lysate (a more stringent test of 
expression, since polysome-associated proteins can often be detected on gradient 
purifications even when undetectable in total lysates), even when the film was 
overexposed.  RNA was prepared from these lysates as before and reverse transcribed 
products were PCR amplified as before using primers in exon 16 and the 3’UTR and with 
the addition of 
32
P-dCTP in the final two cycles.  Two products of expected sizes (0.6kB 
and 1.3kB) were observed in the +Cre samples, expressed at more equivalent levels than 
was observed for Cre-transfected ES cells (Figure 42).  Although the 1.3kB product was 
somewhat less strongly detected, this was expected due to mosaic expression of EIIa-Cre 
and less efficient amplification of larger PCR products. 
 
To further characterize expression of the cTAG allele, protein lysates and RNA were 
prepared from a panel of 16 mice varying in Fmr1 genotype, Cre expression, and 
retention of the Neo selection cassette (Table 7, Figure 44).  Importantly, Western blot 
analysis showed that mice homozygous for the cTAG allele expressed normal levels of 
wt FMRP in the absence of Cre, showing that the cTAG allele is truly bifunctional.  In 
mice expressing Cre, AcGFP-FMRP was detected at levels commensurate with the 
strength and expression pattern of the Cre driver (note that our male EIIa Cre mouse 
expressed extremely low levels of Cre, unlike its female counterpart and consistent with 
this line exhibiting mosaicism).  AcGFP-FMRP bands reacted with both the 17722 
FMRP antibody and two different GFP antibodies.  Unexpectedly, removal of the Neo 
selection cassette resulted in a low level of leaky AcGFP-FMRP expression in the 
absence of Cre.  Although we are unsure why this occurs, one possibility is that removal 
of the Neo cassette might change the nucleosome context of the associated lox site, which 
could in theory promote some level of Cre-independent recombination.  To more 
carefully quantify relative levels of wt Fmr1 and AcGFP-Fmr1, QPCR primers were 
designed to amplify the region between exon 16 and either the 3’ end of exon 17 (to 
quantify total Fmr1 mRNA from both wt and cTAG alleles) or the 5’ end of AcGFP (to 
quantify mRNA from the cTAG allele alone).  Two sets of primers were designed for 
each region, to ensure consistency of results.  Amplicons were all within range of 
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efficient QPCR amplification (130-192nt).  Primer efficiencies were measured using 
serial dilutions and all had near-perfect efficiencies of 1.97-2.01.  Melt curves and –RT 
controls were also performed.  QPCR analysis showed that AcGFP-Fmr1 was expressed 
in a dose-dependant manner: 26% of total Fmr1 mRNA in a cTAG/+ mouse under the 
EIIa Cre driver, 45% in a cTAG/+ mouse under the panneuronal Emx1 Cre driver, and 
59% in a cTAG/Y mouse under the Emx1 driver.  AcGFP-Fmr1 mRNA constituted 6%-
7% of total Fmr1 mRNA in –Cre, -Neo cTAG/Y mice, indicating a moderate level of 
leaky Cre-independent AcGFP-FMRP expression upon removal of the Neo cassette.  In 
future experiments, AcGFP-FMRP may be expressed in a minor fraction of cells, thus, 
leaky expression at low levels in the majority of cells is a major concern.  However, 
leaving the Neo cassette in place is not expected to interfere with expression of wt FMRP 
from the cTAG allele, since Neo is downstream of the polyA site and transcription of 
Neo occurs in same direction as Fmr1.  It is also unlikely that transcription of the GFP-
tagged exon occurs from the Neo promoter, as we do not observe any aberrant short GFP-
positive isoforms by Western.  Finally, the Neo cassette will not interfere with expression 
of AcGFP-FMRP, as it will be floxed out upon Cre expression.  Therefore, the Neo 
cassette was left in place in the final cTAG mouse. 
 
Alternative splicing of Fmr1 likely plays an important role in the function of FMRP.  For 
example, exon 12, which encodes part of the KH2 domain critical for FMRP function, is 
alternatively spliced.  In addition, exons 15 and 17 have three and two splice acceptor 
sites, respectively, and use of the downstream splice acceptor sites for exon 15 excludes 
FMRP’s major phosphorylation site (Ser499 in mouse).  Although AcGFP-FMRP 
typically appears as a single band on Western, multiple isoforms can be detected with use 
of commercial gradient gels (Figure 42).  To characterize the splicing of AcGFP-Fmr1, 
RNA was prepared from cTAG/Y mice +/-Cre, as well as from wt mice.  This allowed 
comparison of AcGFP-Fmr1, Fmr1 expressed from the cTAG allele, and Fmr1 expressed 
from the wt allele.  Reverse transcribed products were PCR amplified as before using 
primers in exon 11 and either exon 17 (for the –Cre mice) or in AcGFP (for the +Cre 
mice, in order to select for AcGFP-Fmr1 isoforms).  Hot 
32
P-dCTP was added in the final 
two cycles and products were separated by urea-PAGE for 5 hours.  At least four 
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isoforms of in the expected size range of 580-780nt were observed (Figure 45).  
Reassuringly, all three forms of Fmr1 mRNA, both tagged and untagged, had the same 
isoform expression pattern (AcGFP-Fmr1 products were expected to be slightly larger 
due to downstream placement of the AcGFP-specific primer).  
 
The best evidence that AcGFP-FMRP is functionally equivalent to wt FMRP would be to 
show using HITS-CLIP that mRNA binding activity is unaltered, both in terms of 
identities of targeted transcripts and binding distribution of AcGFP-FMRP on these 
transcripts.  Pilot immunoprecipitations from cTAG/+ brain showed that AcGFP-FMRP 
was efficiently IPed under stringent wash conditions, while no wt FMRP was detectable 
(Figure 46).  To compare mRNA association of AcGFP-FMRP and wt FMRP, HITS-
CLIP was performed on AcGFP-FMRP from a +Cre, cTAG/+ brain using GFP 
antibodies and on FMRP from a wt brain using the 17722 FMRP antibody.  CLIP was 
also performed on wt FMRP from a –Cre, cTAG/Y brain using the 17722 antibody, to 
show that FMRP expressed from the cTAG allele has normal mRNA associations.  
Finally, CLIP was performed on a wt brain using GFP antibodies, as a control to show 
that the signal in the GFP IPs was specific to the presence of GFP.  Brains from the 
appropriate mice in the third postnatal week were rapidly minced under ice-cold buffer 
and immediately UV crosslinked.  Homogenates were treated with DNAse and clarified.  
Supernatants were then subject to limited RNAse digestion prior to IP.  IPs were 
stringently washed and RNAs were ligated to cold linker on-bead and subsequently 
32
P 
labeled. Separation of labeled immunoprecipitates by SDS-PAGE and nitrocellulose 
transfer showed smears of protein:RNA complexes at the expected molecular weights 
above FMRP and AcGFP-FMRP protein bands, while no signal was observed for the 
control IP of GFP from wt lysate.  RNA was cut from the nitrocellulose in the indicated 
regions (Figure 47) and further processed according to the standard HITS-CLIP protocol.  
Separation of products by urea-PAGE again showed RNA smears of expected sizes, 
while control lanes showed only discrete bands reflecting linker-linker ligation products 
that predominate in absence of IPed RNA (Figure 47).  Final samples were sequenced by 
Illumina.  Analysis of the data showed that the three experimental samples were 
extremely similar, both in terms of exonic tags per gene (all pairwise correlation 
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coefficients were at least 0.96 for the top 5000 targets, Figure 48) and in terms of tag 
distributions on target mRNAs (Figure 49).  Finally, the number of exonic tags per gene 
measured in cTAG CLIP was extremely similar to that measured in FMRP CLIP in 
previous experiments (R2=0.94) (Figure 48).  Together, these data provide strong 
evidence that AcGFP-FMRP is functionally equivalent to wt FMRP and that CLIP 
studies on the cTAG mouse should be successful. 
 
Discussion: 
HITS-CLIP has now been successfully performed on a number of RNA-binding proteins 
in brain, yielding a rich database of protein:RNA interaction maps ((Chi et al., 2009), 
(Licatalosi et al., 2008), (Darnell et al., 2011), (Polymenidou et al., 2011)).  From these 
data, it is clear that RBPs extensively regulate neuronal mRNAs in a variety of ways, 
including splicing, alternative polyadenylation, translational expression and targeting by 
miRNAs.  As informative as they are, these maps do not do justice to the rich complexity 
of molecular biology in the brain.  We can already glimpse that some RBPs, such as 
Nova and FMRP, regulate networks of mRNAs with related functions.  Yet our ability to 
perceive such networks is limited by experimental intermingling of mRNAs from all 
types of neurons inherent in whole brain analyses.  Cell type-specific translational 
profiling experiments have begun to reveal the vast diversity of gene expression in 
different classes of neurons.  The ability to perform cell type-specific HITS-CLIP on 
RBPs expressed from their native loci would dramatically improve our ability to 
understand the function of RBPs in local context.  
 
To facilitate cell type-specific CLIP without disturbing native expression levels or 
patterns of FMRP, we have created a knock-in mouse model in which AcGFP-FMRP or 
wt FMRP can be conditionally driven from the same allele.  In the presence of Cre, 
AcGFP-FMRP is expressed, while normal wt FMRP expression is maintained in 
surrounding cells in the absence of Cre.  Inclusion of AcGFP provides a tag that can be 
IPed with high stringency and specificity, allowing HITS-CLIP analysis of discrete 
subpopulations of FMRP:RNA interactions.  We have confirmed that both AcGFP-
FMRP and wt FMRP expressed from the cTAG allele are expressed at normal levels 
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compared to FMRP expressed from the wt allele, and both products are of the expected 
sizes at the RNA and protein levels.  AcGFP-FMRP and wt FMRP have identical 
distributions on sucrose gradients, indicating that AcGFP-FMRP associates normally 
with polysomes.  In the absence of Cre, no AcGFP-FMRP can be detected in +Neo cTAG 
mice, indicating that the expression of AcGFP-FMRP is tightly restricted to the cell 
population of interest.  Splicing of AcGFP-FMRP appears to be normal.  Finally, parallel 
HITS-CLIP experiments performed on both AcGFP-FMRP and untagged FMRP (from 
both the cTAG and wt alleles) yielded near-identical results, providing final confirmation 
that use of AcGFP as an IPable CLIP tag is a viable strategy that does not interfere with 
the mRNA-binding function of FMRP.  Overall, the cTAG mouse may be used to 
investigate FMRP function in any cell type of interest for which specific Cre drivers 
exist. 
 
The most informative cell type-specific HITS-CLIP analyses will be those in which 
regulation of specific mRNAs can be linked to cell autonomous phenotypes relevant to 
neuronal biology and/or human disease.  For example, cell autonomous loss of FMRP in 
Purkinje cells (PCs) has been shown to result in defects in mGluR-LTD at parallel fiber-
PC synapses (Koekkoek et al., 2005) PCs are the sole mediators of signaling output from 
the cerebellum, providing tonic inhibitory feedback onto motor pathways, and specific 
loss of PCs during development results in impairment of motor learning (Chen et al., 
1996).  Individual PCs integrate excitatory input from hundreds of thousands of parallel 
fiber synapses and also receive strong excitatory input from climbing fiber synapses.  
mGluR-LTD at parallel fiber-PC synapses occurs when parallel fiber activity coincides 
with strong PC depolarization in response to climbing fiber activity, and results in relief 
of tonic inhibitory signaling by PCs (Linden, 1994).  mGluR-LTD is central to motor 
learning tasks mediated by PCs, evidenced by impairment of conditioned eyeblink 
responses in global mGluR1 knockout mice that can be rescued by Purkinje cell-specific 
mGluR1 expression ((Aiba et al., 1994), (Kishimoto et al., 2002)).  Eyeblink conditioning 
is a paradigm of associative motor learning that measures the ability of the subject to 
learn to blink in anticipation of an unpleasant stimulus (a puff of air on the eye) when it is 
preceded by a neutral stimulus (playing of a tone).  Deficits in eyeblink conditioning are 
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observed in the PC-specific Fmr1 KO, as well in human patients with FXS ((Koekkoek et 
al., 2005)).  Protein synthesis is required for both parallel fiber-PC mGluR-LTD and 
motor learning of conditioned eyeblink responses ((Bracha et al., 1998), (Linden, 1996), 
(Karachot et al., 2001)), and postsynaptic signaling pathways that mediate parallel fiber-
PC mGluR-LTD are likely to include a number of proteins whose expression is regulated 
by FMRP ((Ito, 2002), (Darnell et al., 2011)).  
 
We propose to cross the Fmr1 cTAG line to the Pcp2/L7 Cre line (Jackson labs #004146, 
Heiman et al 2008) used in the study by Koekkoek et al in order to perform AcGFP-
FMRP HITS-CLIP in Purkinje neurons and gain insight into how loss of translational 
regulation of specific mRNAs leads to observed deficits in synaptic plasticity, spine 
morphogenesis and motor learning.  Cre expression in the Pcp2/L7 line is detectible at P6 
and is fully established 2-3 weeks after birth (Barski et al., 2000).  HITS-CLIP will be 
performed in the third postnatal week, as this is a critical period of synaptogenesis during 
which FMRP is highly expressed, and again in adulthood, to correspond with the age at 
which cell autonomous Fmr1 KO phenotypes were observed (Koekkoek et al., 2005).  
Intact cerebella will be crosslinked and HITS-CLIP will be performed on purified 
polysomes from according to previously established protocols.  AcGFP-FMRP CLIP will 
also be performed on wt littermate controls to ensure that no signal is seen the absence of 
AcGFP.  In the event that the amount of RNA recovered from these studies is low enough 
to cause linker-linker ligation products to predominate in the CLIP assay (an effect we 
routinely see when target RNA substrates are low), we will include biotinylated carrier 
RNA of known sequence in the linker ligation reactions.  Carrier RNA will then be 
removed by streptavidin beads before PCR amplification of products, and the little that 
remains will be subtracted bioinformatically after sequencing.  Specificity of Cre 
expression will be confirmed by performing immunofluorescence (IF) on AcGFP-FMRP.  
If this signal is not detectable, the Pcp2-Cre line will be crossed to the Rosa26R-lacZ 
reporter line (Jackson labs #003474) and Pcp2-Cre expression will be monitored using B-
gal immunohistochemistry. 
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In previous FMRP CLIP experiments, specificity of FMRP:RNA interactions was 
demonstrated by correlation of CLIP data to mRNA abundance on polysomes as 
measured by exon array or to a published database of mRNA expression in neurons 
(Cahoy et al., 2008).  While it was generally clear from these analyses that FMRP 
associates with a subset of mRNAs not correlated with mRNA abundance, a cell 
autonomous method of measuring mRNA translation levels would allow CLIP data from 
the proposed experiments to be accurately compared to the translational status of 
individual mRNAs for the first time.  We propose to perform paired ribosome profiling 
assays using the RiboTag mouse, which expresses triple-HA tagged ribosomal protein 
L22 in a Cre-dependent manner (Jackson labs #011029).  The RiboTag mouse was 
created using the same knock-in conditional tagging strategy as the FMRP cTAG mouse 
and can be crossed to the same Cre expression lines used in cell autonomous AcGFP-
FMRP HITS-CLIP studies (Sanz et al., 2009).  Ribosome profiling is a method of 
ascertaining mRNA translational status by high-throughput sequencing of mRNA tags 
protected from nuclease digest by ribosome binding.  Ribosome profiling thus provides a 
direct readout of translational status, which is not necessarily correlated to mRNA 
abundance.  Immunoprecipitation of HA-tagged ribosomes will allow recovery of mRNA 
tags specifically and cleanly from the cell type of interest, and these tags can be purified 
and processed via the same experimental pipeline used for CLIP. 
 
Pairing cell autonomous HITS-CLIP and ribosomal profiling assays will allow 
pinpointing of the mRNAs most strongly regulated by FMRP in a known cell type that (at 
least for Purkinje neurons) is relatively easy to visualize by IF.  This would offer a 
potential opportunity to detect protein-level changes in FMRP targets, a goal that has 
been largely elusive.  IF will be performed for selected targets in cerebellar slices from 
FMRP/Pcp2-Cre/LacZ and FMRPcKO/Pcp2-Cre/LacZ littermates, normalizing IF 
signals to B-gal staining.  If successful, these results would provide strong support for the 
model that FMRP inhibits the synthesis of specific proteins in vivo, and would provide 
independent validation of results from HITS-CLIP and puromycin runoff assays.  
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It is anticipated that the proposed experiments will reveal a narrowed list of mRNAs 
regulated by FMRP in Purkinje neurons.  As discussed in the Introduction, some of these 
targets may be more directly responsible for demonstrated FMRP-mediated cell 
autonomous defects in Purkinje cell function than others, depending on the dosage 
sensitivity of the proteins in question and the relative influence of other pathways 
controlling protein expression.  Proposed IF studies may provide some information as to 
which targets are most overexpressed in the absence of FMRP.  Furthermore, 
examination of the literature may provide clues as to which FMRP targets are most likely 
to cause the observed phenotypes if overexpressed.  For example, it is known that the 
mGluR-PLC-DAG-IP3-PKC pathway is central to the expression of parallel fiber-PC 
mGluR-LTD, and many proteins supporting this pathway have been shown to be FMRP 
targets (Darnell et al., 2011).  In order to directly demonstrate that translational control of 
particular mRNAs is responsible for cell autonomous loss-of-function phenotypes, 
phenotypic rescue could be attempted by lowering the dosage of particular FMRP target 
proteins, since FXS results from overexpression of these proteins.  This may be most 
easily accomplished by crossing the conditional Fmr1 KO to a conditional KO of the 
target in question.  Such a cross would generate male pups that are -/Y for Fmr1 and +/- 
for the target gene in +Cre cells, resulting in a Cre-dependent halving of the target gene 
dosage in the cell type where FMRP is absent.  If a conditional KO mouse does not exist 
for the protein in question, protein expression could be knocked down by in utero 
electroporation of shRNAs against target mRNAs.  Such a strategy would potentially 
allow the dosage of several proteins to be lowered simultaneously, which might be 
necessary to have an effect on phenotype if several proteins work in concert to achieve a 
function.  However, shRNA-mediated knockdown would not be limited to the desired 
cell type. 
 
Identification of FMRP targets most relevant for disease phenotypes has the potential to 
spur development of therapeutic drugs for treatment of patients with FXS.  
Encouragingly, FXS phenotypes have been shown to be both acutely inducible and 
acutely reversible in adult mice, in agreement with our finding of acute reversibility of 
FMRP-dependent ribosome stalling by kcRNA treatment in puromycin runoff assays.  
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The acute nature of FMRP regulation in adult mice was recently demonstrated by 
crossing both the Fmr1 cKO and Fmr1 cON lines with the tamoxifen-inducible Nestin-
Cre driver line, allowing FMRP expression to be either turned off or turned on 
specifically in adult neural progenitor cells and their progeny (Guo et al., 2011).  
Conditional deletion of Fmr1 in aNPCs in adult mice resulted in defects in the 
proliferation, differentiation and dendritic arbor complexity of these cells and impairment 
in behavioral assays designed to assess hippocampal-dependent learning.  Conversely, 
conditional expression of Fmr1 in aNPCs in an otherwise Fmr1-null background rescued 
these phenotypes.  These results suggest that FXS results from ongoing (and therefore 
potentially treatable) misregulation of protein synthesis, and does not simply reflect 
irreversible consequences of loss of function during development.  Connection of cell 
autonomous HITS-CLIP studies with these types of cell autonomous loss-of-function 
studies has the potential to significantly advance our understanding of FMRP function 
and to rationally guide development of therapies to treat FXS.  
  
Figure 34.  Construct design of the cTAG allele.  
 The terminal exon of Fmr1 is flanked by lox sites so that Cre-dependent recombination 
results in expression of a downstream, AcGFP-tagged version of this same exon 
(including the entire 3‘UTR).  Thus, either wt FMRP or AcGFP-tagged FMRP can be 
expressed from the cTAG allele in a mutually exclusive fashion, dependent on Cre 
expression. AcGFP can then be used as an IP-able tag in cell type-specific CLIP 
experiments while maintaining normal wt FMRP expression in all cells not expressing 
Cre.  LA=left homologous arm; RA=right homologous arm; Pfoot pA=Proudfoot 
consensus polyadenylation site; FNeoF= Frt-Neomycin-Frt cassette.  Exon numbers 
indicated within rectangles; lox sites indicated by triangles. 
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Figure 35. Polysome distribution of wt FMRP and C-terminally tagged AcGFP-
FMRP in 293T cells.  
 Polysomes were fractionated from 293T cells transiently transfected with AcGFP-FMRP 
and fractions were analyzed by Western blot with FMRP antibody 17722, which 
recognizes both tagged (transfected) and untagged (endogenous) forms of FMRP.  
AcGFP adds approximately 30kD to the molecular weight of FMRP.  Presence of the 
AcGFP tag did not alter the polysome distribution of FMRP.  AcGFP-FMRP did not have 
multiple splice isoforms because it was expressed from a cDNA construct. 
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Figure 36.  Retrieval of Fmr1 sequence from BAC RP23-149C7 and targeting of 
upstream lox site.   
14.3kB of sequence was retrieved from the BAC into linearized PL253 by homologous 
recombination at the pink and blue regions.  A lox-neo-lox cassette was then amplified by 
PCR and targeted upstream of Fmr1 exon 17 (the terminal exon) by homologous 
recombination at the green and purple regions.  Finally, the lox-neo-lox cassette was 
reduced to a single lox site by arabinose induction of Cre. 
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Figure 37.  Final cloning of cTAG construct.   
A Bsu36I-Proudfoot polyA-Frt-Neo-Frt-lox cassette was cloned upstream of AcGFP-
tagged Fmr1 exon 17 at the PacI site in pCR4-TOPO.  The final cassette was then cloned 
into a native Bsu36I site downstream of Fmr1 exon 17 in PL253.  This strategy allowed 
uninterrupted homology downstream of AcGFP. 
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Figure 38.  Restriction digests confirming final cTAG construct.   
Digests of the final cTAG construct in PL253 were performed with 2ug of DNA and 1uL 
of enzyme for 90 min.  All bands were correct to high resolution except the 2.5kB PvuII 
band, which was expected to be 2.8kB.  However, the affected fragment is entirely within 
the vector backbone and does not affect the construct. 
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Figure 39a.  Primary Southern screen for presence of Neo cassette in ES cells 
injected with cTAG construct.   
Southern blot was performed using NdeI digest and a 3’ arm probe.  The wt allele 
produces a 7.4kB band, while the correctly targeted allele produces a 10.1kB band due to 
an NdeI site engineered into the Proudfoot FNF-lox cassette.  7/200 clones contained the 
10.1kB band. 
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Figure 39b.  Secondary Southern screen for presence of upstream lox site in ES cells 
injected with cTAG construct.   
Southern blot was performed using EcoRI digest and a 5’ arm probe.  Homologous 
regions that have the potential to create unwanted crossovers are indicated in pink and 
blue.  A 11.9 kB band is seen if the upstream lox site is absent (either in the wt allele or 
due to dropping during targeting), while the correctly targeted allele produces a 9.0kB 
band due to an EcoRI site engineered next to the lox site.  Clones 70, 89, 103, 109 and 
189 (band partially cut off) contain the upstream lox site, although clones 70 and 89 
appear mixed with wt.  Clones 100 and 127 appear to have dropped the upstream lox site 
from the targeted allele. 
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Figure 39c.  Secondary Southern screen for presence of AcGFP in ES cells injected 
with cTAG construct.   
Southern blot was performed using DraIII digest and a 3’ arm probe.  Homologous 
regions that have the potential to create unwanted crossovers are indicated in pink and 
blue.  A 16.0 kB band is seen if AcGFP is dropped during targeting, while a 10.1kB band 
is generated from the wt allele.  The correctly targeted allele produces a 9.5kB band due 
to an DraIII site present in AcGFP.  Clones 70, 89, 100, 127 and 189 contain AcGFP, 
although clones 70 and 89 appear mixed with wt.  Clones 103 and 109 appear to have 
dropped AcGFP from the targeted allele. 
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Figure 39d.  Secondary Southern screen for presence of internal duplications, 
deletions or rearrangements in ES cells injected with cTAG construct.   
Southern blot was performed using NdeI digest and an internal 3‘UTR probe.  
Homologous regions that have the potential to create unwanted crossovers are indicated 
in pink and blue.  The correctly targeted allele produces both a 3.9kB band and a 10.1kB 
band due to an NdeI site engineered downstream of the Proudfoot sequence.  All clones 
contain the 3.9kB band, although this band does not indicate whether the upstream lox 
site is present.  Clones 70, 89, 100, 127 and 189 contain a downstream segment of the 
correct size, although clones 70 and 89 appear mixed with wt.  The downstream segment 
of clones 103 and 109 is smaller because they have dropped AcGFP (see Fig 22c).  Clone 
127 has an unexpected band, which could indicate an unwanted event in the target allele, 
consistent with results from Fig 22e. 
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Figure 39e.  Secondary Southern screen for presence of internal duplications, 
deletions or rearrangements in ES cells injected with cTAG construct.   
Southern blot was performed using DraIII digest and an internal Neo probe.  Homologous 
regions that have the potential to create unwanted crossovers are indicated in pink and 
blue.  The correctly targeted allele produces 7.3kB band.  If AcGFP is absent, a 16.0kB 
band will be observed.  Clones 70, 100 and 189 contain a segment of the correct size, 
although clone 70 also contains an unexpected band.  Clones 103 and 109 contain the 
16.0kB band because they have dropped AcGFP (see Fig 22c).  Clone 127 has an 
unexpected band, which could indicate an unwanted event in the target allele, consistent 
with results from Fig 22d. 
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Figure 40.  Expression of AcGFP-FMRP from the cTAG construct in ES cells.   
ES cells from clone #189 were transfected with pPAC-Cre to induce expression of 
AcGFP-FMRP.  One set of cells was selected with puromycin to enrich for Cre+ cells, 
since transfection rates of ES cells are typically around 1%.  Presence of AcGFP-
containing mRNA was detected by RT-PCR with primers in Fmr1 exon 16 and 3‘UTR, 
in which 
32
P-dCTP was included in the final two cycles.  Inclusion of AcGFP is indicated 
by an increase in product size from 0.6kB to 1.3kB. 
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Figure 41.  cTAG breeding strategy.   
Male albino B6 ES cells carrying the cTAG allele (derived from a B6 BAC) were 
combined with B6 blastocysts (non-albino).  Resulting male chimeric mice were crossed 
with female B6 albinos.  Albinism is a recessive trait, therefore if a pup resulting from 
this cross is albino, one set of chromosomes must have been derived from the ES cell.  
Since Fmr1 is on the X chromosome, all white, female progeny from this cross should 
carry one copy of the cTAG allele and will be fully on the B6 background. 
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Figure 42.  Analysis of AcGFP-FMRP expression in cTAG/+ mice.   
 
A) Western blots of brain lysate from a +Cre, cTAG/+ mouse and a –Cre, cTAG/+ mouse, 
blotted with FMRP antibody 17722 that recognizes both tagged and untagged forms of 
FMRP.  AcGFP-FMRP expression was only detectable in +Cre mice and appeared at the 
expected molecular weight.  Multiple splice isoforms of AcGFP-FMRP were detectable 
at the higher resolution provided by a gradient gel (right hand panel).   
 
B) Presence of AcGFP-containing mRNA was detected by RT-PCR with primers in 
Fmr1 exon 16 and 3‘UTR, in which 
32
P-dCTP was included in the final two cycles.  
Inclusion of AcGFP is indicated by an increase in product size from 0.6kB to 1.3kB. 
In these experiments, two different Cre drivers were used: EIIA and Emx1.  Both should 
drive Cre pan-neuronally but Emx1 is a more efficient driver. 
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Figure 43.  Polysome distribution of wt FMRP and AcGFP-FMRP in –Cre, cTAG/+ 
and +Cre, cTAG/+ mouse brain.   
Brain polysomes were separated over sucrose gradients and fractions were analyzed by 
Western blot with FMRP antibody 17722, which recognizes both tagged and untagged 
forms of FMRP.  AcGFP adds approximately 30kD to the molecular weight of FMRP.  
No AcGFP-FMRP was detected in -Cre polysome fractions even after extended exposure.  
Presence of the AcGFP tag did not alter the polysome distribution of AcGFP-FMRP in 
brain. 
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Table 7: Mice used in characterization of cTAG allele.   
Shown from left are: Mouse number, mouse genotype, presence of neomycin cassette, 
expression of Cre, Cre driver, and mouse age.  Note: The EIIa male mice expressed Cre at 
extremely low levels, most likely due to mosaic expression of the driver. 
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 Number Genotype Neo Cre Cre Driver Age 
1 +/Y (+) (-)  P17 
2 cTAG/Y (+) (-)  P17 
3 +Y (-) (-)  P17 
4 cTAG/Y (-) (-)  P17 
5 +/Y (+) (+) EIIa (male) P17 
6 cTAG/Y (+) (+) EIIa (male) P17 
7 +/Y (-) (-)  P23 
8 cTAG/Y (-) (-)  P23 
9 cTAG/Y (-) (-)  7wk 
10 cTAG/Y (-) (-)  7wk 
11 cTAG/+ (+) (-)  P23 
12 cTAG/+ (+) (+) EIIa (female) P17 
13 +/+ (+) (+) Emx1 P16 
14 cTAG/+ (+) (+) Emx1 P16 
15 +/Y (+) (+) Emx1 P16 
16 cTAG/Y (+) (+) Emx1 P16 
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Figure 44.  Analysis of AcGFP-FMRP expression at RNA and protein levels in panel 
of 16 mice (listed in Table 7).   
The 16 mice vary in terms of presence of cTAG allele, presence of Neo cassette and 
expression of Cre.  Protein and RNA was prepared from total brain.   
 
Top panel: Western blot using FMRP antibody 17722 that recognizes both tagged and 
untagged forms of FMRP.  Mice # 12, 14 and 16 express Cre.  Degree of Cre expression 
was correlated to degree of AcGFP-FMRP expression.  A small amount of leaky AcGFP-
FMRP expression was observed in mice in which the Neo cassette was removed (#4, 8, 9 
and 10).  
 
Middle panels: Western blots using two different GFP antibodies (sc-9996 and 19C8) 
specifically detect AcGFP-FMRP.   
 
Bottom panel: The ratio of AcGFP-Fmr1 mRNA to wt Fmr1 mRNA was determined for 
the 16 mice by QPCR using primers in Fmr1 exon 16/exon 17 (to detect untagged Fmr1 
mRNA) and primers in exon 16/AcGFP (to detect tagged AcGFP-Fmr1 mRNA).  A 
small amount of leaky AcGFP-FMRP expression in the absence of the Neo cassette was 
also detected by QPCR.  Therefore, the Neo cassette was left in place, since it did not 
appear to otherwise affect the expression of FMRP. 
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Figure 45.  Comparison of Fmr1 splice isoforms.   
 
A) Splice isoforms spanning exons 12-17 were detected by RT-PCR with primers in 
Fmr1 exons 11/17 or exon 11/AcGFP, in which 
32
P-dCTP was included in the final two 
cycles.  From left to right: Fmr1 expressed from the wt allele, Fmr1 expressed from the 
cTAG allele, and AcGFP-Fmr1 (these are mice #1, 2 and 16 from Table 7, respectively). 
Multiple splice isoforms appeared similar in all three samples (products amplified with 
exon 11/AcGFP primers were slightly larger because the AcGFP primer is positioned 
44nt downstream of the exon 17 primer).   
 
B) Cartoon showing relative positioning of FMRP exons and Fmr1 splice isoforms, with 
known alternative splice isoforms indicated. Reproduced with permission from Steve 
Warren, from Bassell & Warren 2008. 
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Figure 46.  Immunoprecipitation of AcGFP-FMRP from +Cre, cTAG/+ mouse 
brain.   
Immunoprecipitations were performed using mixed GFP monoclonals 19C8 and 19F7 
and standard CLIP conditions.  Although the cTAG/+ mouse expressed both AcGFP-
FMRP and wt FMRP, AcGFP-FMRP was specifically immunoprecipitated.   
 
Upper panels: Western blot with GFP antibody sc-9996 showed successful depletion 
and IP of AcGFP-FMRP, with no signal detected in a control IP from a wt mouse (final 
lane).   
 
Lower panels: Western blot with FMRP antibody 17722 (that recognizes both wt FMRP 
and AcGFP-FMRP) showed specific depletion and IP of AcGFP-FMRP, without 
detectible depletion or IP of wt FMRP.  5% of input/post-IP supernatants were loaded. 
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Figure 47. AcGFP-FMRP CLIP of whole mouse brain.  
 
A) Autoradiogram of labeled RNA:protein complexes immunoprecipitated from cTAG 
and wt mouse brains after RNAse digest.  Lane 1: AcGFP-FMRP was IPed from brain 
lysate containing both wt FMRP and AcGFP-FMRP.  Lane 2: FMRP was IPed from wt 
brain lysate.  Lane 3: FMRP was IPed from brain lysate containing untagged FMRP 
expressed from the cTAG allele.  Lane 4: Control IP performed with GFP antibodies on 
a wt lysate, showing that the signal in Lane 1 was specific to presence of GFP.  
Nitrocellulose membrane was cut out in regions indicated by dots.   
 
B) RNAs purified from nitrocellulose were reverse transcribed, amplified by PCR and 
further purified by urea-PAGE .  DNAs of correct size are visualized as a smear between 
100-150nt. DNA was recovered from the gel cut at bracketed regions.  
 
C) Agarose gel showing final CLIP DNA products.   
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Figure 48. Correlation of CLIP data from AcGFP-FMRP and wt FMRP mouse 
brains.   
For each sample, the number of unique exonic CLIP tags mapping to each mRNA was 
plotted for the top 5000 targets.  A) AcGFP-FMRP CLIP was highly correlated with wt 
FMRP CLIP performed in parallel.  B) CLIP performed on FMRP expressed from the 
cTAG allele was highly correlated with CLIP performed on FMRP expressed from the 
endogenous allele, performed in parallel.  C) AcGFP-FMRP CLIP was highly correlated 
with an earlier wt FMRP CLIP experiment. 
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Figure 49.  Comparison of tag distributions from wt FMRP and AcGFP-FMRP 
CLIP experiments.   
The experimental tracks are represented in the following order:  Upper track: FMRP 
CLIP from wt brain; middle track: FMRP CLIP from (-)Cre, cTAG/Y brain; lower track: 
AcGFP-FMRP CLIP from (+)Cre, cTAG/+ brain.  Two gene examples are shown: Bat2 
(this page) and Dlg4 (next page).  Very similar tag numbers and distributions were 
observed in all three samples, indicating that the three forms of FMRP (AcGFP-FMRP, 
FMRP expressed from the cTAG allele, and FMRP expressed from the wt allele) are 
functionally equivalent. 
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Chapter VI: General Discussion 
 
We have shown that FMRP stalls ribosomes on a specific set of mRNAs previously 
identified as FMRP targets by HITS-CLIP.  FMRP remains in dense fractions of sucrose 
gradients after treatment of brain lysates or cells with puromycin, a drug that causes 
translocating ribosomes to dissociate from mRNA.  Since FMRP is well-characterized as 
a polysome-binding protein, this finding suggests that FMRP-associated mRNAs harbor 
nontranslocating ribosomes.  FMRP loss-of-function in four different models was 
sufficient to increase the sensitivity of these nontranslocating ribosomes to puromycin, 
suggesting that FMRP is directly responsible for stalling these ribosomes and that loss of 
FMRP association with polysomes containing stalled ribosomes allows the stalled 
ribosomes to resume translocation.  mRNAs that are not FMRP targets did not show this 
effect, providing further evidence that FMRP regulates the translation of specific target 
mRNAs.  We have directly visualized FMRP-containing polysomes remaining in dense 
gradient fractions after both puromycin runoff and micrococcal nuclease treatment, 
lending support to a model in which FMRP-associated mRNAs contain multiple stalled, 
closely packed ribosomes.  In an effort to address the origin of FMRP’s target specificity, 
given that FMRP was observed to associate along the entire coding sequence length of its 
targets without discrete binding sites in polysome CLIP (Darnell 2011), we performed 
FMRP HITS-CLIP on total extracts and purified nuclear extracts from mouse brain.  We 
did not find evidence of FMRP binding to intronic RNA or ncRNA, suggesting that the 
vast majority of FMRP appears to be associated with mature mRNA.  However, our 
results did suggest that FMRP locally regulates translation of perinuclear mRNAs, a facet 
of FMRP biology that has received essentially no attention in the literature.  We also 
performed FMRP HITS-CLIP on mice after seizure, and found that FMRP association 
with some mRNAs, including classical immediate-early genes such as c-fos, was altered 
after seizure compared to resting mice.  This pilot experiment suggests future avenues for 
further research, such as an expanded timecourse of CLIP experiments after seizure and 
paired RNA-Seq profiling.  Finally, we have designed a method of purifying membrane-
associated and cytosolic polysomes from mouse brain, and have shown that FMRP-
associated mRNAs are present in both compartments. 
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In order to refine our ability to understand how FMRP functions in diverse types of 
neurons, we have designed and generated a new knock-in mouse model, the FMRP 
conditional-tag (cTAG) mouse.  In this mouse model, wt FMRP or AcGFP-tagged FMRP 
can be expressed from the same allele in a Cre-dependent, mutually exclusive fashion.  
AcGFP-FMRP is expressed in cells expressing Cre, while wt FMRP expression is 
maintained in all other cells.  We have performed extensive analyses to confirm that the 
AcGFP tag does not alter the expression level or function of FMRP and that expression 
of the tagged isoform does not occur in the absence of Cre.  Finally, we have shown that 
HITS-CLIP experiments performed using AcGFP-FMRP give near-identical results to 
CLIP experiments performed with wt FMRP.  We plan to pair FMRP cTAG CLIP 
experiments with cell type-specific ribosome profiling experiments using the RiboTag 
mouse, which express HA-tagged ribosomes in a similar Cre-dependent manner.  
Together, these experiments will allow comprehension of translational regulation by 
FMRP with an unparalleled degree of specificity. 
 
Section I: General model for FMRP function 
Overall, the data presented here support a model in which FMRP inhibits translational 
elongation on specific mRNAs by stalling ribosomes.  Although the canonical view has 
been that translational control occurs primarily at initiation, there are many examples in 
the literature of translational control during elongation.  For example, the rate of 
ribosome progression can be slowed by mRNA pseudoknots (Somogyi et al., 1993), rare 
codons (Kimchi-Sarfaty et al., 2007), or interactions between the nascent polypeptide 
chain and the peptide exit tunnel (Fang et al., 2004).  Ribosome stalling during elongation 
also occurs during targeting of mRNAs to the endoplasmic reticulum (ER) (Keenan et al., 
2001).  mRNAs encoding integral membrane or secreted proteins contain N-terminal 
signal sequences which, when translated, are bound by the signal recognition particle 
(SRP) as they emerge from the ribosome.  This pauses ribosomal elongation until the 
SRP docks at the ER, at which point elongation resumes.  Interestingly, the mechanistic 
basis for this elongational pausing was recently solved by crystallization of the SRP-80S 
ribosomal complex, in which it can be seen that the SRP is shaped like a telephone 
receiver, with one end binding the signal peptide near the ribosome exit channel and the 
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other end fitting into the intersubunit space where the elongation factor eEF2 usually 
binds (Wild et al., 2004).  Although mRNAs associated with the ER are less sensitive to 
puromycin in runoff assays than free mRNAs ((Unsworth et al., 2010) and see discussion 
in previous chapter), we found that mRNA associations with the ER and with FMRP 
were not correlated; therefore, SRP stalling appears to be unrelated to FMRP function.  
Finally, two recent papers propose models in which 3’UTR-associated factors (hnRNPE1 
or a Puf/Ago complex) inhibit activity of the elongation factor eEF1, thus stalling 
ribosomes shortly after elongation begins (Hussey et al., 2011), (Friend et al., 2012).   
 
Interestingly, phospho-inhibition of the elongation factor eEF2 is emerging as an 
important element of translational control in neurons.  Conceptually this makes some 
sense, as eEF2 kinase is a Ca
2+
/calmodulin dependent kinase, and as such is poised to 
respond to neuronal activity.  Phosphorylation of eEF2, which prevents its association 
with ribosomes and thus blocks ribosomal translocation, has long been a prominent 
example of nonspecific translational control during elongation.  For example, 
phosphorylation of eEF2 is associated with decreased protein synthesis in the presence of 
intact polysomes during mitosis (Sivan et al., 2007).  In neurons, eEF2 phosphoregulation 
has been shown to be locally and bidirectionally regulated in response to different forms 
of synaptic signaling (Sutton et al., 2007).  Although eEF2 is a nonspecific elongation 
factor, synthesis of certain proteins actually increases when eEF2 is inhibited.  For 
example, synthesis of the synaptic plasticity protein Arc in response to mGluR1 signaling 
was found to be dependent on both eEF2 phosphorylation and FMRP (Park et al., 2008).  
In another example, NMDAR activation and subsequent eEF2 phosphorylation resulted 
in increased translation of CamKIIa, and effect that was reproduced by low dose 
cycloheximide treatment, which limits elongation independently of eEF2 function 
(Scheetz et al., 2000).  Both authors suggest that this paradoxical effect may be explained 
by inefficient initiation of affected transcripts.  If competition for initiation factors is 
reduced by largescale reduction of translation, these mRNAs may be able to initiate more 
readily and achieve a modest level of translation even in the presence of phospho-eEF2.  
Such an effect was recently also found for Map1B, one of the top FMRP targets (personal 
communication, Nairn lab).  However, given that Arc, CaMKIIa and Map1B are all 
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FMRP targets, it is tempting to speculate that FMRP and eEF2 might actually regulate 
elongation of separate sets of mRNAs, for example those coding for housekeeping genes 
versus those with synaptic functions.  
 
Overall, it is clear there are a number of situations in which translational inhibition at 
elongation is important.  In some of the above examples, translation of the nascent 
peptide is required to direct pausing as part of feedback inhibition loops or to target 
translation to certain compartments.  More generally, inhibition of translation at 
elongation may markedly refine the temporal aspect of regulatory control.  Translational 
pausing during elongation has the potential to provide instantaneous and rapidly 
reversible control on protein production.  In contrast, inhibition at initiation provides less 
sharp temporal control, as ribosomes already in transit will still complete elongation and 
there will be a lag in protein synthesis when translation resumes, as ribosomes must 
translate the entire coding sequence from scratch before new protein is produced.  Since 
initiation is usually considered the rate-limiting step of translation, translational pausing 
during elongation may also allow ribosomes to complete the time-consuming steps of 
initation during periods of low translational demand and then “wait in the wings” until 
new protein synthesis is needed.  These benefits may be of greater magnitude for long 
mRNAs, and thus of particular relevance for some FMRP targets such as Bassoon.  
 
In the case of FMRP, the even distribution of CLIP tags along the coding sequence of 
target mRNAs suggests that FMRP-directed ribosome stalling may occur randomly along 
the length of the coding sequence.  Since CLIP tag maps represent FMRP:RNA 
interactions at the population level, individual transcripts could associate with single or 
multiple molecules of FMRP, and by extension could have single or multiple stalled 
ribosomes.  In vivo, any ribosomes upstream of a stalled ribosome will eventually also 
become stalled.  Stacking of multiple ribosomes with <30nt spacing has been observed 
when ribosomes are stalled in vitro (Wolin and Walter, 1988).  Such a model is 
potentially consistent with our results showing that micrococcal nuclease treatment does 
not alter the size or physical appearance of polysomes that survive puromycin runoff.  
Together with results showing that little FMRP is released from these polysomes by 
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nuclease treatment, we suggest a model in which FMRP and ribosomes are tightly 
stacked together on stalled transcripts.  One issue brought up by this model concerns the 
fact that we did not observe steady state differences in polysome size in the absence of 
FMRP, as might be expected if a stalled ribosome(s) was/were blocking passage of 
upstream ribosomes.  One possible explanation for this result is that initiation could be 
secondarily inhibited, perhaps as a feedback response to elongational stalling.  There are 
cases where concurrent phosphorylation of eEF2 and initiation factors has been observed 
(for example, (Kanhema et al., 2006)).  However, it cannot be inferred in these cases 
whether initiation and elongation are inhibited on the same transcripts.  Alternately, 
ribosome buildup behind a stalled ribosome might be balanced, on average, by ribosome 
runoff downstream of the stalled ribosome. 
 
The fact that FMRP CLIP tags coat the coding sequence of target mRNAs without 
apparent discrete binding sites suggests the possibility that FMRP associates directly with 
ribosomes, traveling along and making close transient associations with the coding 
sequence during elongation.  Although we cannot conclusively confirm such a model 
from our data, early studies did characterize FMRP as a ribosome-associated protein 
(Khandjian et al., 1996), (Siomi et al., 1996), (Eberhart et al., 1996), (Feng et al., 1997a).  
The acute reversibility of FMRP-mediated ribosome stalling demonstrated by kcRNA 
treatment during puromycin runoff suggests a model of dynamic ribosome stalling, 
perhaps in response to neuronal activity.  It has been reported that unphosphorylated 
FMRP associates with more actively translating polysomes than a phosphomimetic form 
of FMRP (Ceman et al., 2003).  Although this result could not be replicated in our lab, it 
suggests that ribosome stalling by FMRP could be phosphoregulated, for example in 
response to synaptic signaling.  This conjecture is supported by the observation that the 
phosphorylated residue involved (Ser499 in mouse) is highly conserved, suggesting that 
phosphorylation at this site is likely important for FMRP function (Siomi et al., 2002).  In 
such a model, derepression of FMRP-induced ribosome stalling would result in bursts of 
protein synthesis, thus tuning levels of specific proteins important for neuronal function 
in response to signaling.  In the absence of FMRP, chronic overexpression of target 
proteins would uncouple synaptic signaling from dynamic responses in protein 
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expression and upset the finely controlled stoichiometry of synaptic proteins, leading to 
inappropriate expression of synaptic plasticity and subsequent defects in learning and 
memory. 
 
Section II: Functional outcomes of FMRP regulation of target mRNAs 
 
Role for FMRP in regulation of receptor signaling 
The role of metabotropic glutamate receptors (mGluRs) in FXS has received a great deal 
of attention in the last decade.  A link between FMRP and group I mGluRs was first 
suggested when Fmr1 was identified as an mRNA present at synapses whose translation 
was upregulated in response to mGluR stimulation (Weiler et al., 1997).  Although this 
finding suggested that mGluR-LTD might require FMRP and thus might fail to be 
expressed in the absence of FMRP, researchers were surprised to find that mGluR-LTD 
was in fact exaggerated in Fmr1 KO mice (Huber et al., 2002).  A model was formulated 
in which FMRP governs an inhibitory feedback loop that limits expression of mGluR-
LTD, and it was suggested that this feedback might be particularly important during the 
critical period of synaptogenesis, when overexpression of LTD slows the process of 
synaptic maturation (Bear et al., 2004).  Later it was found that in the absence of FMRP, 
mGluR-LTD no longer requires protein synthesis (Nosyreva and Huber, 2006).  This 
finding suggested that in the absence of FMRP, proteins required for the expression of 
LTD are constitutively overexpressed, and thus additional synthesis is not required to 
facilitate LTD.  Since this model was proposed, mGluR activity has been by far the most 
commonly used paradigm to assay the activity dependence of FMRP-mediated effects 
(Cruz-Martin et al., 2012), (Kao et al., 2010).  Increased mGluR-LTD results in a long-
term decrease in surface expression of postsynaptic AMPARs, which is associated with 
long thin spines and smaller PSDs (for review see (Luscher and Huber, 2010)).  mGluRs 
mediate synaptic plasticity through a variety of mechanisms depending on cell type.  In 
cerebellar parallel fiber-Purkinje cell synapses (the most well-studied mGluR-LTD 
system), mGluR activity is linked to phospholipase C hydrolysis of phosphoinositol, with 
subsequent release of intracellular calcium from the endoplasmic reticulum and activation 
of protein kinase C.  This results in phosphorylation of AMPAR subunit GluR2, which 
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reduces its affinity for the postsynaptic scaffolding molecule GRIP and results in 
AMPAR endocytosis (Chung et al., 2003), (Steinberg et al., 2006).  In contrast, mGluR-
LTD in hippocampal region CA1, while less well characterized, does not require PKC 
and is thought to involve tyrosine dephosphorylation of AMPARs (Zhang et al., 2008), 
(Gladding et al., 2009).  HITS-CLIP results show that mRNAs encoding mGluR subunits 
are targets of FMRP, suggesting that overexpression of mGluRs may contribute to 
enhanced mGluR-LTD expression in the Fmr1 KO mouse. 
 
Interestingly, FMRP also targets mRNAs encoding many other specific types of 
receptors, indicating that other forms of synaptic plasticity may also contribute to FXS.  
For example, the NMDA receptor and kainate receptor families are also highly targeted, 
while the AMPA receptor family, in contrast, is not.  NMDA receptors induce plastic 
changes at synapses by passaging Ca
2+
 (in addition to Na
+
) upon relief of a magnesium 
ion block of the channel pore during cellular depolarization.  Crucially, the channel opens 
only when glutamate signaling corresponds with postsynaptic depolarization, signaling an 
effective correspondence between these two events.  As is the case for mGluRs, changes 
in NMDAR activity mediate synaptic plasticity through modulation of postsynaptic 
AMPAR currents.  The mechanistic details by which this occurs vary in different types of 
synapses; however, they are in general dependent on calcium and expressed through a 
combination of exocytotic changes in AMPAR surface expression, lateral diffusion of 
AMPARs between extrasynaptic sites and the PSD, and modulation of receptor 
conductance (for review see (Malenka and Bear, 2004)).  Interestingly, a recent report 
found that NMDAR-LTP is enhanced upon loss of FMRP (Pilpel et al., 2009) and FMRP 
targets exhibit a high degree of overlap with the NMDAR-associated proteome (Darnell 
2011).  This suggests that the so-called “mGluR-LTD theory of FXS” in which chronic 
overexpression of “plasticity proteins” leads to exaggerated expression of synaptic 
plasticity may be a paradigm that applies to other forms of plasticity, including LTP. 
 
FMRP also targets a number of other metabotropic receptors, many of which respond to 
stimuli other than glutamate.  For example, latrophilins, which are brain-specific 
presynaptic adhesion-receptors, are very strongly targeted.  Latrophilins are most well 
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known for binding to alpha-latrotoxin, a.k.a. black widow spider venom, which causes 
massive release of neurotransmitters.  The teneuins, postsynaptic adhesion molecules 
with established roles in axon guidance and synaptogenesis, were recently identified as 
the endogenous ligands for latrophilins (Silva et al., 2011).  Interestingly, teneuins are 
also FMRP targets.  This suggests that the latrophilin-teneuin signaling axis may 
constitute an important facet of FMRP biology.  In a second example, FMRP targets 
muscarinic acetylcholine receptors (mAChRs), which govern a form of protein-synthesis 
dependent LTD that is enhanced in the Fmr1 KO (Volk et al., 2007).  In a third example, 
FMRP targets certain receptor tyrosine kinases and phosphatases, a family of receptors 
that bind growth factors, cytokines and hormones and are linked to a variety of 
downstream signaling pathways including the PLC-IP3, Ras-ERK and PI3K-Akt 
pathways (for review see (Dabrowski and Umemori, 2011)).  Receptor tyrosine kinases 
dimerize upon ligand binding and each subunit’s kinase domain phospho-activates the 
reciprocal subunit.  Conversely, receptor tyrosine phosphatases dimerize in the resting 
state, occluding their phosphatase domains.  Ligand binding causes monomerization, 
which exposes their phosphatase activity.  Specifically, FMRP targets TrkB, TrkC and 
ephrin receptors, suggesting possible roles for FMRP in axon guidance and neurotrophic 
signaling.  Interestingly, although the ErbB receptors are not strong targets, Erbb2ip, a 
PDZ domain-containing interacting protein for Erbb2 (otherwise known as HER2, a 
famous breast cancer oncogene) is a strong target, exemplifying that in general FMRP 
might modulate function of receptors even if the receptor genes themselves are not 
targeted.  Finally, FMRP targets metabotropic GABA receptors (GABAB receptors), 
suggesting that its role is not exclusively limited to modulation of excitatory signaling. 
 
Although FMRP does not broadly target ionotropic receptors, there are some prominent 
exceptions.  Voltage gated calcium channel genes, especially those encoding the pore-
forming #1 subunits, are highly targeted.  In particular, Cacna1e appears to be a major 
target.  Cacna1e is present in postsynaptic spines and modulates plasticity through 
calcium-dependent activation of SK channels, which repolarizes the spine, reducing 
NMDAR activity (Bloodgood and Sabatini, 2009).  Ligand gated calcium channels are 
also important targets, notably the inositol triphosphate (IP3) and ryanodine receptors, 
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which release calcium from the endoplasmic reticulum in response to IP3 and calcium, 
respectively.  Finally, FMRP targets a few potassium and sodium channel genes, in 
particular the channel-forming subunit of the calcium-activated Big Potassium (BK) 
channel, Kcnma1, further underlining a major role for FMRP in regulation of calcium 
signaling. 
 
Overall, HITS-CLIP data suggest that FMRP specifically targets metabotropic receptors 
and other non-conducting signaling receptors and receptors that either passage calcium or 
open in response to binding it.  Most other monovalent cation channels are not 
significantly targeted.  Inhibitory receptors such as glycine and GABA receptors are also 
not significantly targeted, with the exception of the metabotropic GABAB receptor.  In 
general, this suggests that FMRP regulates the expression of a broad variety of receptors 
with specific roles in modulation of synaptic signaling, and future research into plasticity 
mechanisms in addition to mGluR-LTD may be productive. 
 
Role for FMRP in regulation of synaptic plasticity pathways: 
PSD proteins: Postsynaptic receptors are associated with a variety of signaling and 
scaffolding proteins clustered below the membrane, termed the postsynaptic density 
(PSD).  Key roles of PSD proteins include anchoring receptors at the postsynaptic 
membrane and mediating signaling cascades initiated by the receptors (for review see 
(Feng and Zhang, 2009)).  FMRP strongly targets members of the Dlg, Dlgap and Shank 
families of PSD proteins.  All of these proteins contain PDZ domains, which facilitate 
scaffolding interactions, as well as numerous other protein-protein interaction domains, 
such as SH3 and GuK domains.  The Dlg family, which includes the well-studied PSD-
95, plays a critical role in clustering receptors, the canonical example being NMDARs, at 
the postsynaptic membrane (Gardoni et al., 2009).  Interestingly, while FMRP strongly 
targets Dlg1, 2 and 4, it barely targets Dlg3, even through Dlg3 is the most abundant 
member of the family and clearly has an important role in synaptic function, especially in 
early postnatal development when FMRP function is at its peak (Zheng et al., 2010).  The 
cTAG mouse should be useful in the resolution of such cases: by combining cell type-
specific HITS-CLIP with cell type-specific ribosome profiling, it should be possible to 
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address whether lack of association between FMRP and Dlg3 is due to lack of 
coexpression in the same cells, or reflects functional discrimination by FMRP among Dlg 
family members.  Dlgaps (a.k.a. SAPAPs) were originally identified as Dlg-binding 
proteins (Takeuchi et al., 1997) and were later shown to also bind to Shank proteins 
(Boeckers et al., 1999), which link to the actin cytoskeleton underlying the spine 
(Boeckers et al., 2002).  Shanks also interact with mGluRs through another PSD protein, 
Homer (Hayashi et al., 2009).  FMRP strongly targets all members of the Dlgap and 
Shank families, and members of both families have been strongly implicated in autism 
(Pinto et al., 2010) (Phelan and McDermid, 2012).  It has been suggested that PSD 
proteins such as Dlgs constitute “slots” for receptor binding that determine how many 
receptors of a given type can occupy a synapse, even while individual receptors cycle in 
and out of the postsynaptic region (Malinow et al., 2000), (Schnell et al., 2002).  Thus, 
FMRP’s regulation of protein level of genes such as Dlg’s is likely to have a direct 
impact on receptor signaling.  Also, there is evidence that the relative stoichiometries of 
different PSD proteins is important; for example Shank and Homer appear to form a 
mesh-like structure in which Shank proteins form nodes connecting rod-like Homer 
proteins (Hayashi et al., 2009).  Thus, FMRP could indirectly regulate the level of 
synaptic Homer proteins by controlling the amount of available Shank proteins.  In 
contrast to the strong targeting of PSD proteins involved with NMDAR and mGluR 
signaling, FMRP does not target several PSD proteins that mediate AMPAR insertion 
and retention at the membrane, notably Grips, Grasp1 and Pick1 (Ye et al., 2000), (Kim 
et al., 2001), (Chung et al., 2000), consistent with AMPARs themselves not being FMRP 
targets. 
 
Any discussion of the PSD inevitably includes CaMKIIa, by far the most abundant 
protein in the PSD and an important FMRP target (for review see (Lisman et al., 2012)).  
The CaMKIIa holoenzyme is a two-layer ring consisting of twelve subunits.  Low levels 
of Ca
2+/
calmodulin binding briefly activates CaMKIIa.  However, if calmodulin binding 
is high enough that neighboring CamKIIa subunits are simultaneously bound, these 
subunits become autophosphorylated, extending the timecourse of activity even after 
calcium levels have returned to baseline.  Thus, CamKIIa has properties that allow 
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integration of calcium signaling over time.  The unusually high abundance of CaMKIIa at 
the PSD suggests a possible major structural role in addition to an enzymatic role.  
Coupled with CaMKIIa’s ability to retain activity for extended periods, it suggests that 
CaMKIIa could coordinate long-lasting structural changes that could possibly be a 
substrate for memory storage.  As discussed above, CaMKIIa translation increases under 
conditions in which global levels of translation decrease (Scheetz et al., 2000), suggesting 
that translational control is an important element in regulation of CaMKIIa expression. 
 
Cytoskeletal proteins: Changes in synaptic plasticity are highly correlated with changes 
in spine shape and size: large spines tend to be more stable over time and have greater 
synaptic strength (expressing higher levels of AMPA receptors), while small spines tend 
to be weaker and more plastic (Kasai et al., 2003).  It has long been recognized that FXS 
is associated with abnormal spine morphology in the form of long, thin, tortuous spines 
(Hinton et al., 1991), (Rudelli et al., 1985).  Such changes in spine shape and size are 
primarily driven by actin dynamics.  The actin network underlying spines is connected to 
various proteins in the PSD, such as Shanks, which allows transmission of information 
about signaling at the membrane to the underlying cytoskeleton (Boeckers et al., 2002).  
FMRP only weakly targets actin itself, but it does regulate several other cytoskeletal 
elements and regulatory proteins.  For example, tropomodulins control rates of actin 
polymerization by capping the pointed ends of actin filaments.  A mouse knockout of 
tropomodulin-2, a strong FMRP target, had enhanced LTP at Schaffer collateral 
synapses, demonstrating the necessity of proper actin polymerization for expression of 
synaptic plasticity (Cox et al., 2003).  FMRP also targets ankyrins (which cluster 
membrane proteins such as receptors and adhesion molecules and anchor them to the 
actin/spectrin cytoskeleton), plakophilins (which link cadherins to intermediate 
filaments), and dystonin (which links intermediate filaments to actin).  These molecules 
provide direct links between signaling proteins already shown to be FMRP targets and 
actin.  Although cytoskeletal proteins are important for synaptic function, results from 
FMRP nuclear CLIP suggest that FMRP also locally regulates translation of cytoskeletal 
proteins around the nucleus.  Therefore, translational control by FMRP of mRNAs 
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encoding cytoskeletal proteins likely has multiple functional outcomes, including but not 
limited to expression of synaptic plasticity. 
 
Finally, six out of the top ten FMRP targets are involved with microtubule dynamics.      
Microtubules mediate fast transport of a variety of cellular components such as vesicles 
(for example synaptic vesicle precursors or vesicles carrying membrane receptors), 
mitochondria and translationally repressed RNA granules (for review see (Namba et al., 
2011), (Kapitein and Hoogenraad, 2011), (Hirokawa, 2006).  Transport is carried out by 
motor proteins in the kinesin and dynein families.  Each member of these families has 
specificity for particular cargoes, facilitated by a variety of adaptor proteins.  For 
example, rab GTPases are key mediators of vesicle transport, recruiting effector 
molecules that orchestrate motor-cargo assemby (Horgan and McCaffrey, 2011).  Major 
FMRP targets include Maps (which bind and stabilize microtubules), kinesins and 
dyneins.  Map1B is one of the few targets for which protein-level increases in whole cell 
lysate can be detected by Western blot after the loss of FMRP (Lu et al., 2004), (Zhang et 
al., 2001).  Since the microtubule system trafficks key synaptic components such as 
receptors, a major facet of FMRP function appears to be downregulation of the delivery 
system for these components.  This suggests that FMRP plays a role in cell-wide 
dampening of neuronal activity, by limiting the availability of “parts” for synaptic 
function. 
 
cAMP signaling 
Loss of FMRP has been linked to lowered cAMP levels in a variety of systems (Kelley et 
al., 2007), (Berry-Kravis and Huttenlocher, 1992), (Berry-Kravis and Sklena, 1993).  
cAMP is produced from ATP by adenylate cycles, which respond to G protein signaling 
from a variety of receptors.  Consistent with lowered cAMP levels, FMRP targets Adcy1, 
5 and 8, which are all calcium-sensitive adenylate cyclases.  Synergistic response to G 
proteins and calcium positions adenylate cyclases as coincidence detectors for the 
activities of GPCRs and other receptors that admit calcium, such as NMDARs or calcium 
channels.  Differing sensitivities to calcium can also tune different adenylate cyclases to 
varying stimulation thresholds; for example, Adcy1 reaches half maximal activity at 
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150nM Ca
2+
 (resting levels are 100nM), while Adcy8 is not half-active until 800nM Ca
2+
 
(during activity, Ca
2+
 levels can locally approach 1-10uM (Banerjee and Hasan, 2005)) 
(Ferguson and Storm, 2004).  FMRP also targets several phosphodiesterases, which 
hydrolyze cAMP, representing a counterbalance on the activity of adenylate cyclases. 
 
cAMP stimulates members of the PKA family and the RapGEF Epac (discussed below in 
the section on small GTPase regulation).  FMRP does not target any members of the PKA 
family.  However, PKA activity is directed to particular microdomains by a diverse 
family of anchoring proteins known as AKAPs (Bauman et al., 2004).  Interestingly, 
FMRP does target several of the AKAPs, including Akap6, which is a major target that 
anchors PKA to the nuclear envelope and whose mRNA was found to be associated with 
FMRP in the perinuclear compartment by FMRP nuclear CLIP. Modulation of PKA 
through cAMP is predicted to have broad effects on neuronal function; for example, PKA 
stimulates the transcription factor CREB, which upregulates important plasticity genes 
such as BDNF and secondary transcription factors such as c-fos, illustrating the potential 
complexity of downstream ripple effects of FMRP regulation. 
 
Small GTPase signaling  
Small GTPases are membrane-associated monomeric G proteins of 20-25kD that bind 
GTP in their active state.  Regulation of small GTPase function is an essential component 
of FMRP biology (Darnell 2011).  Several families of small GTPases including the Ras, 
Rho, Rab and Rheb families have been implicated in control of neuronal plasticity and 
memory (Ye and Carew, 2010), (Tolias et al., 2011), (Newey et al., 2005).  The activity 
of small GTPases is controlled by accessory proteins called GAPs (GTP activating 
proteins) and GEFs (GTP exchange factors).  GAPs reduce the activity of GTPases by 
promoting GTP hydrolysis, while GEFs activate GTPases by exchanging GDP for GTP.  
GEFs and GAPs are large multidomain proteins that interact with a wide variety of 
binding partners, allowing given GTPase activity to be tuned to particular localizations 
and inputs.  Small GTPase signaling impinges on key cellular pathways including the 
MAPK/ERK and PI3K/AKT/mTOR pathways.  Well-characterized downstream effects 
of GTPase signaling include actin remodeling (Rho family), membrane trafficking (Rab 
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family) and translational control (Rheb family).  Small GTPase activity has profound 
consequences for cells (most prominently, excessive Ras signaling leads to overactive 
cell growth and tumorigenesis), so it is logical that their activity is under tight and 
complex regulation. 
 
Most literature concerning FMRP’s link to small GTPase activity has focused on Rac1 
and actin remodeling, because FXS is associated with defects in spine morphogenesis.  
Some data show that phenotypes linked to loss of FMRP (enhanced mGluR LTD in 
mouse hippocampus; reduced dendritic branching in Drosophila) can be reversed by 
respectively inhibiting or overexpressing Rac1 (Bongmba et al., 2011), (Lee et al., 2003).  
This suggests that actin remodeling is important in the downstream expression of FMRP 
function, but does not show that FMRP directly regulates small GTPase activity.  There is 
limited and conflicting data concerning direct effects of FMRP on Rac1 levels or activity 
(Bongmba et al., 2011), (Chen et al., 2010).  The CLIP data shows that Rac1 is not a 
target of FMRP (in fact, as a general rule small GTPases themselves are not targeted by 
FMRP).  However, a large number of GAPs and GEFs are strong FMRP targets, 
indicating that FMRP has a major and direct role in regulation of small GTPase activity, 
with implications for cytoskeletal remodeling and translational control (see section 
below). 
 
Several major FMRP targets are GAPs or GEFs with functions at the PSD.  These include 
syngap1, rapGEF4 (Epac2), kalirin and plexinB1.  Syngap1 is a calcium-activated Ras 
GAP that is associated with Dlgs and NMDARs (Ye and Carew, 2010).  Bidirectional 
manipulation of syngap1 expression affects AMPAR-mediated synaptic transmission, 
dependent on both PDZ and GAP domains (Rumbaugh et al., 2006).  Epac2 is a cAMP-
responsive RapGEF linked to spine remodeling (Woolfrey et al., 2009).  Kalirin is a 
RhoGEF involved in spine formation and NMDAR-LTP (Ma et al., 2008), (Kiraly et al., 
2011), (Lemtiri-Chlieh et al., 2011).  PlexinB1 is a semaphorin receptor with a 
cytoplasmic Ras/Rap GAP domain (Bos and Pannekoek, 2012).  Activation of Rap1 by 
plexinB1 requires both semaphorin binding and intracellular binding of a Rho GTPase 
next to the GAP domain (Oinuma et al., 2004).  These targets exemplify the prominence 
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of small GTPase signaling at the synapse, although much work remains to better 
understand the steps between GTPase activity and downstream readouts such as spine 
remodeling or neurite outgrowth. 
 
FMRP also strongly targets two GAPs that influence translational control through the 
mTOR pathway: NF1 and Tsc2.  This is of particular interest because potential links 
between mTOR and FMRP have received a lot of attention (discussed further below).  
Both NF1 and Tsc2 are associated with diseases characterized by tumorigenesis 
(neurofibromatosis and tuberous sclerosis, respectively), due to overactivity of cellular 
growth pathways such as the PI3K/Akt/mTOR pathway (for review see (Hoeffer and 
Klann, 2010)).  NF1 is a negative regulator of Ras (Cichowski and Jacks, 2001), while 
the Tsc1/2 complex is a negative regulator of Rheb (Huang and Manning, 2008).  Both 
ultimately inhibit mTOR signaling and dampen translation (Johannessen et al., 2005), 
(Inoki et al., 2002); thus, targeting of NF1 and Tsc2 by FMRP would be predicted to 
increase global translation.  This is contrary to the standard model of translational 
repression by FMRP, and complicated by the fact that FMRP also targets PIKE, PI3K, 
Akt, mTOR and the mTORC1 protein Raptor, which collectively would be predicted to 
have the opposite outcome (decreasing global translation).  The paradox of why FMRP 
would target both positive and negative regulators of the same pathway may reflect an 
insufficiently subtle understanding of the situation, since FMRP may not target all of 
these mRNAs in every cell.  The cTAG mouse could provide clarity in this case.  
Alternatively, NF1 and/or Tsc2 may participate in additional signaling pathways that are 
relevant FMRP biology.  For example, NF1 het mice have elevated ERK activity, which 
is predicted to potentiate translation (Guilding et al., 2007). 
 
Because most literature on Tsc2 and NF1 relates to oncogenesis, most of what is known 
about their function was deduced from non-neuronal systems.  However, recent studies 
have demonstrated roles for Tsc2 in axonal pathfinding (Nie et al., 2010) and mGluR-
LTD (Auerbach et al., 2011), both processes that require translation.  The finding that 
Tsc2+/- mice have decreased mGluR-LTD was a surprise to the authors of the second 
study, who presumed that since loss of Tsc1/2 activity activates mTOR, which is 
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canonically considered to result in overactive translation, Tsc2 het mice might have 
increased mGluR-LTD like Fmr1 KO mice, which also exhibit overactive translation.  
Instead, they found that Tsc2+/- mice had decreased mGluR-LTD and decreased de novo 
protein synthesis in hippocampal slices, both phenotypes opposite to what the authors 
observe in Fmr1 KO mice.  In fact, the effects caused by loss of Tsc2 are reversed if 
FMRP is also absent, which suggests that FMRP and Tsc2 normally counterbalance each 
other.  One unresolved issue is why the rapamycin-dependent phenotypes in the Tsc2 het 
are linked to translational suppression.  The authors suggest that if mTOR inhibits FMRP, 
then loss of Tsc2 would result in increased inhibition of FMRP, which could explain the 
repression of protein synthesis.  However, they supply no evidence in support of this 
idea.  As a side note, both Tsc2+/- and Fmr1 KO mice displayed similar phenotypes at 
the behavioral level, despite opposing phenotypes at the biochemical and 
electrophysiological levels.  Similar situations have been demonstrated by others, for 
example the Syngap1 KO and the PSD-95 KO have decreased/increased hippocampal 
LTP respectively, but both mice perform poorly in the Morris water maze (Komiyama et 
al., 2002), illustrating that behavioral readouts indicative of synaptic dysfunction are not 
always informative about the nature of the specific underlying molecular defect. 
 
 
Translational control of presynaptic proteins 
Overall, it is clear that FMRP regulates numerous mRNAs with well-characterized 
functions in synaptic signaling and synaptic plasticity.  Local postsynaptic translation is 
necessary for the expression of several forms of plasticity including mGluR-LTD (Huber 
et al., 2000) and FMRP is present at synapses (Antar et al., 2005).  Nonetheless, most 
FMRP is somatic and there are also a few reports of a role for FMRP in axons or at the 
presynaptic terminal.  For example, Antar et al reports localization of FMRP in puncta in 
axons and growth cones of young (4 DIV) primary hippocampal neurons and that growth 
cones from Fmr1 KO neurons have more filopodia and reduced motility (Antar et al., 
2006).  In addition, FMRP-containing granules (FXGs) have been found in axons of 
young neurons undergoing synaptogenesis, for example in olfactory bulb neurons 
(Christie et al., 2009).  In agreement with the findings in growth cones, FXGs were more 
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abundant during periods of heightened synaptogenesis, for example in young mice or 
during reinnervation of the olfactory epithelium after injury.  FMRP CLIP has revealed a 
number of targets classically associated with presynaptic functions.  Several of these are 
involved with vesicle fusion and SNARE complex formation.  However, the proteins that 
form the SNARE complex – syntaxin, synaptobrevin and SNAP-25 – are not strongly 
targeted even though they are highly abundant.  Rather, several proteins with modulatory 
roles in SNARE complex formation are targeted.  A key event in vesicle priming is the 
transition of syntaxin from a “closed” state, bound very strongly to munc18, to an “open” 
state capable of forming SNARE interactions (Dulubova et al., 1999).  This transition is 
regulated by several FMRP targets, including munc13, syntaphilin, rabphilin3a, syntaxin 
binding protein-5 (tomosyn) and RIMs 1 and 2.  Tomosyn and syntaphilin are both 
reported to bind to syntaxin and promote its association with the SNARE complex (Fujita 
et al., 1998), (Lao et al., 2000).  Munc13 is reported to bind munc18, also promoting 
release of syntaxin from the closed state (Ma et al., 2011) (interestingly, munc13 is a 
diacylglycerol receptor, linking it to pathways highly targeted by FMRP as discussed 
above).  In contrast, rabphilin is a negative regulator of vesicle release, binding SNAP-25 
(Deak et al., 2006).  RIMs are scaffolding proteins that bind a variety of presynaptic 
proteins; for example they are reported to activate munc13 by relieving autoinhibitory 
homodimerization (Deng et al., 2011).  Overall, it seems that FMRP regulates vesicle 
exocytosis by means of targeting a number of modulatory proteins, a role that has 
received very little attention in the literature. 
 
FMRP also plays a role in regulation of clathrin-mediated endocytosis, as revealed by 
targeting of synaptojanins and several of the adaptor-related protein complex (AP) genes, 
in particular the AP-2 subfamily.  AP proteins are hubs that organize vesicle fusion, 
binding phosphoinositides, clathrin, and a variety of accessory factors (eg membrane 
deforming proteins and adaptors that recruit vesicle formation around particular 
membrane proteins) (Rodemer and Haucke, 2008).  Synaptojanins are phosphatases that 
act on PIP2 and PIP3 to release and recycle AP-2 complexes and other factors involved 
with clathrin-mediated endocytosis (Cremona et al., 1999).  While these processes are 
critical for recovery of vesicles into the presynaptic membrane after neurotransmitter 
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release, they may also play roles in postsynaptic endocytosis of receptors (Gong and De 
Camilli, 2008).  By the same token, proteins involved in SNARE-mediated exocytosis 
could have postsynaptic roles, for example in vesicle-based delivery of receptors to the 
postsynaptic membrane.  For example, tomosyn can be visualized on both sides of the 
synapse by electron micrograph (Fujita et al., 1998). 
  
FMRP strongly targets Bassoon and Piccolo, two very large presynaptic proteins.  Based 
on their size, one might conjecture a major structural role for these proteins.  However, 
most synapses lacking Bassoon appear structurally normal by electron micrograph 
(Altrock et al., 2003), with the exception of unanchored ribbon synapses (specialized 
synapses that sustain slow, continuous vesicle release in response to “analog” variation in 
sensory input) (Lagnado, 2005).  Nonetheless, truncation of most of Bassoon’s protein 
sequence causes mice to have defects in vesicle release and to die of seizures, so Bassoon 
must play a more subtle but critical role in regulation of exocytosis (Altrock et al., 2003).  
Although Bassoon and Piccolo are major presynaptic proteins, they are translated 
somatically and axonally transported in Golgi-derived dense core vesicles (Dresbach et 
al., 2006), a model consistent with our finding that 92% of Bsn mRNA and 91% of Pclo 
mRNA is present on ER membranes.  This mechanism might be a way to ensure that 
Bassoon and Piccolo avoid aggregation after translation since they are so large, or it 
could reflect a mechanism of pre-fabrication of proto-active zones that are then delivered 
to developing synapses.  In any case, while targeting of Bassoon and Piccolo almost 
certainly indicates presynaptic consequences for FMRP function, it constitutes an 
example of somatic translational control of ER-associated mRNAs by FMRP. 
 
Finally, FMRP targets several synaptic adhesion molecules, which occur in postsynaptic-
presynaptic pairs and are of particular interest because some have been strongly linked to 
autism (Betancur et al., 2009).  Neurexins, neuroligins, plexins and protocadherins are all 
important FMRP targets.  These molecules make physical contact in pairs across the 
synaptic cleft (neurexins, which are presynaptic, bind neuroligins, which are 
postsynaptic; plexins bind semaphorins, which can be either secreted or membrane 
bound; protocadherins bind each other in homophilic or heterophilic interactions).  The 
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diversity of adhesion molecules, both in terms of gene families and extensive alternative 
splicing, helps specify synaptic connections in a complex network environment (Ding et 
al., 2012).  The best characterized of the adhesion molecules are the neuroligins and 
neurexins (Sudhof, 2008).  The cytoplasmic portions of each bind to PDZ domain-
containing proteins in the presynaptic active zone or PSD, harnessing a transsynaptic 
signaling complex that is essential for neuronal function; loss of neuroligins in mice is 
associated with severe defects in synaptic transmission (Varoqueaux et al., 2006) and 
mutations in either are strongly associated with autism (Betancur et al., 2009).   Again, 
while we cannot infer local presynaptic translation of synaptic adhesion molecules from 
the CLIP data, FMRP clearly regulates targets with crucial functions on both sides of the 
synapse. 
 
Meta-Regulation of Translational Control 
FMRP directly regulates translation of specific mRNAs, as is evidenced by its RNA-
dependent association with polysomes, its direct association with coding sequence as 
assayed by HITS-CLIP, its effect on the puromycin sensitivity of ribosomes associated 
with target mRNAs, and its effect on 
35
S-methionine incorporation during translation of 
target mRNAs.  However, a number of FMRP target mRNAs encode translation factors 
or proteins in signaling pathways that regulate translation.  Therefore, regulation of these 
targets by FMRP is predicted to have secondary effects on global translation.  FMRP has 
considerable specificity for particular translation factors.  For example, of the myriad of 
initiation factors, FMRP strongly targets only one family, the eIF4Gs.  The joining of 
eIF4G with eIF4E is a major control point of initiation, controlled by a family of 4E-
binding proteins (4EBPs) that occlude eIF4G binding.  Inhibition of eIF4G translation 
constitutes an alternate mechanism of limiting eIF4F assembly and illustrates a prime 
example of how FMRP can enforce secondary, nonspecific inhibition of translation. 
 
FMRP is also predicted to have secondary effects on translational elongation.  While 
there is a report that FMRP binds eEF1 mRNA (Sung et al., 2003), this finding is based 
on interaction of in vitro transcribed message with recombinant FMRP under low salt 
conditions, all elements that reduce the probability that this is a specific interaction.  
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Furthermore, binding was not dependent on the I304 residue required for polysome 
binding that is central to FMRP function.  However, the considerably more stringent 
CLIP assay shows that FMRP associates with eEF2 mRNA to a much greater extent than 
with eEF1 mRNA.  However, inhibition of eEF2 translation should not be construed as 
the primary mechanism by which FMRP acts, as this would be inconsistent with 
demonstrated direct FMRP association with hundreds of other target mRNAs.  
Nonetheless, downregulation of eEF2 protein levels by FMRP likely represents a 
secondary mode of translational control that may be important for neuronal function, 
since phospho-inhibition of eEF2 has been shown to occur in response to synaptic 
signaling (Scheetz et al., 2000), (Kanhema et al., 2006). 
 
Another facet of translational control under secondary regulation by FMRP is the 
Argonaute/miRNA system.  miRNAs are short, ~21nt long RNAs that, together with 
members of the Argonaute family and other factors, repress expression of target proteins.  
It is estimated that at least 60% of mammalian mRNAs are regulated by miRNAs (Bartel, 
2009).  miRNA processing begins in the nucleus, where the RNAse III enzyme Drosha 
trims out the miRNA hairpin loop from the larger RNA (multiple hairpin loops 
containing separate miRNA genes are often transcribed as a single unit).  The hairpin 
loop is then exported to the cytoplasm, where the loop is cut off by another RNAse III 
enzyme, Dicer, leaving the stem as a short, double-stranded RNA.  One strand of this 
intermediate is then assembled into a complex with Argonaute and other proteins, termed 
the RNA-induced silencing complex (RISC).  The RISC then binds target mRNAs, 
guided by miRNA sequence complementarity and resulting in decreased protein 
production.  Whether this occurs via translational suppression or mRNA degradation has 
been the subject of intense debate, but a reasonable current model is that initial steps of 
miRNA silencing involve inhibition of translational initiation, followed by targeting of 
the message to P-bodies, where deadenylases and decapping enzymes degrade the mRNA 
unless other pathways direct its release from P bodies (Djuranovic et al., 2011).  
However, much about this process remains to be resolved.  For example, although 
miRNA binding sites are canonically thought to be located in 3’UTRs, more than 35% of 
Ago binding sites identified by CLIP are in introns or coding regions (Chi et al., 2009), 
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indicating the mechanism and/or scope of Ago function is not yet fully understood.  
FMRP targets all of the well-expressed Ago genes (Ago 1-3) as well as Dicer, suggesting 
that FMRP crosstalks with the Argonaute pathway and suppresses its function.  This is in 
contradiction to suggestions in the literature that FMRP mediates its effects on translation 
through Ago.  That this might be the case was originally suggested when large-scale 
purification of the RISC complex from Drosophila S2 cells revealed copurification of 
dfmr (Caudy et al., 2002).  Because the HPLC-based purification scheme did not involve 
an antibody-based step, direct interaction of dfmr with RISC could not be proven.  
However, dfmr and Ago2 were subsequently coIPed (in the same cell system), using 
either TAP-tagged or T7 tagged (and overexpressed) dfmr (Caudy et al., 2002), (Ishizuka 
et al., 2002).  While both authors claimed the associations were RNAse-resistant, data 
were either not shown (Caudy et al) or the association in fact appeared to be RNAse-
sensitive (Ishizuka et al).  This control is critical to show that dfmr and Ago2 directly 
interact and do not merely coexist on polysomes.  Another issue with these experiments 
is that Drosophila Ago2 has no mammalian ortholog, so results are not necessarily 
translatable to mammalian Argonautes (mammalian Ago2 is orthologous to Drosophila 
Ago1).  The coIP result was replicated in mammalian cells; however an Fmr1 KO control 
was not included to demonstrate that (mammalian) Ago2 association was FMRP-
dependent (Jin et al., 2004).  This turned out to be a fatal flaw, as the antibody used (7G1-
1) was later shown to indeed bind Ago2 in the absence of FMRP (oddly, this appeared to 
be due to contamination of the 7G1-1 clone with a separate monoclonal that recognized 
Ago2 (unpublished observation from our lab)).  In addition, since we show in this thesis 
that polysome-associated FMRP appears to be largely inaccessible to antibodies (Figure 
11), these coIPs may only capture the small portion of FMRP that is nonpolysomal in 
vivo.  Another way to show that FMRP facilitates translational inhibition through Ago 
would be to show that knockdown of Ago2 results in translational derepression of FMRP 
target mRNAs.  Such an experiment has not been published; instead, several attempts 
have been made to show the reverse – that knockdown or loss of FMRP reduces RNAi-
mediated knockdown of reporter constructs (Ishizuka et al., 2002), (Caudy et al., 2002), 
(Plante et al., 2006), (Didiot et al., 2009). Results were mixed, with two of four groups 
finding that loss of FMRP reduced efficacy of RNAi.  However, the reporters were not 
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FMRP targets and nonspecific binding may have occurred due to overexpression of the 
reporters.  Finally, FMRP was not found in P bodies, which would be expected if FMRP-
bound transcripts were entering the Ago pathway (Didiot et al., 2009).  Together, these 
results do not provide sufficient evidence to conclude that FMRP induces translational 
repression by recruiting the RISC complex to target mRNAs.  However, based on the 
CLIP results, we predict that FMRP may downregulate expression of Ago pathway 
components. 
 
The mTOR and ERK pathways are important regulators of translational control that 
mediate the expression of several forms of protein synthesis-dependent synaptic 
plasticity, making their relationship to FMRP function the focus of intense study (Tang et 
al., 2002), (Richter and Klann, 2009), (Hoeffer and Klann, 2010).  mTOR associates with 
two different complexes, mTORC1 and mTORC2, which direct mTOR activity towards 
particular substrates.  The best-studied of these complexes, mTORC1, phosphorylates 
4EBP1 and 4EBP2, relieving their inhibition of eIF4E and promoting translation.  
mTORC1 also phosphoactivates S6 kinases.  S6 kinases phosphorylate ribosomal protein 
S6, which is associated with increased translation of messages containing 5’ terminal 
polypyrimidine tracts in their UTRs.  So-called 5’TOP mRNAs encode ribosomal 
proteins and translation factors, so activation of S6 kinase represents a second mechanism 
of eliciting a general increase in translation.  Like mTOR, ERK also phosphorylates 
4EBPs and S6 kinase.  In addition, ERK can phosphoactivate eIF4E through Mnk1.  
These events are associated with a number of forms of synaptic plasticity (Richter and 
Klann, 2009), (Hoeffer and Klann, 2010).  In particular, both mTOR and ERK signaling 
are required for hippocampal mGluR-LTD (Hou and Klann, 2004), (Banko et al., 2006), 
the form of synaptic plasticity most well-studied in FXS. 
 
FMRP does not target MEK, ERK or Mnk mRNAs involved in the ERK pathway.  In 
contrast, FMRP does target PIKE, PI3K, Akt, Tsc2, mTOR and Raptor, indicating a high 
level of control over the mTOR pathway.  Except for Tsc2 (see above discussion), these 
results are consistent with a general downregulation of translation through limiting 
activity of the mTOR pathway.  Literature supporting relationships between FMRP and 
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the mTOR pathway is complicated and conflicting.  Before discussing it, it is worthwhile 
to consider the theoretical possibilities for FMRP interaction with the mTOR pathway.  
Following are three hypothetical scenarios: 
 
FMRP could indirectly regulate the mTOR pathway by downregulating pathway 
components at the mRNA level.  Based on CLIP data, this appears to be true, and should 
be expressed as an increase in these proteins in the Fmr1 KO at least under some 
conditions, such as during mGluR5 activation. 
 
FMRP could modulate the mTOR pathway at the protein level.  For example, FMRP 
could dampen protein synthesis by binding/inhibiting mTORC1 or binding/activating the 
Tsc1/2 complex.  If this were true, the mTOR pathway should be upregulated in the Fmr1 
KO, and treatment with rapamycin should mitigate KO phenotypes.  Conversely, 
treatment of wt with rapamycin might have effects similar to FMRP overexpression, for 
example hypoactivity or increased anxiety (Peier et al., 2000).  Although this scenario 
does not account for the importance of direct RNA binding in FMRP function, FMRP 
could theoretically have a secondary functional mode involving protein-protein 
interaction. 
 
FMRP could be an effector of the mTOR pathway (meaning it acts directly on the 
translational machinery but is modulated by mTOR signaling).  mTOR phosphorylation 
of FMRP could inhibit its catalytic activity, interfere with its binding activity/partners, or 
target it for degradation.  If this were true, we would expect mTOR pathway activity to be 
unchanged in the Fmr1 KO (excluding possible feedback effects).  Treatment with 
rapamycin would be difficult to interpret because FMRP would not be the only mTOR 
effector. 
 
Several studies have attempted to address whether or not the mTOR or ERK pathways 
are upregulated in the Fmr1 KO, either basally or in response to mGluR activation by 
DHPG.  In hippocampal slices, the ERK pathway was activated in response to DHPG 
(Banko et al., 2006), (Ronesi et al., 2012), (Osterweil et al., 2010), and the level of 
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activation was similar in wt and Fmr1 KO (Ronesi et al., 2012), (Osterweil et al., 2010).  
There is a report of aberrant ERK signaling in Fmr1 KO cortical synaptoneurosomes 
correlated with increased protein phosphatase 2A (PP2A) activity (Kim et al., 2008).  The 
protein phosphatase genes Ppp2r2c and Ppp2r5b are strong FMRP targets, so increased 
PP2A activity in the Fmr1 KO is consistent with CLIP results.  However, the bulk of the 
evidence, including the fact that FMRP does not target members of the ERK pathway, 
indicates that ERK signaling acts independently of FMRP. 
 
Results concerning the mTOR pathway are more complicated, and appear to depend in 
part on whether hippocampal slices are rested before assaying.  In non-rested slices, basal 
mTOR signaling was increased in the Fmr1 KO; upon DHPG stimulation mTOR 
signaling increased in wt but remained saturated in the KO (Sharma et al., 2010).  This 
group also found upregulation at the protein level of PIKE, one of the top FMRP targets.  
Since PIKE is an upstream driver of the mTOR pathway, increased synthesis of PIKE in 
the Fmr1 KO could explain the overall increased activity of the pathway (Sharma et al., 
2010), (Gross et al., 2011).  These results are consistent with an earlier report that mTOR 
signaling was upregulated in response to DHPG (Hou and Klann, 2004).  In contrast, 
Osterweil et al found that the mTOR pathway was basally unchanged in the Fmr1 KO 
and not inducible by DHPG in either wt or KO (Osterweil et al., 2010).  However, the 
slices used in this experiment were rested for four hours prior to assay; if non-rested 
slices were used the mTOR pathway was basally upregulated in the Fmr1 KO, consistent 
with Sharma et al.  Which result is correct is unclear – freshly dissected slices may better 
represent the in vivo state, or they may be more subject to transient stresses induced in 
preparation.  Finally, a third group reported that the mTOR pathway was upregulated in 
wt but not Fmr1 KO in response to DHPG (in rested slices (Ronesi et al., 2012)).  
However, this interpretation is unclear because data are normalized to the baseline state.  
If basal mTOR signaling is upregulated in the Fmr1 KO and not further increased by 
DHPG as seen by Sharma et al, this would be plotted as a lack of rather than a saturation 
of mTOR signaling in the KO – very opposite conclusions based on what could be similar 
results. 
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The above results are insufficient to allow firm conclusions about whether FMRP affects 
mTOR signaling, either as a modulator or an effector, although together with the CLIP 
results they do suggest that FMRP at least has an indirect effect on the pathway through 
translational inhibition of its components.  However, one report does attempt to address 
whether FMRP is directly affected by mTOR and/or ERK signaling (ie, whether FMRP is 
a downstream effector).  The authors found that basal FMRP phosphorylation was absent 
in the S6K1 KO hippocampus, and that stimulation of primary neurons with DHPG 
resulted in increased S6 and FMRP phosphorylation over similar timecourses, which 
could be attenuated by mTOR and ERK inhibitors (Narayanan et al., 2008).  Together, 
these results suggest that both mTOR and ERK activate S6K1, which then 
phosphorylates FMRP.  Phosphorylation of FMRP has been reported to result in 
decreased translation of its targets (Narayanan et al., 2008), (Ceman et al., 2003).  The 
finding that mGluR-LTD was correlated with increased phosphorylation of S6K1 but 
remained expressed in S6K1 KO mice seems to suggest that S6K1 is not a central player 
in the expression of mGluR-LTD (Antion et al., 2008).  However, these results could be 
consistent with a model in which S6K1 phosphorylates FMRP (causing translational 
suppression) during mGluR-LTD in order to maintain expression of LTD within normal 
limits.  Loss of S6K1 and subsequent dephosphorylation of FMRP would be predicted to 
result in translational derepression of FMRP targets.  Since loss of FMRP increases 
expression of mGluR-LTD, inactivation of FMRP by dephosphorylation might be 
expected to similarly increase mGluR-LTD.  Thus, mGluR-LTD would continue to be 
expressed in the S6K1 KO, as observed. 
  
Overall, it is clear that FMRP can indirectly affect translational control via several 
avenues.  Interestingly, FMRP does not target mRNAs coding for ribosomal or 
proteasomal proteins, even though many of these mRNAs are very abundant and this 
would represent a very direct route of secondary control over protein homeostasis.  
Instead, FMRP appears to indirectly tune global translation by controlling levels of select 
translation factors and signaling pathways.  However, it is also possible that seemingly 
nonspecific translational control could in fact preferentially affect FMRP target mRNAs 
(Hay and Sonenberg, 2004).  For example, it has been suggested that since eIF4A is a 
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helicase, decreased formation of the eIF4F complex (as caused by FMRP inhibition of 
eIF4G expression) might preferentially inhibit translation of mRNAs with long and/or 
highly structured 5’UTRs, which tends to be the case for FMRP target mRNAs (personal 
communication, Chaolin Zhang). 
 
Summary 
Overall, FMRP clearly regulates coherent functional modules of genes with critical roles 
in neuronal function.  For example, FMRP regulates multiple mRNAs required for the 
expression of synaptic plasticity at many levels, including those encoding receptors, 
scaffolding proteins, signaling molecules and cytoskeletal modulators.  Interestingly, a 
general theme emerges from this analysis: that FMRP appears to target modulators rather 
than core effectors.  For example, FMRP targets metabotropic receptors and certain 
calcium-responsive or calcium-passaging channels but does not target most monovalent 
ionotropic channels such as AMPARs that actually mediate the bulk of depolarization.  
Additionally, FMRP targets a number of genes that regulate formation of the SNARE 
complex, but only weakly targets the core SNARE components themselves.  In a third 
example, FMRP targets several proteins that modulate actin polymerization or link actin 
filaments to receptors, but only weakly targets actin itself.  In a fourth example, FMRP 
strongly targets several PKA anchoring proteins, but does not target PKA.  Finally, 
FMRP strongly targets a large number of GAPs and GEFs but does not regulate the 
expression of small GTPases directly.  This suggests that a major role for FMRP is to 
regulate the expression of a diverse range of modulator proteins that control core features 
of neuronal function.  
 
Taken together, the data suggest a model in which FMRP regulates the translation of 
specific mRNAs by stalling ribosomes during elongation.  Ribosome stalling was acutely 
reversible in vitro, suggesting that regulation of FMRP activity in vivo may constitute a 
highly reactive means by which to adjust the expression of specific proteins important for 
neuronal function.  The HITS-CLIP data suggest that FMRP regulates hundreds, if not a 
few thousand, of mRNAs in this manner, and examination of the functional roles of 
FMRP targets makes it clear that much of FMRP’s functional biology remains 
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unexplored.  The newly developed cTAG mouse provides a valuable tool to perform 
focused studies of FMRP function in specific cells and circuits relevant to FXS 
phenotypes.  In particular, I plan to continue these studies by performing parallel cell 
autonomous HITS-CLIP and ribosome profiling assays in Purkinje neurons, with the goal 
of defining which mRNA targets of FMRP are most responsible for the defects in spine 
dysmorphogenesis, parallel fiber:PC mGluR-LTD and eyeblink conditioning observed 
when FMRP is specifically knocked out in these cells.  These studies will provide the 
first high-resolution view of FMRP function in a single cell type and will begin to paint a 
more detailed picture of how loss of FMRP results in complex neurological dysfunction. 
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